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Abbreviations 
 
 
6-OH-DA 6-Hydroxy-DopAmine 
α-MyHC alpha-MYosin Heavy Chain 
ANS  Autonomic Nervous System 
AP  Action Potential 
APD  Action Potential Duration 
ATP  Adenosine-1,4,5,-TriPhosphate 
AV  AtrioVentricular 
AVN  AtrioVentricular Node 
β-AR  beta-Adrenergic Receptor 
BBB  Bundle Branch Block 
BSA  Bovine Serum Albumin 
cAMP  Cyclic-Adenosine MonoPhosphate 
ChR2  ChannelRhodopsin-2 
CICR  Calcium-Induced Calcium Release 
CM  CardioMyocyte 
CTRL  Control 
Cy3  Cyanine-3 
Cx  ConneXin 
DAPI  4,6-DiAmidino-2-Phenyl-Indole 
DNA  DeoxyriboNucleid Acid 
DTT  DiThioTreitol 
ECC  Excitation Contraction Coupling 
ECG  ElectroCardioGram 
ENDO  subEndocardium 
EPI  subepicardium 
ERP  Effective Refractory Period 
FOXO3 Forkhead Box O3   
FRET  Föster Resonance Energy Transfer 
GAPDH GlycerAldehyde 3-Phosphate DeHydrogenase 
GFP  Green Fluorescent Protein 
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HR  Heart Rate 
HRP  HorseRadish Peroxidase 
ICD  Implantable Cardioverter Defibrillator 
IF  ImmunoFluorescence 
ISH  In Situ Hybridization 
IVS  InterVentricular Septum 
KO  Knock-Out 
Kv 4.2  Voltage-gated K+ channel 4.2 
LA  Left Atrium 
LAD  Left Anterior Descending coronary artery 
LBB  Left Bundle Branch 
LBBB  Left Bundle Branch Block 
LED  Light Emitting Diode 
LV  Left Ventricle 
MI  Myocardial Infarction 
MOPS  4-MorpholinePropane Sulfonic acid 
MuRF1 Muscle RingFinger protein 1 
NCX  Na+/Ca2+ eXchanger 
NE  NorEpinephrine 
NGF  Nerve Growth Factor 
NT-3  NeuroTrophin-3 
OCT  Optimal Cutting Temperature embedding matrix 
OPT  Optical Projection Tomography 
PBS  Phosphate Buffered Saline 
PCR  Polymerase Chain Reaction 
PF  Purkinje Fiber 
PFA  Para-Formaldehyde 
PKA  Protein Kinase A 
PLB  PhopshoLamBan 
PVDF  PolyVyniliDene Fluoride 
PVC  Premature Ventricular Complex 
RBB  Right Bundle Branch 
RBBB  Right Bundle Branch Block 
RFP  Red Fluorescent Protein 
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RNA  RiboNucleic Acid 
RT  Room Temperature 
RT-qPCR Real Time Quantitative Polymerase Chain Reaction 
RV  Right Ventricle 
RVOT  Right Ventricular Outflow Tract 
RyR2  Ryanodine Receptor 2 
SAN  SinoAtrial Node 
SCD  Sudden Cardiac Death 
SDS  Sodium Dodecyl Sulfate 
SEM  Standard Error Mean 
SER  SarcoEndoplasmic Reticulum 
SERCA Sarco-Endoplasmic Reticulum Calcium ATPase 
SN  Sympathetic Neuron 
SNS  Sympathetic Nervous System 
SR  Sarcoplasmic Reticulum 
TBS  Tris Buffered Saline 
TnC  Troponin-C 
TnI  Troponin-I 
TnT  Troponin-T 
TOH  TyrOsine Hydroxylase 
TTBS  Tween20-Tris Buffered Saline 
UPS  Ubiquitin Proteasome System 
VERP  Ventricular Effective Refractory Period 
VF  Ventricular Fibrillation 
VT  Ventricular Tachycardia 
WB  Western Blot 
WGA  Wheat Germ Agglutinin 
WT  Wild Type 
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Summary 
 
 
 
Rationale 
Cardiac sympathetic neurons (SNs) are the main physiologic regulators of heart 
activity during stress conditions, operating in the so called “fight or flight” response, which 
is mainly composed by an increase in heart rate (chronotropy) and an increase in contraction 
force (inotropy). The former is exerted by SNs innervating heart physiological pacemaker 
(sinoatrial node) and the latter by SNs innervating the working myocardium. At the level of 
the working myocardium, we have recently uncovered an additional novel role for SNs in 
modulating cardiomyocyte (CM) trophism. Indeed, we have demonstrated that SNs 
modulates CM proteolysis rate through the activation of β2-adrenoceptors and the 
downstream AKT/FOXO pathway, resulting in the repression of the two main muscle 
specific ubiquitin ligases: MuRF1 and Atrogin11. We described that SNs distribute inside 
the ventricular myocardium with a well-defined pattern. Moreover, data obtained in our 
laboratory from electron microscopy and immunofluorescence analysis provided structural 
suggestions of a direct contact between SNs and CMs: such as thickening of the CM 
membrane juxtaposed to the neuronal terminal, polarization of the neurotransmitter-
containing vesicles into SN terminal and a close distance between the membrane of SN 
terminal and the one of contacted CM, all features that resemble a sort of neuro-cardiac 
junction, similar to what is described in literature for the neuromuscular junction. This 
concept has been already proposed in literature, in descriptive studies although it has never 
been directly proved so far.  
 
Aims and scopes 
In this thesis I will investigate the characteristics of SN-CM interaction, to elucidate 
if the control of CM activity by SNs occur through a direct cell to cell interaction. I will 
study SN-CM interaction at the level of the working myocardium, to assess if SN innervation 
is able to modulate locally CM structural properties. Moreover, using an in vitro model of 
SNs and CMs coculture I will test the hypothesis of the direct interaction between SN and 
CM and I will evaluate the functional effects of this interaction, in vivo, at the level of the 
sinoatrial node, exploting the advantages of a novel optogenetic approach. To reach this aim, 
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I will implement cardiac optogenetics on CM, Purkinje fibers and SNs. Finally, I will inquire 
possible translational applications of cardiac optogenetics for clinically relevant situations.  
The understanding of the mechanism of SN-CM interaction is of great clinical relevance 
since cardiac innervation impairment has been associated to a growing amount of 
pathological situations, such as myocardial infarction, diabetes and different types of 
cardiomyopathies. 
 
Results 
Based on our recently published evidence that cardiac SNs provide trophic signal to 
CMs by constitutive repression of proteolysis (see Appendix), we aimed to define whether 
the distribution of SN throughout the myocardium could determine the appearance of local 
differences in CM size. We quantified the SN density inside the ventricular wall, and we 
observed that SNs are mainly concentrated in the outer part of the ventricular wall, which is 
called subepicardium (hereafter EPI), as compared to the inner part, which is called 
subendocardium (hereafter ENDO) in the mouse heart, while they had an inverse distribution 
in the heart of other mammals, such as rat, rabbit and also in the human heart. By 
morphometric analysis we observed a correlation between CM size and SN density, which 
showed that regions that are more innervated, present CMs with bigger size. We decided to 
analyze in better detail this correlation focusing on the mouse heart, given the well known 
advantages of this animal model in terms of genetic, pharmacology and handling, moreover, 
mouse heart seems to show the highest heterogeneity among the species analyzed. Cardiac 
sympathetic innervation occurs during the first three postnal weeks, and consistently our 
results showed that differences in EPI vs ENDO CM size establishes progressively along 
with the process of myocardium innervation, reaching the definitive pattern in the adult. On 
the contrary, mice denervated since birth never show heterogeneity in CM size from the 
neonatal life till the adulthood. We then demonstrated that SN modulation of CM size is not 
only established in the neonatal life but also maintained in the adulthood, since hearts mice 
denervated in the adulthood loss the CM heterogeneity. Moreover, the systemic continuous 
delivery of either an agonist (i.e. clenbuterol) or an antagonist (i.e. ICI 118,551) of the β2-
AR, resulted in the abolishment of CM heterogeneity. In these hearts SN patterning was 
unaltered, but consistently with our hypothesis, its regional control over CM size was by-
passed by the diffuse action of the drug. To assess if SN modulates one of the two major 
proteolitic systems i.e. the ubiquitin proteasome system (UPS) in CMs differentially 
throughout the myocardium, we evaluated the mRNA expression level of MuRF1 using in 
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situ hybridization (ISH) in control and denervated adult mouse hearts. In normal condition 
mRNA levels of MuRF1 are comparable between EPI and ENDO, but when we perturbed 
this equilibrium by the ablation of SNs we found that upregulation of MuRF1 is significantly 
more pronounced in the EPI region compared to the ENDO.  
Altogether, our results indicate that cardiac SNs, by exerting a regional modulation 
of CM proteolytic machinery, determine the physiological patterning of CM size into the 
myocardium. Moreover, these results points in the direction of a direct contact between SNs 
and CMs. The elucidation of the physiological mechanism implicated in the “SN-to-CM” 
signalling is of great relevance since impairment of this signalling has been implicated in 
several cardiovascular disorders and β-blockers represent the pharmacological tool widely 
used in such disease conditions.  
To test the functional implication of this direct contact in the intact heart, we 
implemented the technique of optogenetics to the heart cells. Optogenetics exploits the 
targeting of photoactivatable ion channels in specific cell types to achieve non-invasive 
control of membrane potential in excitable cells. Channelrhodopsin-2 (ChR2) is a microbial 
derived cation channel that undergoes a conformational change upon illumination resulting 
in the immediate increase in ionic permeability, with high conductance to Na+. We have 
generated transgenic lines of mice expressing ChR2 selectively in different excitable cells 
of the heart such as: CMs, conduction system cells and sympathetic neurons. First we set up 
the technique using the models in which ChR2 is expressed in the working and conducting 
CMs and we succeeded in inducing ectopies with high spatial and temporal resolution, 
arising from working or conducting CMs selectively. Exploiting the high versatility of 
optogenetics, that allowed us to finely shape the volume of illuminated tissue, and by 
developing a mathematical modelling of light penetration into the myocardium, we have 
been able to measure the minimal number of depolarized working CMs (≈1800) and 
PFs(≈160) needed to evoke an extrasystole. By using the same epicardial photostimulation 
assay, we successfully obtained ectopic beats arising from the AV bundle, the septal 
branches and the distal part of the PFs and measured, in vivo, the PF effective refractory 
period, an electrophysiological parameter that so far has only been estimated in ex vivo 
preparations. Cardiac optogenetics allowed us to identify a site, at the origin of right 
ventricular outflow tract, that is highly prone to develop arrhythmias during acute ischemia, 
probably because of the presence of an underlying complex arrangement of PFs that we 
described through a 3D reconstruction. In conclusion, we quantified the minimal number of 
cells needed to evoke an ectopic beat from working and conducting CMs in the intact heart; 
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we achieved the first characterization of PFs electrophysiology in vivo and defined their role 
in arrhythmogenesis during acute ischemia. All these results have been published in PNAS. 
After having set up cardiac optogenetic experiment in mice models expressing ChR2 
in working and conducting CMs, we then moved to the model in which ChR2 is expressed 
in cardiac SNs. To investigate in detail the functional implications of the direct interaction 
between SNs and CMs, we first used optogenetics in an in vitro model of SN-CM co-culture 
and performed real-time live imaging by the application of FRET-based biosensors to 
explore the effects of the SN-CM interaction at the subcellular level. We demonstrated that 
even a minimal activation of SNs (i.e. one action potential) is sufficient to stimulate cAMP 
pathway exclusively in the contacted CMs, while it exerts no effects on non-innervated CMs, 
providing evidence of a direct cell to cell interaction. Then we moved to the in vivo situation 
where we exploit optogenetics to stimulate SN processes directly at the level of sinoatrial 
node, in order to dissect the effect of SN activation on heart rate. Sinoatrial node is highly 
innervated by SNs, which are closely associated to pacemaker cells. Indeed, in vivo 
photostimulation experiments showed a short delay between light pulse and the onset of the 
next p wave (44±3 ms), which results in a fast increase in heart rate upon the start of 
photostimulation and a fast decrease after stopping the stimulation. Moreover, we found that 
stimulations can be repeated several times without apparent changes in the kinetics of the 
heart rate increase and that just 2 light pulses are sufficient to provoke a shorter sinus beat. 
In conclusion the photostimulation of SN projections, probed the kinetics of sympathetic 
heart rate control, which are characterized by a fast, repeatable and efficient mechanism and 
add a strong evidence in favor of the existence of a quasi-synaptic interaction between SNs 
and CMs. 
Finally, having demonstrated that optogenetics could be successfully applied to 
obtain cell type-specific control of the different cells composing the myocardium. We 
wanted to provide a proof-of-principle of the possibility to translate cardiac optogenetics 
from a scientific investigation tool to a potential therapeutic approach in the treatment of 
heart rhythm diseases. Indeed, the use of electronic devices for the treatment of arrhythmia 
had improved life expectancy and reduced mortality in different types of acquired and 
inherited cardiac diseases. Nevertheless, electric stimulation of heart tissue still has some 
disadvantages, especially in the longer period, deriving from the lack of specificity of this 
approach, the inherent damages produced by the electrical currents imposed to the 
myocardium and the physical contact between the electrodes and the tissue. The specific 
features of selectivity, non invasiveness and harmlessness of cardiac optogenetics, could 
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overcome the limits of the current technologies used for the control of heart rhythm. In detail, 
we demonstrated, in an in vivo mouse model, the feasibility of cardiac optogenetics in 
obtaining: prolonged cardiac pacing without functional nor structural damage, cardioversion 
from ventricular arrhythmias and recovery from atrioventricular block. 
 
Conclusions 
In conclusion during my PhD training I obtained the following results: I) Uncovered a novel 
role for sympathetic innervation of the heart in modulating the proteostasis of CMs; II) 
Demonstrated that SNs locally modulate CMs properties; III) Implemented cardiac 
optogenetics on CMs and PFs; IV) Proposed the first in vivo determination of the critical 
mass of working and conducting CMs needed to obtain an extrasystole; V) Characterized 
PF physiology in vivo with unprecedented detail and specificity; VI) Performed the first 
example of in vivo optogenetic stimulation of sympathetic efferents to the heart; VII) 
Demonstrated that fast, efficient and repeatable control of heart rate is achieved through a 
quasi-synaptic interaction between SNs and CMs; VIII) Provided a proof-of-principle study 
for the application of cardiac optogenetics in clinical relevant conditions, as an alternative 
to current therapies based on electrical stimulation of the heart 
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Riassunto 
 
Razionale 
I neuroni simpatici cardiaci (NS) sono i principali regolatori fisiologici dell’attività 
cardiaca in condizioni di stress, attuando la cosiddetta risposta “combatti o fuggi”, che è 
composta principalmente da un aumento della frequenza cardiaca (effetto cronotropo) e un 
aumento della forza di contrazione (effetto inotropo). Il primo effetto viene esercitato dai 
NS che innervano il pacemaker fisiologico del cuore (il nodo seno-atriale), e il secondo dai 
NS che innervano il miocardio di lavoro. A livello del miocardio di lavoro, il nostro gruppo 
ha scoperto di recente un ruolo aggiuntivo per i NS nella modulazione del trofismo dei 
cardiomiociti (CM). Abbiamo dimostrato che i NS modulano la proteolisi nei CM attraverso 
l'attivazione dei recettori beta2-adrenergici e la via di segnalazione AKT/FOXO, con 
conseguente repressione delle due principali ubiquitina ligasi muscolo specifiche: MuRF1 e 
atrogin-1. Inoltre, abbiamo osservato che i NS si distribuiscono all'interno del miocardio 
ventricolare con un profilo ben definito. Inoltre, dati ottenuti nel nostro laboratorio, 
provenienti da analisi di microscopia elettronica e immunofluorescenza, forniscono 
evidenze strutturali di un contatto diretto tra NS e CM quali: ispessimento della membrana 
del CM giustapposto al terminale neuronale, polarizzazione delle vescicole di 
neurotrasmettitore nel terminale del NS e la stretta distanza tra la membrana del terminale 
neuronale e quella del CM contattato, caratteristiche che suggeriscono una sorta di giunzione 
neuro-cardiaca, simile a quanto avviene nella giunzione neuromuscolare. Questo concetto è 
stato proposto in letteratura, in studi principalmente descrittivi, anche se mai dimostrato 
direttamente finora. 
 
Obiettivi e scopi della tesi 
In questa tesi intendo indagare l'interazione tra NS e CM, per chiarire se il controllo 
dell’attività dei CM operato dai NS avvenga attraverso un signalling locale. Studierò questa 
interazione a livello del miocardio di lavoro, per valutare se l’innervazione simpatica generi 
delle differenze regionali in termini di dimensioni dei CM. Inoltre, utilizzando un modello 
in vitro di co-coltura NS-CM testerò l’ipotesi di una interazione diretta tra NS e CM e 
valuterò l’effetto funzionale di questa interazione, in vivo, al livello del nodo senoatriale, 
sfruttando i vantaggi di un nuovo approccio optogenetico. Per raggiungere questo obiettivo, 
intendo implementare l’optogenetica cardiaca su CM, fibre di Purkinje e NS e fornire delle 
prove di principio per possibili applicazioni traslazionali di questa tecnica. 
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La comprensione del meccanismo di interazione NS-CM è di grande rilevanza clinica poiché 
uno squilibrio nell’innervazione cardiaca è stato associato ad una quantità crescente di 
situazioni patologiche, come l’infarto miocardico, il diabete e diversi tipi di cardiomiopatie. 
 
Risultati 
Sulla base della nostra recente pubblicazione in cui abbiamo dimostrato che i NS 
cardiaci forniscono un segnale trofico ai CM che va a reprimere la proteolisi (vedi 
Appendix), abbiamo voluto verificare se la distribuzione dei NS nel miocardio possa 
determinare delle differenze nella dimensione dei CM. Abbiamo scoperto che i NS sono 
principalmente concentrati nella parte esterna della parete ventricolare, definita subepicardio 
(di seguito EPI), rispetto alla parte interna, definita subendocardio (di seguito ENDO), nel 
cuore del topo, mentre hanno una distribuzione inversa nel cuore di altri mammiferi, come 
il ratto, il coniglio e nel cuore umano. Abbiamo osservato una correlazione tra le dimensioni 
dei CM e la densità dei NS. In particolare la regione più innervata (EPI per il topo ed ENDO 
per gli altri mammiferi analizzati), presenta CM con dimensioni maggiori, ed è interessante 
notare come questo sia vero anche per il cuore umano. Abbiamo deciso di analizzare più in 
dettaglio questa correlazione concentrandosi sul cuore del topo, dati i ben noti vantaggi di 
questo modello animale, in termini di genetica, farmacologia e manipolazione, inoltre, il 
cuore del topo sembra mostrare la massima eterogeneità tra le specie analizzate. 
L’innervazione simpatica cardiaca si verifica durante le prime tre settimane di vita postnatale, 
in accordo con questo, i nostri risultati hanno dimostrato che le differenze nelle dimensioni 
dei CM tra EPI ed ENDO si stabiliscono progressivamente con l’avanzare del processo di 
innervazione del miocardio, raggiungendo il compimento definitivo nell'adulto. Abbiamo in 
seguito dimostrato che la modulazione della dimensione dei CM da parte dei NS non solo si 
stabilisce nella vita neonatale, ma viene anche mantenuta nell’età adulta, dal momento che i 
cuori di topi adulti denervati con 6-OH-DA perdono l'eterogeneità dimensionale dei CM. Ad 
ulteriore sostegno di questi dati, il rilascio sistemico continuo sia di un agonista 
(clenbuterolo), che di un antagonista (ICI 118.551) del β2-AR, ha portato alla perdita della 
eterogeneità dimensionale dei CM. In questi cuori la distribuzione dei NS era inalterata, ma 
in coerenza con la nostra ipotesi, il controllo regionale sulla dimensione dei CM è stato by-
passato dall'azione diffusa del farmaco. Per valutare se i NS modulassero uno dei due 
principali sistemi proteolitici vale a dire il sistema ubiquitina proteasoma (UPS) nei CM in 
modo diverso all’interno del miocardio, abbiamo valutato il livello di espressione di MuRF1 
usando ibridazione in situ (ISH) in cuori di topi adulti di controllo e denervati. In condizioni 
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normali i livelli di mRNA di MuRF1 sono comparabili tra EPI e ENDO, ma quando abbiamo 
turbato questo equilibrio tramite l'ablazione dei NS abbiamo scoperto che l’espressione di 
MuRF1 è significativamente aumentata nella regione EPI rispetto a quella ENDO. 
Nel complesso, i nostri risultati indicano che i NS cardiaci, esercitando una 
modulazione regionale della proteolisi dei CM, determinano il pattern fisiologico di 
dimensione dei CM nel miocardio. Inoltre, questi risultati puntano nella direzione di un 
contatto diretto tra NS e CM. Chiarire il meccanismo fisiologico implicato nell’interazione 
NS-CM è di grande rilevanza in quanto difetti nel funzionamento del sistema nervoso 
simpatico cardiaco sono associati a numerosi disturbi cardiovascolari e i farmaci 
betabloccanti rappresentano lo strumento farmacologico ampiamente usato in tali condizioni 
di malattia.  
Per testare l'implicazione funzionale di questo contatto diretto nel cuore intatto, 
abbiamo sviluppato la tecnica dell'optogenetica applicata alle diverse cellule che 
compongono il miocardio. L’optogenetica sfrutta l’espressione di canali ionici fotoattivabili 
in tipi cellulari specifici per ottenere il controllo non invasivo del potenziale di membrana. 
Channelrhodopsin-2 (ChR2) è un canale cationico derivato da un microrganismo, che 
subisce un cambiamento conformazionale in seguito a illuminazione, con conseguente 
immediato aumento della permeabilità ionica con un’alta conduttanza per Na+. Abbiamo 
generato delle linee transgeniche di topi che esprimono ChR2 selettivamente nelle diverse 
cellule eccitabili del cuore quali: CM, cellule del sistema di conduzione, e neuroni simpatici. 
In primo luogo abbiamo settato la tecnica utilizzando i modelli in cui ChR2 si esprime nei 
CM di lavoro e del tessuto di conduzione e siamo riusciti a indurre extrasistoli con elevata 
risoluzione spaziale e temporale, derivanti da CM di lavoro e da CM di conduzione in modo 
selettivo. Sfruttando l'elevata versatilità dell’optogenetica, che ci ha permesso di modellare 
con precisione il volume del tessuto illuminato, e attraverso lo sviluppo di un modello 
matematico di penetrazione della luce nel miocardio, siamo stati in grado di misurare il 
numero minimo di cardiomiociti di lavoro depolarizzati (≈1800) e fibre di Purkinje (FP) 
(≈160) necessari per evocare un’extrasistole. Utilizzando lo stesso sistema di 
fotostimolazione epicardico, abbiamo ottenuto con successo battiti ectopici derivanti dal 
fascio AV, i rami settali e la parte distale delle FP e misurato, in vivo, il periodo refrattario 
effettivo delle FP, un parametro elettrofisiologico che finora era stato solo stimato in 
preparati ex vivo. L’optogenetica cardiaca ci ha permesso di identificare un sito, all'origine 
del tratto di efflusso del ventricolo di destra, molto incline a sviluppare aritmie durante 
ischemia acuta, a causa della presenza di un complesso reticolo sottostante di FP che 
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abbiamo descritto attraverso una ricostruzione 3D. In conclusione, abbiamo quantificato il 
numero minimo di CM di lavoro e conduttivi necessari per evocare un battito ectopico nel 
cuore intatto; abbiamo ottenuto la prima caratterizzazione dell’elettrofisiologia delle FP in 
vivo e definito il loro ruolo nella aritmogenesi durante l’ischemia acuta. Tutti questi risultati 
sono stati pubblicati in PNAS. 
Dopo aver settato l’esperimento di optogenetica cardiaca in modelli di topi che 
esprimono ChR2 nei CM di lavoro e di conduzione, ci siamo spostati al modello nel quale 
ChR2 è espresso nei NS cardiaci. Per indagare l’implicazione funzionale del contatto diretto 
tra NS e CM, abbiamo dapprima utilizzato l’optogenetica in un modello in vitro di co-colture 
NS-CM e eseguito esperimenti di live imaging utilizzando biosensori FRET per esplorare 
gli effetti dell’interazione NS-CM al livello subcellulare. Abbiamo dimostrato come anche 
una minima attivazione dei NS (e.g. un solo potenziale d’azione) sia sufficiente ad attivare 
la via di cAMP esclusivamente nei CM innervati, mentre non abbia alcun effetto su quelli 
non innervati, suggerendo l’esistenza di un contatto diretto tra NS e CM. Successivamente 
ci siamo spostati nel modello in vivo, nel quale abbiamo sfruttato l’optogenetica per 
stimolare le efferenze dei NS direttamente a livello del nodo senoatriale, per isolare l'effetto 
dell'attivazione dei NS sulla frequenza cardiaca. Il nodo senoatriale è altamente innervato 
dai NS, che sono strettamente associati alle cellule pacemaker. Infatti, esperimenti di 
fotostimolazione in vivo mostrato un breve ritardo tra impulso di luce e l'inizio della 
successiva onda P (44 ± 3 ms), che si traduce in un rapido aumento della frequenza cardiaca 
all'avvio delle fotostimolazione e una diminuzione rapida dopo l'arresto della stimolazione. 
Inoltre, abbiamo trovato che stimolazioni possono essere ripetute più volte senza 
cambiamenti apparenti nella cinetica di aumento della frequenza cardiaca e che solo 2 
impulsi di luce sono sufficienti a provocare un ritmo sinusale più veloce. In conclusione, la 
fotostimolazione dei processi dei NS, ha dimostrato che la cinetica del controllo della 
frequenza cardiaca attuata dal sistema nervoso simpatico, è caratterizzata da un meccanismo 
rapido, ripetibile ed efficiente e fornisce una forte evidenza a favore dell'esistenza di 
un'interazione quasi-sinaptica tra NS e CM. 
Abbiamo dimostrato che l’optogenetica può essere applicata con successo per 
ottenere il controllo del potenziale di membrana delle diverse cellule che compongono il 
miocardio. Con il presente studio vogliamo fornire una prova di principio della possibilità 
di traslare l’optogenetica cardiaca da uno strumento di indagine scientifica ad un potenziale 
trattamento terapeutico per le patologie del ritmo cardiaco. Infatti, l'uso di dispositivi 
elettronici per il trattamento delle aritmie ha migliorato la speranza di vita e ridotto la 
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mortalità in diversi tipi di malattie cardiache acquisite e ereditarie. Tuttavia, la stimolazione 
elettrica del tessuto cardiaco ha ancora alcuni inconvenienti, soprattutto nel lungo periodo, 
derivanti dalla mancanza di specificità di questo approccio, dai danni prodotti dalle correnti 
elettriche imposte al miocardio e dal contatto fisico tra gli elettrodi ed il tessuto. Le 
caratteristiche specifiche di selettività, non invasività e innocuità dell'optogenetica cardiaca, 
potrebbero superare i limiti delle attuali tecnologie utilizzate per il controllo del ritmo 
cardiaco. In particolare, abbiamo dimostrato, in un modello di topo in vivo, la fattibilità 
dell’uso dell’optogenetica cardiaca per ottenere: una prolungata stimolazione cardiaca senza 
danni funzionali e strutturali, la cardioversione da aritmie ventricolari e il recupero dal 
blocco atrioventricolare. 
 
Conclusioni 
In conclusione, durante il mio dottorato ho ottenuto i seguenti risultati: I) Scoperto un nuovo 
ruolo dell’innervazione simpatica del cuore nel modulare la proteostasi dei CM; II) 
Dimostrato che i NS modulano localmente le proprietà dei CM; III) Implementato 
l’optogenetica cardiaca in CM e FP; IV) Proposto la prima determinazione in vivo della 
massa critica di CM di lavoro e di conduzione necessaria per ottenere un’extrasistole; V) 
Caratterizzato la fisiologia delle FP in vivo con un dettaglio ed una specificità senza 
precedenti; VI) Eseguito il primo esempio di stimolazione optogenetica in vivo di efferenze 
simpatiche del cuore; VII) Dimostrato che un controllo rapido, efficiente e ripetibile della 
frequenza cardiaca è ottenuto attraverso una interazione quasi-sinaptica tra i NS e i CM; 
VIII) Fornito una prova di principio per l'applicazione dell'optogenetica cardiaca in 
condizioni cliniche, come alternativa alle attuali terapie basate su stimolazione elettrica del 
cuore. 
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Introduction 
 
The heart: structure and function  
 
Organ architecture 
The heart is the organ responsible for the flowing of blood in the organism, by 
pumping the blood from the lungs to the systemic circulatory system and from that back to 
the lungs. Thus delivering oxygen and nutrients to all the cells of the body. The mammalian 
heart can be viewed as two pumps working in series: the right (RA) and the left atria (LA), 
which collect the blood coming respectively from systemic circulation and pulmonary 
circulation, that pump blood into the ventricular cavities, and the right (RV) and left 
ventricles (LV) that pump blood into the pulmonary and systemic circulation, respectively. 
At the interface between the atria and ventricles there are the atrioventricular (AV) valves, 
which guarantee the unidirectional flow of blood from atria to the ventricles, named tricuspid 
valve for the right section and mitral valve for the left section. Moreover, with the same 
scope the semilunar valves are located at the interface between ventricles and their great 
artery. 
 (Figure I)  
 
 
Figure I: Anatomy of the heart. 
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All these four valves lie in a plane within a scaffold of connective tissue, which electrically 
insulates the atria from the ventricles. The AV bundle (also called His bundle), a strand of 
specialized ventricular myocardium, penetrates this barrier and provide the only electrically 
conducting pathway between the atria and the ventricles, forming the AV node in the atrial 
region2. The larger cusps of the mitral and tricuspid valves are bound to a fibrous structures 
called chordae tendinae that link the leaflet of the valves to particular regions of the 
myocardium, called papillary muscles, that projects from the right and left ventricular 
cavities3. The four chambers of the heart are different in shape and morphology: the atria 
have an almost rounded shape and similar morphology, while left and right ventricle are 
different in size and morphology and possess a thicker wall compared to the atria. In detail, 
the LV is considerably thicker than the RV, and it has a cavity, which resembles a cone with 
inflow from the mitral valve and outflow from the semilunar valve placed side-to-side in the 
wider end. RV instead has a crescent shape with blood entering through the tricuspid valve 
at one end and exiting through the semilunar valve at the other2. The portion of myocardium 
that lies between RV and LV is called interventricular septum (IVS). A fibrous sac called 
pericardium, encapsulates externally the heart and its inner surface is in contact with the 
epicardium, a layer of endothelial cells that lies just above the myocardium. A similar layer 
of connective cells called endocardium, instead, lines the cavity of atria and ventricles4. 
Blood supply to the heart is provided by large epicardial coronary arteries, the most 
important being: left main coronary artery, right coronary artery, left anterior descending 
(LAD), circumflex and posterior descending coronary artery; these large vessels then branch 
into smaller ones and penetrate into the myocardium to ensure a homogenous perfusion. 
 
 
Histology and cytoarchitecture of the myocardium 
The myocardium is composed by different cell populations including: 
cardiomyocytes (CMs), fibroblasts, endothelial cells, smooth muscle cells and neurons (see 
below). CMs are the cells responsible for heart contraction and although are only the 30% 
of the total number of heart cells, they represent most of the myocardial mass. CMs can be 
divided into two main populations: working CMs, responsible for the contractile activity and 
conducting CMs, specialized cells that lost their contractile apparatus and conduce the 
electrical impulse that initiate heart contraction.  
Working CMs can be subdivided into atrial, smaller in size, and ventricular CMs. 
Moreover, inside the ventricular walls three subtypes of ventricular CMs can be found, that 
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are distinguished for their different electrophysiological properties5-7. These cells are 
organized in the transmural direction into three juxtaposed layers, that differ for fiber 
orientation, that are called, going from the outer part to inner part: subepicardium (EPI), 
midmyocardium (MID) and subendocardium (ENDO). Recent studies in the murine heart, 
using the technique of “diffusion tensor cardiovascular magnetic resonance” (DTI), that 
exploits the anisotropy of water diffusion exerted by the molecular environment8,9, allowed 
to precisely define the CMs orientation in the different regions of the ventricles and showed 
that CMs in EPI and ENDO have their long axis aligned parallel to the base-apex direction, 
while CMs in MID have an orientation that progressively changes moving from the border 
zone with EPI to the one with ENDO10-14 (Fig. II). 
 
 
 
 
Conducting CMs are distributed as a network into the heart in order to achieve the 
coordinated activation of CMs that allow the sequential contraction of atria and ventricles. 
Conducting CMs can be divided into two subtypes of cells: Nodal cells, found in the 
sinoatrial node (SAN) and AV node, which are characterized by a small size and a slow 
electrical conduction and Purkinje fibers (PF), found in the AV bundle, right (RBB) and left 
bundle branch (LBB) and interspersed throughout the subendocardium, which in turn are 
bigger and show a rapid electrical conduction.  
  
Figure II: (a) 3D reconstruction of the myocardial fiber orientation in the ventricles of mouse heart, 
obtained with DTI (left panel). False color map indicating the angle formed by the intersection of the long 
axis of CMs and the transversal plane (right panel). (b)3D reconstruction of a ventricular myocardial 
section showing the complex cytoarchitecture of the tissue with highlighted the three regions composing the 
ventricular wall (Healy 2011, Sands 2008). 
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Ultrastructure of cardiomyocytes  
Working CMs have most of their cytoplasmic volume occupied by contractile 
proteins (≈50%), organized in myofibrils, the remaining volume is mainly occupied by 
mitochondria (≈35%) and by the other subcellular compartments. Contractile proteins are 
organized into fundamental units called sarcomeres. The sarcomere is composed of 
overlapping thick and thin filaments. The thick filaments are made of myosin polymers that 
interact with the thin filaments, made of double-stranded actin polymers, through the 
globular part of myosin thus generating the so-called "cross bridges". In addition to actin, 
the thin filaments are composed of other interacting proteins, namely tropomyosin and 
troponins. There are three different troponins: troponin I (TnI), troponin C (TnC) and 
troponin T (TnT), that form a complex attached to tropomyosin. Sarcomere shortening takes 
place by the interaction between actin and myosin. When Ca2+ binds to TnC, it induces a 
conformational change in the troponin complex proteins allowing the direct interaction 
between actin and myosin. TnI exposes a site on the actin molecule that binds the myosin 
ATPase located on the myosin head. Such event results in ATP hydrolysis that supplies 
energy for a conformational change to occur in the actomyosin complex: the actin and 
myosin filaments slide along each other, thereby shortening the sarcomere length and thus 
inducing cell contraction. The length of thick and thin filaments remains constant during the 
phases of contraction and relaxation, the shortening of the cell is solely due to the extent of 
overlap between the filaments15.   
 
 
 
Figure III: Structure of a cardiac myofiber (Grazia). 
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Plasma membrane of CM is called sarcolemma and it possesses particular 
invaginations called transverse tubules (t-tubules) that are in contact with extracellular space 
and are important for cell contraction as described below (Figure III).  
A specialized form of endoplasmic reticulum is present in muscle cells which is 
called sarcoplasmic reticulum (SR) or sarcoendoplasmic reticulum (SER) with the 
specialized function of regulation of cytosolic calcium Ca2+ concentration16. 
 
 
Excitation-contraction coupling 
In the heart the process whereby an action potential triggers the CM to contract is 
called Excitation-Contraction Coupling (ECC)17. CM contraction is triggered by an action 
potential (AP) that opens voltage-gated L-type Ca2+
 
channels located in the t-tubules. The 
resulting Ca2+ influx in the cytoplasm activates a much larger release of Ca2+ from the 
sarcoplasmic reticulum (SR), the intracellular Ca2+ store. The massive release of Ca2+ from 
SR is due to Ryanodine Receptor-2 Ca2+ channels (RyR-2) opening, these channels are 
located in the sarcoplasmic reticulum membrane and are very sensitive to changes in [Ca2+] 
in the cytosol18.  
 
 
 
 
When Ca2+ binds to the cytosolic part of RyR-2 this opens and creates a Ca2+ release as a 
Figure IV: Excitation contraction coupling model in the cardiomyocyte  
(Bers 2002). 
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passive flux along the concentration gradient, since the [Ca2+] in the SR is several order of 
magnitude larger than [Ca2+] in the cytosol, and is called calcium-induced-calcium-release 
(CICR)19.The elevated [Ca2+] in the cell is thus able to trigger sarcomere shortening. Then 
RyR-2 immediately closes and the cytosolic [Ca2+] is restored by the activity of 
sarcoendoplasmic reticulum calcium atp-ase pump (SERCA) that pumps it back into the SR. 
A minor part of cytosolic Ca2+ is extruded from the cell via the sodium-calcium exchanger 
(NCX) located in the sarcolemma and also a little amount is taken up by mitochondria 
(Fig.IV). When cytosolic [Ca2+] comes back to original levels, troponins complex rearrange, 
tropomyosin reattach to actin and contraction is terminated. 
 
 
Electrical conduction of the heart 
The myocardium is a functional syncytium, where CMs, although maintaining an 
individual identity, are tightly connected each other, mechanically and electrically, by 
specialized structures called intercalated disks20-23. The mechanical tethering is provided by 
fascia adherens, a region in which sarcomeric actin is linked to cytoskeletal one, and by 
desmosomes, structures where intermediate filaments of adjacent CMs are bound together24.  
The electrical connection between adjacent CMs is operated by gap junctions, 
nonselective channels that allows ions and small molecules to diffuse freely between cytosol 
of two connected CMs. These channels reduce internal electrical resistance thus creating a 
functional syncytium in which all CMs are electrically coupled25 21(Fig. V). 
 
 
 
Figure V: Complex arrangement of cardiomyocytes in the myocardium: 
structural and mechanical connections between them. 
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Gap junctions are constituted by a family of proteins called connexins (Cx), which 
are arranged in esamers at the sarcolemma to form a non selective channel24 (Fig. VI). In 
the heart many different isoforms of connexins are described, the most abundant being: 
connexin 43 (Cx43), connexin 40 (Cx40) and connexin 45 (Cx45). Gap junctions formed by 
the different isoforms of connexin present different permeability to ions and so conduce 
electrical impulse with different efficiency, and since gap junctions are the links between 
each single CM, this means that the speed of propagation of electrical stimulus is affected 
by the isoform of connexin present at the gap junction. Cx40 is the isoform that confers the 
highest speed of impulse propagation, then there is Cx43 and finally Cx45, which is the 
slowest26. Cx43 is the most abundant since it is expressed by all the working CMs and the 
distal Purkinje fibers, while Cx40 is expressed in atrial working CMs, in coexistence with 
Cx43, and in Purkinje fibers, and Cx45 is expressed almost exclusively in SAN and AV 
node, while a very low expression was also detected in PFs27-29. 
 
 
 
Every heartbeat is preceded by the spontaneous depolarization of sinoatrial node cells, 
raising an action potential that is spread, through the other cells of the conduction system of 
the heart, to all the working CMs. This wave of depolarization opens the voltage gated 
calcium channels in the sarcolemma of working CMs and starts the ECC, culminating in the 
systolic contraction. The cardiac action potential (AP) is the result of the ordered opening 
and closing of the several different ion channels present at the sarcolemma of working and 
conductive CM. AP characteristics are different between each cell type of the heart, and this 
Figure VI: Structure of the gap junctions formed by the connexins. 
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depends on the different array and expression level of the ion channels involved. Purkinje 
fiber AP can be divided into five phase: a rapid and large upstroke (phase 0), due to the 
inward INa current, a transient fast repolarization (phase 1), due to the outward Ikto current, a 
plateau (phase 2), due to the balance of different inward ICa and different outward Ik currents, 
a repolarization (phase 3), due to the closure of ICa and different Ik currents and a steady state 
when membrane potential is at its resting level (phase 4). The AP of ventricular CMs differs 
between each region of the ventricular wall, is similar in the morphology to the one of the 
Purkinje fibers in the midmyocardium, is shorter, with almost no phase 2 in the 
subepicardium (EPI) region and a little bit longer in the subendocardium (ENDO)30. The AP 
of sinoatrial node cells, instead, is more slowly rising, lack phase 1 and 2 and during phase 
4 exhibits gradual spontaneous depolarization (Fig. VII). 
 
 
 
 
SAN is the physiologic pacemaker of the heart and it is located in the RA. Every 
conductive cardiomyocyte possess an intrinsic capacity of spontaneous depolarization, 
which is called automaticity. Since SAN cells exhibits the fastest spontaneous depolarization 
rate among all conductive CMs, this structure usually takes the lead and initiate the 
depolarization wave that spreads throughout the heart. SAN cells, as described above, 
expresse the slowest isoform of connexin in order to allow a unidirectional propagation of 
Figure VII: AP characteristics of the different myocardial cells. 
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the depolarization wave to the surrounding atrial myocardium, which instead expresses Cx40 
and Cx43 and so propagate more rapidly the electrical stimulus.  
After been propagated to both atria the depolarization wave reaches the AV 
insulating region (see above) and can only propagate through the AV node, where it is 
slowed by the Cx45 expressing nodal cells. The delay that the depolarization wave 
encounters before passing to the ventricles is fundamental for the correct sequence of 
contraction of atria and ventricles. Once passed through the AV node the depolarization 
wave reaches AV bundle in the IVS where it divides into the right (RBB) and left bundle 
branches (LBB) that propagate the electrical impulse to the distal part of Purkinje fiber 
network that in turn are interspersed throughout the subendocardium and contacts the 
working ventricular CMs31 (Fig.VIII).  
 
 
 
 
Inside the ventricles, the depolarization wave propagates first throughout the Cx40-
expressing ventricular conduction system (AV bundle, bundle branches and Purkinje fibers) 
because of its faster conduction and then it propagates to the remaining working CMs. This 
allows the correct and simultaneous depolarization, and subsequent contraction, of the 
ventricles. After the depolarization process the action potential of each heart cell is ended by 
the action of a complex set of repolarizing currents, that restore the membrane potential at 
its baseline negative value2. 
The rhythmic depolarization of the heart, described above, precedes every heart beat 
and it is defined sinus rhythm. A depolarization wave that follows a different path than the 
Figure VII: Central conduction system of the 
heart (Cunningham 2002). 
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one described above generate a so called arrhythmic beat also known as ectopic beat or 
extrasystole, that becomes an arrhythmia if this aberrant depolarization wave is able to self 
renew and thus overcome the sinus rhythm. Generally, these arrhythmic beats are the result 
of the abnormal depolarization of a group of CMs. The myocardium is protected by these 
events by the source-sink mismatch, which is the intrinsic capacity of the electrically coupled 
myocardium (sink) to buffer an ectopic current arising from depolarization of a small group 
of CMs (source), by distributing it to all the other repolarized cells coupled. For this reason 
a depolarizing current to be able to propagate throughout the myocardium needs to be 
sufficiently higher to overcome this protective factor32,33. The minimal number of 
synchronously depolarizing CMs, sufficient to generate this propagating current is referred 
to as critical mass34. This depends on the type of CMs involved (working or conducting) and 
their location and it is an important parameter in the genesis of arrhythmia, although its 
calculation is difficult and so far it is only estimated using mathematical modeling35. 
Arrhythmias can be divided, based on their location, into supraventricular (arising from atria 
and nodal cells) and ventricular and, based on their effect on heart rate, into tachycardia 
(increasing heart rate) and bradycardia (decreasing heart rate) (Fig.IX). The most important 
in terms of epidemiology and severity of symptoms are tachycardia and, especially the ones 
with ventricular origin are the principal cause of death in many acquired and genetic cardiac 
disease36. 
 
  Figure IVIII: ECG traces of a mouse heart showing an 
example of sinus rhythm (a) and ventricular tachycardia (b). 
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The electrocardiography 
 
 
The electrocardiography is the technique that allows to record the electrical activity 
of the heart and is among the most useful diagnostic tests in clinical medicine, since it is 
routinely used to investigate disorders of the cardiac rhythm and detect heart diseases such 
as acquired or inherited cardiomyopathy among others. Electrocardiogram (ECG) is the trace 
that arises from the recording of heart electrical activity, in terms of voltage over time, 
through the use of electrodes placed on the skin. It provides information about the heart rate 
and also other important parameters of the electrical activity of the heart. The typical 
appearance of an ECG trace, is constituted by the cyclic repetition of specific deflections 
which represent the depolarization and repolarization of different heart regions. The first, in 
chronological order, is the so called “p wave” which is the manifestation of the current 
arising from the depolarization of the atria, then comes the “QRS complex”, which 
represents the depolarization of the ventricles and the interventricular septum and then at the 
end there is the “T wave”, which is the sign of the repolarization of the ventricles (Fig. X). 
Electrical currents arising from the depolarization or repolarization of other sites of the heart, 
SAN or AV node for example, cannot be recorded because of their little intensity, due to the 
small amount of cells involved. These typical deflections were first described for the human 
heart but this classification is applicable also to the ECG of different mammals, indeed the 
morphology of the principal deflections in the ECG is similar, although, mainly due to size 
differences, the amplitude of each deflection and the length of the intervals between them 
are very different, in particular in the case of rodent heart, the interval between the end of 
the QRS complex and the start of the T wave is so reduced that the T wave appears on top 
of the final part of the QRS (Fig.X). 
The amplitude of each deflection realizes the intensity of the underlying current, 
while the length realizes the conduction velocity. For example, defects in the conduction of 
the depolarization wave throughout the ventricular myocardium, as it happens for example 
after myocardial infarction when necrotic myocardium is substituted with an electrical inert 
fibrotic scar, result in the prolongation of the QRS complex. Wide QRS complexes are also 
feature of an ectopic arrhythmic beat arising from the ventricles. The longer duration of the 
QRS complex of an arrhythmic beat is explained by its origin, indeed, it arises from the focal 
depolarization of a small group of CMs, that generates a depolarizing wave that spreads 
throughout the ventricles, this event is slower than the physiologic depolarization of the 
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ventricles, which occurs due to the simultaneous activation of CMs in multiple sites of 
contact between the distal part of the Purkinje fibers network, and so it results in a wider 
QRS complex (Fig.IX). When the heart is in its sinus rhythm every p wave is followed by a 
QRS at a precise distance, reflecting the delaying filter of the AV node.  When AV node or 
AV bundle are impaired, the normal conduction from the atria to the ventricles is hampered 
and this phenomenon is called AV block. Based on the severity is classified into three types, 
I, II and III. The last is called also complete AV block, meaning that heart rhythm is no more 
controlled by the SAN and ventricular contractions depends on the automaticity of 
ventricular conduction system cells. In the ECG this condition is seen as p waves completely 
uncorrelated with QRS complexes, the latter being abnormally wide due to their ventricular 
origin.  
 
 
 
 
 
 
 
 
 
 
 
Figure X: (a) Comparison between the anatomy of human and rodent 
heart and (b) respective deflections seen in the ECG.  
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Innervation of the heart 
 
 
Anatomy of heart innervation 
The heart is densely innervated by autonomic nervous system (ANS), which 
comprises sympathetic (SNS) and parasympathetic nervous system, and at a lower extent 
also by sensory nervous system (Fig.XI). Parasympathetic and sympathetic branch of the 
ANS work in a reciprocal fashion to modulate heart activity by acting on heart rate 
(chronotropy) and conduction velocity (dromotropy) at the level of central conduction 
system. In addition, SNS modulates heart contractility, by acting on the force of contraction 
(inotropy) and relaxation (lusitropy) at the level of working myocardium37. Parasympathetic 
neurons are derived from cardiac neural crest cells which migrate into the developing heart 
and forms cardiac ganglia located in the base of the atria. From these ganglia postganglionic 
cardiac parasympathetic nerves extend to SAN, AV node, atria and heart's blood vessels, 
while the innervation of ventricular myocardium is limited. Parasympathetic neurons use 
mainly acetylcholine as neurotransmitter. Sensory neurons, located in the dorsal root ganglia, 
project their processes into the myocardium and are responsible for pain perception and 
initiation of feedback mechanism after myocardial injury.  
The developmental origin of sympathetic neurons (SNs) is from trunk neural crest 
cells that migrate and form sympathetic ganglia where they proliferate and differentiate into 
mature neurons. Postganglionic SNs that innervate the heart have nearly all of their cell 
bodies in the middle-cervical and stellate ganglia, with the superior cervical and the 4th to 
6th thoracic ganglia contributing to a little extent. From these ganglia SN extend their 
projections from the base of the heart throughout all the myocardium38-40 (Fig.XI). SN 
processes in the myocardium have a peculiar structure which is quite different from other 
peripheral neurons such as the motoneuron for example.  When reaching their targets SN 
terminals show the typical “pearl and necklace” morphology, with regular varicosities 
corresponding to the neurotransmitter releasing sites that contacts the target cell. Although 
SNs release a number of molecules (e.g. adenosine triphosphate, serotonin and histamine), 
the two main sympathetic neurotransmitters are norepinephrine (NE) and neuropeptide Y 
(NPY) that are stored in vesicles, abundant in the neuronal varicosities. Effects of SN 
activation on CMs involve mainly NE, with NPY that seems to have a minor impact in the 
short term while it seems to have a role, in the long term, in the regulation of CM ion currents, 
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through the modulation of ion channel expression41-43 although its functions are not 
completely elucidated.  
 
 
 
 
 
Sympathetic innervation pattern 
The myocardium starts to be innervated by sympathetic neurons in the early post-natal weeks 
and axonal sprouting is guided by the balance between chemoattractant neurotrophins (e.g. 
nerve growth factor, NGF) and chemorepellent factors (e.g. semaphorin-3a) released by the 
target cells of SN. SN axons penetrate into myocardium, following blood vessels, an 
intermediate target, that express the neurotrophin-3 (NT-3). The neurotrophins NGF and 
NT-3 signal through the same receptors: tropomyosin receptor kinase A (TrkA) and p75 
neurotrophin receptor (p75), to coordinate distinct stages of sympathetic neuron 
Figure XI: Anatomy of heart innervation (Kimura 2012). 
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development44. NT-3 derived from vascular smooth muscle cells activates TrkA on 
sympathetic axons, allowing axonal extension along the vasculature. As axons approach 
heart, and begin to acquire CMs-derived NGF, the ensuing retrograde NGF/TrkA signaling 
promotes survival, anabolic responses, and expression of p75. The increase in p75, in turn, 
diminishes axonal responsiveness of TrkA to NT-3, enabling NGF to become the dominant 
axonal growth factor and so to establish a stable contact between CM and SN.  
Chemorepellent factors, such as semaphorin-3A, instead interfere with neuronal 
process growth, causing their retraction, and inhibit the interaction of the neuron with the 
target cells43. In the mouse heart, it is described that in the embryonic stages semaphorin-3A 
is expressed homogeneously by CMs of the nascent ventricles, while during the postnatal 
development, instead, it was observed a gradual decrease in the expression of semaphorin-
3A that starts in the subepicardial CMs and progresses to subendocardial ones. It has been 
demonstrated, indeed, that mice lacking semaphorin-3A showed an hyperinnervation of the 
myocardium and an unbalance of the innervation pattern, while mice overexpressing 
semaphorin-3A showed an almost denervated myocardium and are subjected to increased 
mortality due to sudden cardiac death45.  
When the developmental process is completed, the balance between chemoattractant 
and chemorepellent factors generate a well defined pattern of innervation in the heart. In the 
murine heart this pattern is well described and shows a heterogeneous distribution among 
the four chambers. In detail, the highest density of nerve fibers is found in the atria, followed 
by the RV and LV, moreover inside the ventricular walls there is a decreasing gradient of 
SN density from the EPI region to the ENDO region. Regarding other mammalian species, 
although it is described a peculiar organization of the SN, the innervation pattern is not so 
well characterized. In the case of the human heart, regional differences in innervation have 
been reported, mainly based on observational EM studies, and similarly to the rodent heart, 
higher innervation density was observed in the atria compared to the ventricles, while on the 
contrary, no differences between the RV and LV have been reported. It has to be clarified, 
however, that these data come from post-mortem samples of patients undergone prolonged 
medical treatments that might alter the SN patterning and further ad hoc studies are needed 
to define the SN distribution in normal human hearts 43. 
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Modulation of cardiomyocyte activity by sympathetic neurons 
Cardiac SNs exert a positive effect on force (inotropy) and frequency (chronotropy) 
of heart contraction, by the release of NE and the consequent activation of β-adrenergic 
receptors (β-ARs) on CMs. β-ARs, are G protein-coupled receptor (GPCR) localized on the 
membrane of the CM. GPCRs contain seven transmembrane α-helices and a large cytosolic 
C-terminal loop. The ligand-binding sites include hydrophobic regions of α-helices, while 
the G proteins-binding sites include both transmembrane α-helices and the intracellular 
domain2,46,47. G proteins or heterotrimeric GTP-binding proteins, that mediate the response 
of these receptors, are composed of one member of each of three different protein families: 
Gα, Gβ and Gγ, organized as two separate units, one monomer of Gα and a dimer of  Gβ-
Gγ. Moreover, two types of Gα subunit are present in CMs: Gαs and GαI exerting different 
functions. CMs express two major β-AR subtypes: β1 and β2. Both are members of the 
GPCR family of proteins, but, although are activated by the same agonist, the selective 
stimulation of one subtype leads to different downstream responses. Indeed β1-ARs are 
coupled to Gαs stimulatory subunit only, and mediate the acute inotropic and chronotropic 
functional response while β2-AR seems to be coupled to Gαs, mediating regulatory 
responses that are weaker than those initiated by β1-ARs and Gαi, mediating counter-
regulatory responses and anti-apoptotic effects48,49. 
The increase in the force of contraction of CMs is exerted by SN at the level of 
working myocardium through the release of NE that interacts with β-ARs. This leads to a 
cascade of downstream events: first there is the activation of Gαs, which in turns activates 
adenylyl cyclase (AC), which is the enzyme responsible for the production of the second 
messenger cyclic-AMP (cAMP). cAMP activates its main effector, protein kinase A (PKA), 
that phosphorylates L-type Ca2+
 
channel and the RyR-2, enhancing the CICR and resulting 
in the increase of the cytoplasmic Ca2+ content. This increase leads finally to an augmented 
sarcomere contraction during systole. PKA activity is also essential in the control of Ca2+ 
reuptake in the SR during diastole, indeed, through the phosphorylation of phospholamban 
(PLB), a protein that positively modulates the activity of SERCA, PKA increase the speed 
of cytosolic Ca2+ clearance, thus resulting in shortening of Ca2+ transient (Fig.XII)50. This 
allows CMs also to be prone to an increase in the frequency of contraction.  
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The frequency of heart contraction, that is dictated by SAN depolarization, is 
positively modulated by SNs innervating SAN cells. SAN is the physiological pacemaker of 
the heart and SAN cells spontaneously depolarize through the activation of a number of 
different ion channels. The depolarization of these cells starts with the opening of non 
specific cation channels called hyperpolarization activated cyclic-nucleotide gated channels 
(HCN), which open when the membrane potential is below a specific negative value and 
carry an inward depolarizing current called If, then the L type Ca2+ channels open and 
contribute to depolarize the cell. Moreover, the Ca2+ entered in the cytosol is extruded by 
NCX that, by exchanging each Ca2+ with 3 molecules of Na+, generate an additional inward 
current. The repolarization, instead, is ensured by two potassium channels, which carry Ik 
and Ik,Ach currents. Ik,Ach is modulated by parasympathetic nervous, while Ik is controlled by 
SNS. 
Figure XII: Sympathetic nervous system positive modulation of 
CM contraction force (inotropy) (Opie 2004). 
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SNs innervating the SAN, accelerates its depolarization rate through the release of 
NE and activation of β-ARs in nodal cells. This leads to the increase of cAMP through the 
Gαs/AC pathway that is able directly to positively modulate HCN opening and thus increase 
If . Moreover, cAMP mediated activation of PKA results in the phosphorylation of L type 
Ca2+ channels and Ik channels, which increase depolarization and repolarization currents 
respectively, leading to the shortening of nodal cell action potential duration. This effects 
ultimately result in the increase of depolarization frequency of SAN that determines an 
increase in heart rate (Fig.XIII). 
The activation of the autonomic nervous system (both sympathetic and 
parasympathetic branches) generates changes in heart rate, that are seen in the ECG as 
variations in the distance between two consecutive QRS complexes, a phenomenon which 
is defined heart rate variability (HRV). The measure of HRV offers the possibility to 
quantify the amount of activation of the autonomic nervous system in a specific situation. 
Another important extrinsic modulator of heart activity is constituted by the release 
of catecholamines from the adrenal glands into the circulatory system, which reach the heart 
and activate β-ARs of CMs exerting a positive inotropic and chronotropic effect. This is the 
result of an endocrine signaling, which simultaneously targets various organs eliciting a 
systemic response in cases of elevated stress. SN modulation of heart activity, instead, is 
highly selective and is able to finely tune heart function with gradual responses to different 
stress conditions and also to physiological situations such as postural changes or exercise.   
Figure XIII: Sympathetic nervous system positive modulation of heart frequency at the level of sinoatrial 
node (chronotropy). 
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The cardiac sympathetic nervous system plays a key role in the 
regulation of the myocardial mass 
 
 
The protein degradation systems 
The myocardium is traditionally defined as a post mitotic tissue, CMs, indeed, stop 
to divide few days after birth. Nevertheless, myocardium is a dynamic tissue that needs to 
adapt to intrinsic and extrinsic stresses. Thus to ensure the integrity and the viability of CMs, 
protein quality control needs to be tightly regulated to ensure the correct turnover of proteins. 
This is regulated through the synthesis of new proteins and the degradation of damaged or 
misfolded ones. Removal of damaged, misfolded/unfolded proteins, is operated by two main 
systems: the Ubiquitin Proteasome System (UPS) and the Autophagy-Lysosome System 
(ALS) (Fig.XIV). 
The UPS is responsible for the degradation of almost 90% of the sarcomeric proteins, 
thus ensuring the removal of misfolded or damaged proteins51. UPS degrades single proteins 
that are marked for degradation with a specific signal in a highly controlled manner 52 
(Fig.XIV). UPS is made of two functional units: a targeting unit and a degradation unit. The 
first is composed of 3 families of enzymes called E1, E2 and E3 that mediate the recognition 
of proteins to be degraded and their targeting to the second unit, the proteasome, which 
performs the degradation of the proteins into their constituents. The proteins to be degraded 
are labeled by the addition of a small protein, called ubiquitin, in the form of polymeric 
chains. These chains are assembled on the substrate by a cascade of enzymes, which starts 
with the activation of ubiquitin by the binding of it to the first enzyme which is called E1, 
or activator, and then continues with the formation of the polyubiqutin chain by the action 
of E2 conjugator enzyme. Finally, E3 enzyme, also called ubiquitin ligase, mediates the 
transfer of the polyubiquitin chain formed to a lysine residue of the substrate54,55. With only 
few exceptions, this lysine residue is constant for all proteins to be degraded and it is the 
lysine 48. E1 and E2 family of enzymes are composed of only a few number of members, 
while almost 650 types of E3 ubiquitin ligases are found so far in the human genome, and 
this occur because E3 is the enzyme which confers the specificity to the system, each E3 
selectively targets only a small number of proteins56. The screening of gene expression in 
different models of atrophy in skeletal muscle, lead to identification of a common group of 
genes which are overexpressed in all the different models and so these were called atrogenes. 
 
 
 40 
Among these genes two of the main upregulated and represented are two ubiquitin ligases, 
which are also muscle specific: atrogin-1 and MuRF157,58.   
Atrogin-1, also known as MAFbx (muscle atrophy F-box), was also found in cardiac 
muscle, which appeared to be a key regulator of myocardial remodeling59,60. Recent studies 
have shown that high levels of atrogin-1 suppress the hypertrophy of CMs induced by 
adrenergic stimulation and increased pressure load, respectively, in vitro and in vivo. 
Atrogin-1 prevent CM hypertrophy by regulating the degradation of calcineurin, a calcium-
activated phosphatase that well described as involved in pathological hypertrophy61-63.  
 
 
 
 
MuRF1 (muscle-specific RING finger 1), is present at the level of skeletal and 
cardiac muscle64-66. Its involvement in cardiac atrophy was demonstrated in different studies: 
its overexpression was found in isolated cardiac tissues from patients that underwent 
implantation of a left ventricular assist device, a condition associated to myocardial 
atrophy67; is up-regulated also in heart failure68 and in an animal model of induced atrophy 
with administration of dexamethasone67,69. The molecular targets of MuRF1 in the CMs are 
Figure XIV: Protein degradation systems: Autophagy Lysosome System (ALS) and 
Ubiquitin Proteasome System (UPS). 
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sarcomeric proteins, such as for example cardiac troponin I (cTnI)70 or myosin heavy chain 
(MyHC)69. 
The other main system for protein degradation is ALS (Fig.XIV). ALS is a highly 
conserved process, mediating the degradation of complex cytoplasmic structures such as 
protein aggregates and organelles. There are various types of autophagy that differ in their 
mechanisms of action and functions75,76: the chaperone-mediated autophagy, which is 
characterized by the selective degradation of cytosolic proteins which expresses a particular 
aminoacidic domain77; the microautophagy, which is an aspecific mechanism of direct 
uptake of cytosolic components into the lysosome membrane through invagination78; and 
the macroautophagy, hereafter called just autophagy, the most important one, which  is 
characterized by the formation of a compartment delimited by a double membrane, named 
autophagosome, engulfing the cytoplasmic material and delivering it to the lysosome where 
this material is finally degraded79. Among the player of ALS the most known are LC3 and 
p62, which are used as universal markers of ALS activation. At the beginning of autophagic 
process there is the binding of cytoplasmic form of LC3 (LC3 I) to a phospholipid creating 
its lapidated form (LC3 II) that participates in the formation of the autophagosome, so the 
amount of LC3 II can be used as marker of autophagy activation80.  p62 is instead involved 
in the recognition of targets to be degrade and delivery of them to the nascent 
autophagosome81. p62 is retained into the autophagosome and then degraded into the 
lysosome, so its decrease is used as a marker of autophagy activation.   
UPS and ALS have been considered for a long time two completely independent 
mechanisms, but in a study that we recently published in JCI we provided some evidence of 
a role of atrogin-1 in the modulation of UPS and ALS cross-talk82 (see Appendix). In detail 
we described that the loss of atrogin-1, directly causes an impairment in the ALS due to the 
defective elimination of one of its previously unknown target: CHMP2B (Charged 
Multivesicular Body protein 2B), a member of the ESCRTIII family of proteins which are 
involved in the last stages of ALS.  Moreover, in literature there are evidence a block of 
autophagy results in increased levels of ubiquitinated proteins82,83. UPS and ALS 
impairments are associated to various pathologies, such as neurodegenerative diseases and 
cancer71-74 and recently also to some cardiovascular diseases, such as hypertrophic 
cardiomyopathy and heart failure 53. 
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Protein synthesis and degradation: central role of Akt pathway 
Among the molecular mechanisms involved in the regulation of the synthesis of new 
proteins, the signaling pathway PI3K/Akt is among the most important in controlling cell 
size. The protein kinase Akt, also known as protein kinase B (PKB), belongs to the family 
of serine/threonine kinases84. Akt is the mediator of a large amount of anabolic and catabolic 
stimuli, activating the synthesis of new proteins, blocking at the same time the proteolysis 
of existing ones. Akt is also responsible for the phosphorylation and activation of mTOR 
(mammalian Target Of Rapamycin)85, another serine/threonine kinase, which has been 
proven to have a crucial role in the integration of a large number of hypertrophic stimuli, 
from simple nutritional stimulation to the activation of protein growth factors, which lead to 
protein synthesis86. Both Akt and mTOR phosphorylation levels were demonstrated to be 
increased in muscle hypertrophy87. It was demonstrated, mainly in skeletal muscle, that Akt 
regulates transcription factors belonging to the family of FOXO (Forkhead box O). In 
particular, the phosphorylation of FOXO3 mediated by Akt exerts a negative modulation of 
its function, indeed is able to block its nuclear translocation. On the contrary, a reduced 
activity of Akt, and so a reduced phosphorylation of FOXO3, promotes its nuclear 
translocation and consequently leads to increased transcription of a set of genes expressing 
protein mediators of proteolysis, for example in the case of skeletal muscle the E3 ubiquitin-
ligases Atrogin-1 and MuRF1, leading to atrophy88. 
 
The balance between protein degradation and protein synthesis: the proteostasis 
Although myocardium is a post mitotic tissue, it possesses a high plasticity and can 
adapt its mass in response to mechanical, metabolic and neurohormonal stimuli only through 
the modulation of CM size. CM size is the result of the balance between protein synthesis 
and protein degradation, which is called proteostasis89. The unbalance in proteostasis, as in 
the case where protein synthesis prevails on degradation, leads to myocardial hypertrophy, 
while, if protein degradation is increased and protein synthesis is decreased leads to 
myocardial atrophy.  
Cardiac hypertrophy occurs in physiologic conditions, such as post-natal growth, 
pregnancy and exercise, where it mediates the needs for higher perfusional demands and it 
results in a more powerful and efficient heart activity, so it is defined as adaptive 
hypertrophy. On the other hand, hypertrophy can occur also in response to pathological 
stimuli, such as pressure overload due to hypertension, overactivation of SNS as in the case 
of heart failure and some type of familial cardiomyopathies associated to the accumulation 
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of misfolded proteins. This hypertrophic remodeling, initiated to reduce myocardial stress, 
then leads to an abnormal increase in heart size, reprogramming of CMs to an embryonic 
gene program and ultimately leading to decreased cardiac activity90-92; for this reason, is 
defined as maladaptive hypertrophy. 
Cardiac atrophy, instead, can be induced by a great variety of stimuli, such as a 
reduced hemodynamic load, nutrient deprivation and cancer cachexia. Conditions in which 
CMs optimize energy expenditure by degrading or recycling sarcomeric components, thus 
leading to a decrease in CM size. Recent studies have shown a complex scenario, in which 
the two catabolic pathways (UPS and ALS) modulate each other and are often 
interconnected at various levels82. 
 
Novel role for sympathetic innervation of working myocardium in the regulation of 
cardiomyocyte proteostasis 
In the heart adrenergic stimulation has a well described role in the post-natal 
hypertrophic growth45,93, acting through the stimulation of α-ARs in CMs, while in the adult 
heart its role is not completely elucidated. There are evidence in literature, that hyper-
innervated hearts are hypertrophic and animals chronically treated with β-blockers develop 
myocardial atrophy94,95, moreover, in the case of the neuromuscular junction (NMJ), it is 
already described that the adrenergic innervation of the muscle fiber is essential for the 
regulation of its trophism, through a β2-AR signaling pathway96. These data suggest that a 
role of the adrenergic signaling in the modulation of myocardial mass is plausible and in 
favor of this hypothesis, we recently published a study1 (see Appendix) in which we 
demonstrate that SNs modulate CM trophism by acting through the regulation of proteostasis.  
In this work we used an experimental model of cardiac SN ablation in normal adult mice, 
obtained by the administration of 6-hydroxy-dopamine (6-OH-DA), an analogue of 
dopamine, that once internalized by neurons through its transporter causes 
neurodegeneration due to the production of reactive oxygen species, without affecting CMs. 
Adrenergic denervation of the heart resulted in an atrophic remodeling, with a reduction in 
the heart weight normalized to body weight (HW/BW) of 8% and 14% at 8 and 30 days after 
the denervation, respectively. This reduction was not due to the loss of the CMs, since no 
signs of CM death were detected, it was instead due to a reduction in the CM size. Moreover, 
we demonstrated that this denervation induced atrophy was the result of two parallel 
processes: i) the activation of the protein degradation systems, as demonstrated by the up-
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regulation of the ubiquitin ligases MuRF1 and atrogin-1 and ii) the reduction of protein 
synthesis, as shown by the reduction of activated form of AKT and of its substrate S6. The 
key role of MuRF1, in particular, was confirmed by the fact that MuRF1 knock-out are 
protected from denervation induced atrophy. In vitro analysis on primary cultures of CMs 
shown that NE modulates the levels of ubiquitin ligases via β2-AR, moreover, we observed 
that denervated mice treated with the β2-AR specific agonist clenbuterol, were protected 
from atrophy after ablation of cardiac SN and that β2-AR knock-out mice had atrophic hearts 
compared to age and sex matched controls.  
Using various experimental approaches, pharmacological, molecular and 
biochemical as well as several experimental animal models, it has been shown that the SNS 
in addition to having a role in the regulation of cardiac activity under stress conditions, it is 
also essential for the determination of the correct cardiac mass.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure IXV: Molecular pathway through 
which SNs regulate CM size. 
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Optogenetics 
 
 
Exciting cells with light: first approaches 
The idea of stimulating excitable cells with light dates back to the early years of 21st 
century, with seminal works on "caged" neurotransmitters, which consisted in the delivery 
to the neurons of neurotransmitters bound to inactivating molecules, that upon illumination 
changed conformation and restored the functionality of neurotransmitter97,98. This approach 
had some drawbacks, such as the lack of specificity, in fact, this depend on the type of 
neurotransmitter used that does not allow the specific activation of only a certain type of 
neuron. Moreover, the spatial control of activation required a stationary substrate and this 
maked almost impossible to use it for in vivo studies. These problems were circumvented by 
the pioneering studies of Miesenböck’s group99 in 2005 who inserted the gene of an ATP-
gated cation channel from the rat into the genome of Drosophila, in which the channel did 
not exist, and engineered the system so that this was expressed only in specific neurons of 
the fly. Then was given to the fly a "caged ATP", which works in the same way of caged 
neurotransmitters. In this way the researchers succeeded in controlling membrane potential 
of specific classes of neurons in the fly, in vivo, with just the delivery of a flash of light.  
 
 
ChannelRhodopsin: a new member of the rhodopsin family  
Rhodopsins, are a family of proteins that can be found from prokaryotes, where they 
are involved in ionic homeostasis, to monocellular algae where they control the flagellar 
movement and thus phototaxis, till animal cells, like retina cells, where they are implicated 
in the process of vision. All these proteins have in common that they are light-activated and 
once active they are able to change the membrane potential of the cell100.  
Channelrhodopsin-2 (ChR2) is a new member of the rhodopsin family of proteins, 
discovered by Nagel and Hegemann’s group in 2002, in the green alga Chlamydomonas101. 
ChR2 is a light-gated cation channel, sensitive to 470 nm light, composed of seven trans-
membrane helices that form the ion channel and a long C-terminal extension of unknown 
function, which is omitted in the recombinant form of ChR2. The light-absorbing 
chromophore retinal, a vitamin A derivative, is buried within the hydrophobic center of the 
seven helices (Fig.XV). Light absorption by retinal leads to isomerization, followed by a 
protein conformational change and opening of the ion pore101,102. It was immediately clear, 
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when these proteins were discovered, that their structural simplicity, with light sensor 
element and actuator channel linked and transcribed by a single gene, and their fast kinetic 
could turn them into a useful biotechnological tool. 
 
 
 
 
Optogenetics: a new field of study rises 
At the same time of Miesenböck experiments, the group of Carl Deisseroth in 
Stanford103, decided to express ChR2, which was recently discovered by Nagel's group, in 
specific neurons of the mouse brain, in order to control the membrane potential of these cells 
with the simple delivery of flashes of light. This approach simplified a lot the system, since 
once the channel has been inserted into the genome of the cell of interest, then no more 
molecules are to be added, a part from the co-factor retinal which is already present in many 
tissue. Moreover, by exploiting genetic tools for tissue-specific expression, such as the Cre-
Lox system, expression of the channel only in a specific type of neurons inside a complex 
tissue such as the brain can be achieved.  
To describe these experiments later was coined the term: "optogenetics", which 
combines the two aspects of this technique: the use of photo-activated channel to depolarize 
a cell and the selective exogenous expression of this channel in a specific cell type of 
interest104. The innovative aspects of this technique, compared with the conventional 
electrophysiological methods, based on electrical stimulation, are the specificity of the 
stimulation, its non-invasiveness and its spatial-temporal accuracy. The specificity is 
particularly important when a stimulation of only a desired marker-expressing neuron is 
needed, in a complex tissue with a lot of other cells intermingled, such as the brain. This 
Figure XVI: ChannelRhodopsin-2 (ChR2) is a light 
gated cation channel (Nagel 2013). 
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made possible to study the functionality of peculiar regions of the brain or even the single 
neural circuit, without affecting the others105.  
Moreover, the possibility to stimulate such cells multiple times and for a long period, 
without perturbing or damaging them, is an incredible advancement for electrophysiological 
studies in neuroscience. Later the optogenetic toolbox expanded with the exploitation of 
different rhodopsins, such as Halorhodopsin 106which is a chloride channel that upon 
illumination iperpolarize the cell and offered the possibility to “switch off” single neurons 
or entire neural circuits (Fig.XVI). 
 
 
 
Cardiac optogenetics 
Some years after the birth of optogenetics and its application to the neuroscience field, 
the pioneering studies of Bruegmann et al.107 and Arrenberg et al.108 demonstrated that this 
technique could be applied also for the study of heart electrophysiology. In particular, 
Arrenberg and colleagues managed to express halorhodopsin and ChR2 in zebrafish CMs 
and with the light sheet microscopy technology succeeded in controlling the heart rate of the 
animal in vivo, evoking episodes of tachycardia, bradycardia and also cardiac arrest108. 
Bruegmann and colleagues, instead, generated a stable mouse embryonic stem cell line 
(ESC) expressing ChR2 under the constitutive synthetic promoter CAG and, after having 
characterized the cells in vitro, they generate from them a transgenic mouse107. With the use 
of light emitted from the objective of a confocal microscope, they were able to influence 
heart rhythm by evoking ectopic heart beats in vivo.  
Despite these firsts proof of principle studies opened various fascinating perspectives, 
advancements in the new field of cardiac optogenetics lagged behind the following years, 
Figure XVII: Advantages of optogenetics compared to electrical stimulation (Deisseroth 2011). 
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with only sparse studies involving especially in vitro models or computational approaches109-
111. In particular, the group of Entcheva demonstrated in vitro the feasibility of obtaining 
optogenetic stimulation of CMs, through the delivery of non-excitable cells, expressing 
ChR2, that are capable of forming electrical coupling with CMs and conferring to them the 
ability to be light stimulated112. Other in vitro studies tried different approaches to obtain 
ChR2 expression in CMs, using electroporation to express ChR2 in atrial cell line HL-1113 
or lentiviral infection of human ESC that are then differentiated into CMs114. Bingen and 
colleagues used the same approach of lentiviral transduction of ChR2 in isolated neonatal 
atrial CMs, and used optogenetics to study, in a monolayer of CMs, the possible mechanisms 
to obtain light-driven termination of spiral wave arrhythmia, responsible for atrial fibrillation 
in the intact heart115. Moreover, Boyle and colleagues in 2013 provided a computational 
simulation of cardiac optogenetics, that took into account opsin channel kinetics, delivery 
mode and spatial distribution of light sensitive cells inside the heart, to study how these 
variables can be modulated to obtain low energy optical defibrilaltion of the heart116. Beyond 
the use in membrane potential modulation, some studies showed that optogenetics can be 
used to investigate, with unprecedented detail, intracellular signaling in CMs117,118. Beiert 
and colleagues, for example, demonstrated that G proteins signaling can be optically 
modulated in CMs, in detail they used melanopsin, a light sensitive G protein-coupled 
receptor, to modulate intracellular Ca2+ in HL-1 cells and ES-derived CMs119. 
In this thesis are presented the results of a study, published in Proceedings of the 
National Academy of Science (PNAS) by our group, that showed the set up and 
characterization of a cardiac optogenetic experiment in the in vivo animal model and 
exploited this to investigate the tissue requirements for the development of ectopic beats in 
the normal heart and the electrophysiology of Purkinje fibers and their involvement in the 
generation of life-threatening ventricular arrhythmia in the ischemic heart120. 
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Results 
 
 
The results section of this thesis is composed of four research articles, organized in 
introduction, results, discussion and material and methods sections, figure panels are at the 
endo of the discussion section: 
 
 
 
- Sympathetic innervation locally modulates cardiomyocyte 
proteolysis inside the working myocardium 
 
 
- Optogenetic determination of the myocardial requirements for 
extrasystoles by cell type-specific targeting of ChannelRhodopsin-2 
(PNAS (2015) Aug 11;112(32):E4495-504) 
 
 
- Optogenetic interrogation of cardiac sympathetic neurons shed light 
on the “neuro-cardiac junction” 
 
 
- Cardiac optogenetics as an alternative to electrical pacemaking and 
cardioversion: insights from an in vivo animal model  
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Sympathetic innervation locally modulates cardiomyocyte 
proteolysis inside the working myocardium  
(manuscript in preparation) 
 
Collaborators: Valentina Prando, Mauro Franzoso, Anna Di Bona, Marina Campione, 
Marco Sandri, Tania Zaglia and Marco Mongillo 
 
 
 
ABSTRACT  
 
Purpose: The myocardium is highly innervated by Sympathetic Neurons (SNs), that 
distribute within the tissue with a well-defined pattern. We have previously shown that 
neuronal input to cardiomyocytes (CMs) represses proteolysis and activates protein 
synthesis, through the β2-AR dependent signaling. We here test the hypothesis that SNs 
perform a local modulation on CM size, acting through differential modulation of proteolysis. 
Results: In the mouse heart, SNs are predominantly found in the outer myocardial cell layers, 
and, consistently, CMs in the outer layers (EPI) are significantly larger than the similarly 
oriented ones in the innermost (ENDO) layers (SNs/CM: EPI 0.45±0.06 vs ENDO 
0.15±0.02; CM volume: EPI 8590±2121 vs ENDO 4697±1433, in µm3). Such differences 
disappear upon SN ablation in the adult mouse, and never establish when SNs are ablated 
before the postnatal period in which sympathetic innervation of myocardium occurs (P3 to 
P21). Furthermore, systemic delivery of a β2-AR agonist, or antagonist, which diffuse 
throughout the myocardium resulting in hypertrophic and atrophic remodeling respectively, 
abolishes CM heterogeneity, suggesting that SNs act with a limited spatial range on 
neighboring CMs. In support of this we demonstrated, by ISH and RT-qPCR, that CM size 
heterogeneity is the result of local control on proteolysis operated by SNs. This concept 
holds true regardless of the innervation pattern as in the heart of other mammals, including 
humans, characterized by different SN distribution, CM size follows neuronal density. 
Conclusion: This is the first evidence, to the best of our knowledge, of an otherwise 
homogeneous tissue, shaped, after development, by a superimposed innervation network, 
through the modulation of cellular protein turnover. 
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INTRODUCTION 
 
The mammalian ventricular myocardium is a highly heterogeneous tissue, with 
transmural differences in cytoarchitecture and electrophysiology of cardiomyocytes (CMs). 
Based on these different properties, two regions can be defined across the ventricular wall: 
an outer region of CMs that is called subepicardium (EPI) and an inner region, which is 
called subendocardium (ENDO)5,7,121. Between these two regions a third type of CMs can 
be defined, the so-called “M cells”, whose identity and function is still debated122-124. 
Moreover, the level of complexity inside the ventricular wall is increased by the presence of 
sympathetic nervous system (SNS) innervation. SNS is the principal regulator of heart 
activity during stress conditions, and in particular at the level of the working myocardium 
modulates the contraction force of CMs43.  
Our group recently uncovered a novel role for cardiac SNs, in the modulation of CMs 
proteostasis. Indeed, we demonstrated that a constitutive sympathetic stimulus is required to 
maintain the correct CM size by modulating the balance between protein synthesis and 
protein degradation, through β2-adrenoceptor (β2-AR) activation and AKT dependent 
phosphorylation of FOXO3 transcription factor, that lead to down-regulation of ubiquitin 
proteasome system (UPS) activity1. 
The SNS abundantly innervates the working myocardium with a well-defined pattern 
inside the ventricular walls, forming a transmural gradient of sympathetic neurons (SNs) that 
in the murine myocardium decreases from the epicardium to the endocardium, while in other 
mammalian species, including human, the distribution of SNS inside myocardium has not 
been characterized yet45,125. It has been demonstrated, that sympathetic innervation of the 
myocardium is a process starts immediately after birth, and continues for the first post-natal 
weeks40,45. Moreover, it was proved, in mouse heart, that the peculiar pattern of SNs inside 
the ventricular myocardium is guided by the balance between chemoattractant neurotrophins 
(e.g. nerve growth factor, NGF) and chemorepellent factors (e.g. semaphorin-3a) released 
by cardiac cells with a well defined topology 126.  
In this work, based on our published evidence, we aim to asses if the peculiar 
ventricular pattern of SNs might reflect in a transmural modulation of CMs size, suggesting 
the hypothesis of a regional activity of SNs in modulating CM properties. Indeed, in 
literature are present evidence of a close interaction between SNs and CMs coming from  
studies involving electron microscopy analysis127 and in vitro models of co-culture of SNs 
and CMs where was also proved that stimulation of SNs induced an increase in the 
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contraction rate of co-cultured CMs 128-131. However, to date, whether SNs interacts with 
CMs in a local environment or if the interaction is mediated by the diffuse release of 
norepinephrine (NE) in the interstitium is still an open question. 
To understand the role of SN patterning inside the ventricular myocardium in the 
local modulation of CMs properties is of great relevance since many pathological conditions 
are associated to an impairment in the autonomic innervation of the heart and the main 
pharmacological treatment for this pathologies is indeed β-AR blockage. 
 
 
RESULTS 
 
1. Sympathetic neuron innervation pattern reflects in local heterogeneity in CM size in 
the mammalian heart. 
 
Cardiac sympathetic neurons (SNs) abundantly innervate the murine ventricular 
myocardium with a well defined pattern (Figure 1a). We used an antibody specific for 
tyrosine hydroxylase (TOH) to identify SN, since this enzyme is the rate limiting step in the 
biosynthesis of norepinephrine (NE). Consistently with published data38, we observed that 
SNs, mainly concentrate in the outer part of the ventricular wall, the subepicardium (EPI), 
and SN density progressively decreases till reaching the inner part of the ventricle, the 
subendocardium (ENDO) (EPI: 0.45±0.06 vs ENDO: 0.15±0.02, TOH+ fibre/CM) (Fig. 1a-
b). The EPI-to-ENDO SN density gradient is present at the level of the apex, the mid 
ventricles and the heart base (data not shown).  
Based on our finding that SNs are able to modulate CM size1, we evaluated whether 
the heterogeneity in cardiac SN distribution parallels with regional differences in CM size 
throughout the myocardium. To this purpose, we evaluated CM size in both the EPI and the 
ENDO of the left ventricle (LV) of adult mouse hearts (see Method section). Morphometric 
analyses on heart sections stained with an antibody to dystrophin and performed by both a 
blinded operator and an automate software developed in the laboratory (Fig.1e), 
demonstrated that the mean cross-sectional area of EPI CMs is almost two-fold, as compared 
to the ENDO ones (Fig. 1c-e). The same heterogeneity in the cross-sectional area of EPI and 
ENDO CMs was detected at the level of the cardiac apex, mid ventricles and heart base (data 
not shown). Moreover, no significant differences in the long axis length of CMs was 
observed between EPI and ENDO CMs. we evaluated the long axis length of EPI and ENDO 
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CMs (Fig. 2b). To exclude that the differences in CM size are a consequence of the different 
tissue vascularization, we measured the density of capillaries inside the two regions. We 
performed IF co-staining on mouse cryosections, with an antibody for dystrophin, to identify 
CM membrane, and isolectin-B4 to detect capillary vessels and we found no significant 
differences in the capillary density between the two regions (0,981±0,054 vs 0,957±0,044; 
number of capillary / number of CMs) (Fig. 2a).  
All these data suggest that there is a spatial correlation between SN density and CM 
size in the ventricular myocardium of the mouse heart. To assess if this feature is conserved 
among other mammals we analyzed SN distribution and CM size in the hearts from rats, 
rabbits and also humans. In all these species, SN density resulted slightly higher in the 
ENDO region compared to the EPI, an opposite situation to that described for the mouse 
heart (Fig. 3a). Consistently, the size of CMs resulted higher in the ENDO region than in 
the EPI. Thus demonstrating that the correlation between the density of SNs and CM size, 
is conserved regardless of the different innervation present among different species (Fig. 3b) 
In all the experiments described later we decided to analyze in better detail this 
correlation focusing on the mouse heart, given the well known advantages of this animal 
model in terms of genetic, pharmacology and handling, moreover, the mouse heart shows 
the highest heterogeneity in cardiac innervation pattern among the species analyzed.  
 
 
2. Cardiac sympathetic innervation determines the transmural heterogeneity in CM 
size during the postnatal development. 
 
The causal role of the SN innervation patterning in shaping the transmural 
heterogeneity in CM size was asses by measuring CM size at different stages during the 
progression of cardiac sympathetic innervation. The process of myocardial innervation starts 
immediately after birth, in the early post-natal weeks40,45. What we found is that in P1 hearts 
rare SNs are detectable only on the epicardial surface and interestingly, at this stage, no 
significant differences in EPI and ENDO CM size were observed. As SN sprouting proceeds, 
during the following postnatal phases, the transmural heterogeneity in the size of CMs 
becomes more evident and increases independently from the overall progressive postnatal 
CM hypertrophic growth. To further asses this hypothesis, we treated neonatal mice with 6-
hydroxy-dopamine (6-OH-DA): a well known pharmacological treatment that induces the 
SN degeneration, without any side effects on CMs. Then we compared the cross–sectional 
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areas of EPI and ENDO CMs of denervated hearts to control mice treated with the 6-OH-
DA vehicle. Consistently with our hypothesis, in P7, P21 and adult (3 mo. old) denervated 
hearts the postnatal CM hypertrophic growth appeared significantly reduced as compared to 
controls and the transmural EPI-to-ENDO CM size heterogeneity totally disappeared. 
(Fig.4). 
 These results support a causal role for cardiac SNS in the establishment, during the 
postnatal development, of the transmural patterning of CM size observed in the adult heart. 
 
 
3. Sympathetic neurons locally modulate cardiomyocyte size during the adulthood.  
 
To address whether SN activity is also required for the maintenance of the transmural 
patterning of CM size in the adulthood, we evaluated EPI-to-ENDO CM size differences in 
the hearts from mice of two study group: i) mice subjected to denervation in the adulthood 
and ii) mice treated with β2-AR antagonist and agonist. As expected, denervated mice 
developed heart atrophy due to a reduction in CM size, that affected mostly the EPI region, 
resulting in the abolishment of CM size heterogeneity inside the ventricle (Fig. 5a). Such 
alterations were peculiar of denervation-induced atrophy, since the analysis of a mouse 
model of caloric restriction, which induced a significant decrease in cardiac mass, with no 
changes in SN distribution, resulted in an overall decrease of CM size, but a preserved EPI-
ENDO heterogeneity (Fig. 5a). In line with this, the interference with β2-AR activity by the 
systemic continuous delivery of either: β2-AR agonist (i.e. clenbuterol) or β2-AR antagonist 
(i.e. ICI 118,551), although inducing cardiac hypertrophy (heart weight/body weight: 
clenbuterol: 5.5±0.3 vs controls: 4.5±0.2, in mg/g) and atrophy (heart weight/body weight: 
ICI: 4.0±0.1 vs controls: 4.3±0.3 in mg/g), respectively, in both cases resulted in the loss of 
CM size heterogeneity (Fig. 5b). In these hearts SN patterning was unaltered, but 
consistently with our hypothesis, its regional control over CM size was by-passed by the 
diffuse action of the drug. Interestingly, while the EPI-to-ENDO difference in CM size was 
reduced upon ICI 118,551 treatment, an inversion of CM size distribution occurred in 
clenbuterol-treated hearts with the mean cross-sectional area of ENDO CMs appearing 
bigger as compared to the EPI one. This result could be explained by the supersensitization 
effect experienced by ENDO CMs (see discussion)132,133. Consistently, analysis of β2-AR 
mRNA levels by RT-qPCR on tissue extracts from EPI and ENDO regions revealed that at 
baseline the receptor is differentially transcribed between the two regions, being upregulated 
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in the ENDO. After denervation it increases in the EPI region reaching the same level of 
expression of the ENDO region (Fig. 5c). Altogether these data demonstrate that SN pattern 
is essential to maintain the physiologic CM size differences inside the myocardium during 
the adult life, moreover, these finding suggest that SNs operate a local control over CM size. 
 
 
4.  Alterations in the β2-AR signalling pathway associate to a failure in the physiological 
cardiomyocyte size patterning.  
 
To investigate the role of the β2-ARs/AKT/MuRF1 pathway1 in the establishment of 
the physiological transmural patterning of cardiomyocyte size, we measured the size of EPI 
and ENDO CMs in mouse models lacking β2-ARs and MuRF1. No significant changes in 
the SN patterning were detected in hearts from β2-ARs-/- mice, which displayed heart 
atrophy (heart weight/body weight: β2-AR-/-: 3.0±0.02 vs controls: 3.8±0.4 in mg/g), 
accompanied, in accordance  with our previous results, with the disappearance of CM size 
heterogeneity (Fig. 6a). In particular, EPI CMs were smaller in size as the ENDO ones. 
MuRF1-/- hearts, instead, were hypertrophic (heart weight/body weight: MuRF1-/-: 5.2±0.2 
vs WT: 4.6±0.3 in mg/g) but with no sign of on overt cardiomyopathy. MuRF1-/- hearts, 
although displaying a normal SN innervation pattern, do not show CM size heterogeneity in 
the LV, suggesting a fundamental role for this ubiquitin ligase in the process of denervation-
induced cardiac atrophy1 (Fig.6b).  
These results suggest that the transmural CMs differences are dictated by a spatial 
heterogeneity in the activation of the β2-AR/AKT/MuRF1 pathway. 
 
 
5. The cardiac sympathetic neuron patterning reflects in local changes in 
cardiomyocyte proteolytic activity. 
 
To assess if SNs are able to modulate locally proteolysis rate of CMs, we evaluated 
changes in the mRNA expression level of the ubiquitin ligase MuRF1. To achieved this goal, 
we performed in situ hybridization (ISH) in control and denervated adult mouse hearts (30d 
after the denervation). In WT hearts we observed a homogeneous distribution of MuRF1 
mRNA among CMs, while in denervated hearts, we found that it was more expressed in the 
EPI region compared to the ENDO one (Fig.7a). To quantify this difference, we set up a 
protocol for the surgical dissection of the two regions of the heart and performed RT-qPCR 
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on tissue extracts. To verify the quality of our dissection procedure we evaluated the mRNA 
expression level of a subunit of the voltage gated potassium channel (Kv4.2), which is 
reported to be upregulated in the EPI region, obtaining the same results (Fig.7c). With this 
approach we observed that in normal condition mRNA levels of MuRF1 were comparable 
between EPI and ENDO, but when we perturbed this equilibrium by the ablation of SNs we 
found an upregulation of MuRF1 significantly more pronounced in the EPI region compared 
to the ENDO (Fig.7b).  
These results suggest that cardiac SNs are able to modulate CM size by acting on 
their proteolysis rate and thus that the pattern of SN inside ventricular myocardium reflects 
in a related CM size heterogeneity. 
 
 
 
ONGOING EXPERIMENTS 
 
All the data described support the notion that SNs control CM proteostasis through a 
local action, to address this point the following experiments are in progress: I) the regional 
denervation of the myocardium in vivo, II) the 3D reconstruction of SN-CM interaction and 
III) the set up of an in vitro co-culture system mimicking SN-CM interaction occurring in 
vivo.  
 
Regional denervation of myocardium 
We set up a protocol for the denervation of a small portion of the myocardium, through the 
application of phenol on the epicardium. Phenol epicardial painting is described in literature 
as an efficient method to obtain neuronal death, without affecting significantly CMs 
viability146,147. We have performed a first experiment in which we applied phenol to the 
epicardial surface of the LV with a cotton fiber tip with a diameter of 2 mm and obtained 
the denervation of this limited region of the myocardium, as assessed through IF staining for 
TOH, without apparent damage to the tissue. Now we are designing a DNA construct which 
harbors the promoter of MuRF1 fused to GFP, later we will use an adeno-associated viral 
vector to deliver this construct to the heart. With this approach we will assess, from ex vivo 
heart section, if the denervation of a small region of the myocardium results in the 
upregulation of MuRF1, appreciated by the increase in the fluorescence signal, only in this 
confined region. 
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3D reconstruction of SN-CM interaction 
We will also take advantage by the use of the multiphoton microscopy to analyze in great 
detail the structure of the contact between a single SN and its target CM. With this 
technology, already used in literature for the 3D characterization of cardiac SN sprouting 148, 
we will investigate the the close contact between SNs and CMs in the normal heart and also 
the  activation of MuRF1 following regional denervation. To characterize the interaction 
between SNs and CMs we need to fluorescently mark CM membrane and SNs in intact thick 
heart tissue samples, to achieve that we set up a protocol for the IF staining of thick 
myocardial tissue samples (1 mm3) and we have collected some preliminary results showing 
that it is possible to mark CMs and SNs in sections of up to 400 µm thickness (Fig.S1). 
 
In vitro co-culture to study SN-CM interaction 
We have set up an in vitro model of co-culture between CMs and PC12 cells (Fig.S2). PC12 
cells are a cell line derived from pheochromocytoma of the rat adrenal medulla, that upon 
treatment with NGF, terminally differentiate into NE secreting neurons149. In a parallel 
project, in which we analyzed in vitro SN-CM co-culture (see Results), we observed, upon 
SN stimulation, acute changes in cAMP levels only in CMs directly innervated by SNs and 
not in the adjacent ones. These results suggest a functional contact between SNs and CMs. 
Based on these evidence we evaluated the effect of a chronic stimulation of PC12 cells, in 
the PC12-CM co-culture, on CM size. We treated co-culture 7 days after their plating, since 
it is described in literature 96, and confirmed also by our data (see Results), that this time is 
sufficient for neurons to establish functional contacts with CMs. We used nicotine, to 
stimulate neurotransmitter release, with different conditions: a short stimulation (1-hour 
treatment 3 times a day for 5 consecutive days) and a longer stimulation (8-hour treatment 
each day for 5 consecutive days) and different concentrations: 1-10-500 µM. We focused on 
clusters of CMs in which only some of them are directly contacted by neuronal processes, 
and we found that, in the condition with longer stimulation and 500 µM of nicotine, only 
CMs innervated showed a hypertrophic remodeling, compared to non-innervated ones. To 
achieve an even more controlled and precise stimulation of the neurons we are setting up a 
PC12 cell line that stably express ChannelRhodopsin-2. Then we will perform a chronic 
stimulation of PC12 cells co-cultured with CMs and we will asses if this results in changes 
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in the size of CMs directly contacted by PC12 cells compared with the other CMs present in 
culture. 
 
 
DISCUSSION 
 
This study provides evidence in favor of the hypothesis of a local interaction between 
SNs and CMs, rather than the model of a non specific diffusion of neurotransmitter released 
by SNs into the interstitium. One consideration that arises from this work is that the different 
effects of SNS innervation of the heart could be operated through the activation of different 
receptors in CMs, a hypothesis suggested also by other studies in literature134-136. In 
particular, parallel to the well known acute effect of increase in heart contraction operated 
through activation of β1-AR, there is a more long-term effect acting through β2-AR that 
modulates CMs size1,137. How these two effects are discriminated at the level of SN-CM 
interaction is not completely understood, although in literature there are evidence of a 
different localization and response to stimulation of the two receptor subtypes. In particular, 
it was demonstrated that the two receptor subtypes have different compartmentalization, β1-
ARs are enriched in specialized zone that surround contacting axon, in close proximity of 
scaffold protein such as AKAPs and SAP97131 and remain at the plasma membrane upon 
stimulation, while β2-ARs undergo endocytosis and recycling upon stimulation. Moreover, 
it is well described in literature, in fact, that the continuous activation of β-AR result in the 
decrease in numbers of the receptors, a physiological process called desensitization133. While 
chronic treatment with a β2-AR antagonist, impedes the desensitization process and a 
sudden discontinuation of this treatment was shown to be deleterious since the effects of 
neurotransmitters on CMs were then exacerbated, a process called supersensitization, and 
could give raises to arrhythmic events138,139. Our data obtained from pharmacological 
activation of β2-AR through the systemic delivery of clenbuterol, are consistent with the 
supersensitization effect since ENDO region, which is physiologically less innervated by SN 
and thus is supposed to have more β2-AR compared to the more innervated EPI (which we 
demonstrated at the level of transcript mRNA), shows a higher response in terms of 
hypertrophic remodeling. This result implies that in a normal situation there is a local control 
of CM size exerted by SN, which cannot be achieved otherwise if the neurotransmitter is 
released broadly into the interstitium as it can occur for example with circulating 
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catecholamines, and this is a further proof in favor of the model of the direct interaction 
between SNs and CMs. 
The importance of this study is given by the presence of many pathological 
conditions that are associated to autonomic innervation impairment of the heart, where in 
many of them the main pharmacological treatment is indeed β-AR blockage. One of these 
situation is heart failure, where an hyperactivation of SNS is demonstrated. Another 
important pathologic condition in which heterogeneous distribution of the sympathetic 
innervation is observed is myocardial infarction, where hyperinnervated, denervated and 
normally innervated area are present140. Moreover, in literature are present studies that 
provides evidence that stimulation of a small fraction of cardiac cells is sufficient to trigger 
a premature ventricle complex raising the hypothesis that local adrenergic activation is 
involved in triggering arrhythmia32,120 (see Appendix). 
Furthermore, another important clinical implication for this study regards heart 
transplantation, this condition, in fact, is inevitably associated to heart denervation and 
during time also to the process of reinnervation, however, although the importance of heart 
innervation in physiologic modulation of heart activity and in pathological triggering of 
arrhythmic events is clearly demonstrated, there is a lack of studies regarding these aspects 
in transplanted hearts141-145. 
In conclusion, beyond the specific context of heart, this study provides, to the best of 
our knowledge, the first example of an otherwise homogeneous tissue whose cells are shaped 
in terms of their size by a superimposed pattern of neurons. 
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Figure 1. (a) IF staining for TOH of a mouse ventricular cryosection, detail of the LV showing the distribution 
of SNs. (b) Quantification of SN density in the LV of mouse heart. (c) IF staining for dystrophin, identifying 
CM membrane, of a mouse ventricular cryosection, detail of the LV. (d) Morphometric measurement of CM 
cross sectional area in the LV of mouse heart. (e) Pseudocolor map based on the IF staining for dystrophin (left 
panel), obtained with the software developed in this study, detail of the LV of a mouse heart cyosection 
showing each CM with a color code that is based on its cross sectional area.    
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Figure 2. (a) IF double staining for dystrophin (CM membrane) and isolectine (capillary membrane) in the 
ENDO and EPI region of mouse heart and quantification of the ratio between the number of capillary and the 
number of CMs. No significant changes were detected. (b) Details of a IF staining for wheat germ agglutinin 
(WGA) showing CM membrane, the arrows highlight the long axis of CM form ENDO and EPI regions. Graph 
showing the quantification of CM long axis length of the ENDO and EPI CMs. No significant changes were 
detected.  
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Figure 3. (a) Quantification of SN density in the LV of rat, rabbit and human heart. (b) Morphometric analysis 
of CM cross sectional area in the LV of rat, rabbit and human heart.   
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Figure 4. Graph showing the ratio between the cross sectional area of CMs from EPI and ENDO regions of 
neonatal mouse hearts at 1,7 and 21 days after birth. Black bars indicate normal hearts, white bars indicate 
hearts denervated at birth. Red dashed line highlight the ratio value of 1, which corresponds to the situation of 
cells with an equal size. The white bar at P1is absent because the heart is not yet innervated. 
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Figure 5. (a) Graph showing the ratio between the cross sectional area of CMs from EPI and ENDO regions 
in hearts of control, adult denervated and subjected to caloric restriction mice. (b) Graph showing the ratio 
between the cross sectional area of CMs from EPI and ENDO regions in hearts of control, β2-AR antagonist 
(ICI 118,551) and β2-AR agonist (clenbuterol) treated mice. (c) Quantification of RT-qPCR performed on 
heart extracts from EPI and ENDO regions of control and denervated mice which shows the mRNA levels of 
β2-AR relative to housekeeping gene GAPDH. 
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Figure 6. (a) Graph showing the ratio between the cross sectional area of CMs from EPI and ENDO regions 
in hearts of control and β2-AR-/- mice. (b) Graph showing the ratio between the cross sectional area of CMs 
from EPI and ENDO regions in hearts of control and MuRF1-/- mice.  
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Figure 7. (a) ISH on LV sections of hearts from control, denervated and MuRF1-/- mice, showing the 
localization and intensity of mRNA expression of MuRF1as blue signal. (b) Quantification of RT-qPCR 
performed on heart extracts from EPI and ENDO regions of control and denervated mice which shows the 
mRNA levels of MuRF1 relative to housekeeping gene GAPDH. (c) Quantification of RT-qPCR performed 
on heart extracts from EPI and ENDO regions of control mice which shows the mRNA levels of Kv4.2 relative 
to housekeeping gene GAPDH. 
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Figure S1. IF images of a 10 µm section cut from a myocardial tissue sample of 1 mm3 stained with the protocol 
described in the text for wheat germ agglutinin (WGA) that stains CM membrane and tyrosine hydroxylase 
(TOH) that marks SNs. The section was cut at a depth of 400 µm inside the sample, showing the penetration 
of the antibody and the dye into the tissue. 
 
 
 
 
 
 
Figure S2. Confocal IF image of the co-culture CM-PC12 stained for a-actinin to mark CM sarcomeres and 
TOH to mark neuron processes. In this picture is evident the “perl and necklace” morphology of the neurons 
and their varicosities at the contact site with CMs. 
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MATERIALS AND METHODS 
 
Animal models. In this study we analyzed hearts from: P1, P7 and P21 CD1 mice, as well as 
C57BL/6J, FVB (all from Charles River, Milan, Italy), MuRF1-/- (Dr David J. Glass, 
Regeneron Pharmaceuticals, Tarrytown, NY.) and β2-Adenoceptors-/- (β2-AR, P.C. Brum, 
University of São Paulo, Sao Paulo) adult male mice. Hearts from Sprague-Dawley adult 
male rats, rabbits (all from Harlan, Milan, Italy) were also evaluated. All experimental 
procedures described in this manuscript have been approved by the local ethical committee 
(Authorization number C54) and communicated to the relevant Italian authority (Ministero 
della Salute, Ufficio VI), in compliance of Italian Animal Welfare Law (Law n 116/1992 and 
subsequent modifications). 
 
Histological and immunofluorescence analyses. Hearts were harvested from mice and 
immediately placed in a fixative solution. This solution contained 1% (v/v) 
paraformaldehyde (Sigma Aldrich) diluted in PBS 1x, with a concentration of KCl (Sigma 
Aldrich) of 25mM to allow the relaxation of the heart muscle fibers. After fixation hearts 
were washed in PBS 1x and allowed to dehydrate and equilibrate in an aqueous solution 
containing 30% Sucrose (w/v) (Sigma Aldrich) overnight at 4°C. The next day hearts were 
embedded in OCT matrix (Vetrotecnica) and frozen in the vapor phase of liquid nitrogen 
and stored at -80°C. For histological and immunofluorescence analysis heart slices of 10 µm 
were obtained using a cryostat (Leica 1860). For immunofluorescence analyses heart slices 
were incubated with the primary antibody diluted in PBS 1x supplemented with 1% BSA 
(Sigma Aldrich) and 0.5% Triton-X100 (Sigma Aldrich) and secondary antibody diluted in 
PBS 1x supplemented with 1% BSA and mounted using Elvanol solution. The following 
primary antibodies were used: anti-TOH (Millipore), anti-dystrophin (Abcam) and revealed 
using secondary antibody conjugated with fluorophores: Alexafluor-488 or Alexafluor-cy3 
(Jackson). Wheat Germ Agglutinin conjugated with Alexafluor-555 fluorophore and 
Isolectine conjugated with Alexafluor-488 fluorophore(Invitrogen) were also used. 
RNA extraction and RT-qPCR. Total RNA was extracted from heart tissue using the SV 
Total RNA Isolation System Z3100 (Promega), according to the manufacturer’s protocol. 
RNA was reverse-transcribed using SuperScript III enzyme (Invitrogen), according to the 
manufacturer’s protocol. RT-qPCR was performed with Power SYBR Green PCR Master 
Mix (Applied Biosystems) and run on a GeneAmp 7900HT thermal cycler (Applied 
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Biosystems). Relative RNA abundance was evaluated according to the method described by 
Pfaffl150 with GAPDH as reference housekeeping gene, whose levels were unchanged in the 
experimental conditions analyzed. Primers were designed using primer-BLAST software 
(NCBI) and their sequences are: GAPDH fw CACCATCTTCCAGGAGCGAG rv 
CCTTCTCCATGGTGGTGAAGAC; MuRF1 fw ACCTGCTGGTGGAAAACATC rv 
CTTCGTGTTCCTTGCACATC; Kv4.2 fw CCTGGAGAAAACCACGAACC rv 
GACTGTGACTTGATGGGCGA; β2-AR fw TGTGTCTTTCTACGTGCCCC rv 
GGGCGTGGAATCTTCCTTCA. 
Pharmacological sympathectomy. Pharmacological sympathectomy was obtained with 6-
hydroxy-dopamine (6-OH-DA) (100 mg/kg, ip) (Sigma Aldrich). The drug was delivered at 
days 0, 2, and 7. Animals were sacrificed 8 and 30 days after the first 6-OH-DA injection 
using excess anesthesia. Control mice were treated with the vehicle (0.9% NaCl and 0.1% 
ascorbic acid).  
Chronic treatment with drugs in vivo. In vivo drug delivery of the β2-adrenoceptor 
antagonist: ICI 118,551 (Sigma), at a concentration of 1 mg/kg/day, and agonist: clenbuterol 
(Sigma), at a concentration of 3 mg/kg/day, was achieved through the implant of osmotic 
mini-pumps (Alzet 1004, Alzet) in the abdominal cavity of mice. These mini-pumps were 
used to deliver continuously the drug for 14 days, then the mice were sacrificed and the 
hearts were harvested and processed as described above for histology and 
immunofluorescence analysis. 
Evaluation of sympathetic neuron density. SNs were recognized using an antibody to 
Tyrosine Hydroxylase (TOH). TOH is a well-accepted marker of adrenergic cardiac neurons, 
since it is a rate limiting step enzyme in the biosynthesis of noradrenaline. The number of 
SNs per cardiomyocyte (CM) was evaluated through co-staining of TOH, to identify SN, 
and Wheat Germ Agglutinin (WGA), to identify CM membrane. This analysis was 
performed in six non-consecutive 10 µm section at the level of the heart base, the mid-portion 
of the ventricles and the apex. 
 
Human samples: Human autoptic samples were provided by Prof. Cristina Basso from the 
Cardiovascular Pathological Anatomy department already anonymized and used in 
accordance with the relevant authority. The sample analyzed in this study derives from a 2-
month old patient died for non cardiac related causes. The region that we used for the 
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morphometric analysis is the medial part of the LV. We captured the image of random fields 
from EPI and ENDO region of the LV and measured the cross sectional area of 1650 CMs 
for the EPI region and 950 CMs for the ENDO region. Measurement of SN density was 
performed on 3 non consecutive 5 µm sections.  
 
Caloric restriction. Both CD1 and C57BL/6J adult male mice underwent caloric restriction 
for 7 days (3 gr of normal chow food/day)1. At day 8th mice were sacrificed, hearts harvested 
and processed for morphometric and molecular analyses. 
 
Morphometric evaluation of EPI and ENDO cardiomyocyte size. The cross-sectional area 
of the LV EPI and ENDO CMs was evaluated in cryosections stained with an antibody 
specific for dystrophin. The images of six 10µm non-consecutive transversal cryosections, 
distributed in 600 µm, at three anatomical levels around the mid portion of the ventricles, 
were acquired at the fluorescence microscopy (Leica DC130, Leica Microsystems) and the 
image composite was performed with the software AdobePhotoshop8.0. For this analysis, we 
considered only CMs characterized by the same fiber orientation, as evaluated by the 
eccentricity index and the cross-sectional areas were measured both manually, by using the 
software Image J 151, and by an automatized program developed in MatLab (The MathWorks 
Inc., Natick, MA, 2000). All CMs from the posterior, lateral and anterior LV wall were 
evaluated and the distribution of the values of CM areas was fitted with a Gaussian 
approximation, considering only the values included in a 99% confidence interval. Six hearts 
for each study group were analyzed. Longitudinal heart cryosections were also obtained from 
additional subsets of animals, processed for IF as previously described and used to measure 
the long axis of EPI and ENDO CM.  
 
Pseudocolor heart maps and eccentricity index. We developed heart area maps through a 
semi-automated program implemented in Matlab: the program analyses images of the whole 
slice of the mouse heart, segmenting and measuring the area of CMs; then the resulting image 
is displayed on the screen, enabling the user to specifically select the ENDO and EPI area 
and to remove incorrectly segmented CMs. Finally, CM area are calculated (using 
regionprops function) and at every CM is given a grayscale value that is directly proportional 
to its area. Images were recolored using the Lookup Table function in the software Image J. 
The software calculates also the eccentricity index of the segmented CMs and showed no 
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significant differences between the two heart zones (EPI vs ENDO: 0.771 ±0.047 vs 0.779 
±0.046).  
 
Myocardial tissue micro-dissection. To obtain myocardial tissue separately from the EPI 
and ENDO regions, the LV free wall was surgically separated the from the rest of the heart, 
deprived of the papillary muscles, flattened and fixed on a support using 29G needles and 
immediately frozen in liquid nitrogen. Then using a cryostat (LEICA 1860) 20 cryosections 
of the thickness of 20 µm were cut and collected from the EPI region, discarding the 
pericardium and epicardium, and the same number from the ENDO region, here excluding 
endocardium. On these tissue extracts RNA and protein extraction was performed as 
described in the relative sections. 
 
In Situ Hybridization. Complementary RNA probe to full length mouse MuRF1 (Trim63) 
was generated using standard protocols. Non-radioactive in situ hybridization (ISH) on 
paraffin-embedded heart sections, was performed as previously described152. Images were 
taken using a Leica DC300 digital camera and a Leica DMR microscope. All patterns in wild-
type, MuRF1 KO and denervated hearts were observed in at least 3 samples. 
 
Statistical analysis. All data are expressed as the mean±s.e.m. Comparison between the 
experimental groups was made by using the non-paired Student’s t and Anova tests, with 
Bonferroni correction, with p<0.05 being considered statistically significant. * stands for 
p<0.05, ** stands for p<0.01, *** stands for p<0.001, NS stands for not significant. 
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ABSTRACT  
 
Extrasystoles lead to several consequences, ranging from uneventful palpitations to lethal 
ventricular arrhythmias, in the presence of pathologies, such as myocardial ischemia. The 
role of working versus conducting cardiomyocytes (CMs), as well as the tissue requirements 
(minimal cell number) for the generation of extrasystoles, and the properties leading ectopies 
to become arrhythmia triggers (topology), in the normal and diseased heart, have not been 
determined directly in vivo. Here, we used optogenetics in transgenic mice expressing 
ChannelRhodopsin-2 selectively in either CMs or the conduction system, to achieve cell-
type specific, non-invasive control of heart activity with high spatial and temporal resolution. 
By combining measurement of optogenetic tissue activation in vivo and epicardial voltage 
mapping in Langendorff-perfused hearts, we demonstrated that focal ectopies require, in the 
normal mouse heart, the simultaneous depolarization of at least 1300-1800 working CMs or 
90-160 Purkinje fibers. The optogenetic assay identified specific areas in the heart that were 
highly susceptible to forming extrasystolic foci, and such properties were correlated to the 
local organization of the Purkinje fiber network, which was imaged in the three-dimensions 
using optical projection tomography. Interestingly, during the acute phase of myocardial 
ischemia, focal ectopies arising from this location, and including both Purkinje fibers and 
the surrounding working CMs, have the highest propensity to trigger sustained arrhythmias. 
In conclusion, we used cell-specific optogenetics to determine with high spatial resolution 
and cell type specificity, the requirements for the generation of extrasystoles, and the factors 
causing ectopies to be arrhythmia triggers during myocardial ischemia. 
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INTRODUCTION 
 
Aberrant heartbeats, caused by the ectopic depolarization of a group of 
cardiomyocytes (CMs), are associated with a wide range of consequences, from the 
commonly experienced feeling of 'palpitation' to the triggering of potentially lethal 
ventricular arrhythmias in diseased hearts. Physiological conduction of normal heartbeats is 
orchestrated by the interaction of at least two functionally and anatomically distinct 
population of CMs: the working CMs and the conduction system (i.e. Purkinje fibers at the 
ventricular level) 153. The electrotonic coupling of myocardial cells protects the heart from 
abnormal excitation, allowing the effect of spontaneous activity in sparse CMs to be 'sunk' 
by the surrounding myocardium. As a result, a minimal 'critical' number of CMs needs to 
simultaneously depolarize to prevail over such protective mechanism and generate 
conducted beats 20,32,33,154. When this occurs, the source-sink mismatch (abnormal 
depolarization current/myocardial electrotonic sink) is focally overcome, resulting in a 
premature ventricular contraction (PVC) that, in the presence of arrhythmogenic substrates 
may evolve into chaotic and self sustained ventricular arrhythmias 155,156. In fact, ventricular 
tachycardia (VT) and fibrillation (VF) frequently occur in coronary artery disease during 
both the acute ischemic phase and the infarct evolution phase, and are responsible for most 
cases of sudden cardiac death (SCD) occurring yearly in the United States of America (USA) 
157-159. 
The tissue determinants of a focal arrhythmic source (i.e. critical cell number, 
topology) have so far only been estimated using biophysical modeling, suggesting that 
almost one million cells are required to generate ventricular ectopies in the rabbit heart 33. 
Moreover, while pharmacologic approaches and single cell electrophysiological studies 
have suggested that abnormal activation of the Purkinje fiber network is a likely arrhythmia 
trigger in both acquired (e.g. myocardial ischemia) and inherited (LQTS, CPVT) 
arrhythmias 160-165, the role of the cardiac conduction system has not been addressed directly 
in the intact animal so far, mainly due to methodological constraint 166-169. In fact, the 
experimental technique most commonly used to investigate cardiac electrophysiology in 
vivo is based on the delivery of electrical pulses to the epicardial surface during ECG 
recording 170,171. The method, however, cannot discriminate the specific role of the 
conduction system cells, as they are embedded in the myocardium and not easily accessible 
to invasive electrophysiological investigation 169,172-174.  Optogenetics exploits the targeting 
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of photoactivatable ion channels in specific cell types to achieve non invasive control of 
membrane potential 175.  
Channelrhodopsin-2 (ChR2) is a microbial derived cation channel, that, in a similar way to 
visual rhodopsin and bacteriorhodopsin, undergoes a conformational change upon 
illumination resulting in an immediate increase in ionic permeability, with high conductance 
to Na+ 103,176. ChR2 exhibits fast and reversible activation kinetics (in the order of 
milliseconds), that is instrumental to drive reliable trains of high frequency action potentials 
in vivo. Optogenetics is widely used in neuroscience to modulate neuronal circuits in in vivo 
models 177-179 and has been proposed as an attractive tool to control cardiomyocyte 
membrane potential 107,108,180-182. In cardiac research, optogenetics is still in very early stages 
and has mainly been applied to in vitro and regenerative medicine studies 112,116,119,183,184.  
 We have applied optogenetics in transgenic mice with cardiac specific ChR2 
expression to determine the critical cell mass necessary to generate focal ectopic beats ex 
vivo, in the isolated heart, and in vivo. In addition, we addressed the vulnerability of the 
ischemic heart to ventricular arrhythmias, in relation to the characteristics of the focal trigger. 
Furthermore, we exploited genetic targeting of ChR2 to Purkinje cells to interrogate the role 
of this cellular network in cardiac electrophysiology and arrhythmogenesis. 
 
 
RESULTS 
 
1. Non-invasive generation of cardiac ectopies in vivo using cardiomyocyte specific 
expression of ChannelRhodopsin-2.   
 
To achieve ChR2 expression in CMs, we crossed B6.Cg-Gt (ROSA) 26Sortm27.1 
(CAG-COP4*H134R/tdTomato) Hze/J expressing mice with a transgenic strain encoding Cre-
recombinase under the control of cardiac-specific α-Myosin Heavy Chain (α-MyHC) 
promoter. The resulting offspring had the STOP cassette deleted in CMs, driving the 
expression of ChR2 (hChR2 (H134R)-tdTomato fusion protein) (Fig.S1a). ChR2 expression 
was uniformly detected in heart cryosections by tdTomato fluorescence, and was localised 
at the sarcolemma and t-tubules of CMs (Fig.1a,b and Fig.S1b). ChR2-expressing mice had 
normal heart size, morphology, and gross electrophysiology (Heart Rate, α-MyHC-ChR2: 
340±39 vs control: 322±9, in bpm; n=10 mice for each group, under anesthesia) (QRS 
interval, α-MyHC-ChR2: 12.43±0.63 vs control: 13.05±0.87, in ms; n=10 mice for each 
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group) (Fig.S1c-d). To obtain timely and spatially controlled photostimulation of ChR2 
hearts in vivo, we used a fiber optic delivering 470 nm light pulses, generated by a time-
controlled Light Emitting Diode (LED), in open-chest anesthetized mice during continuous 
ECG monitoring (Fig.1c). The effect of local cardiac photostimulation was mapped by 
delivering brief (5 ms) light pulses with the fiber tip placed close to the epicardium of 
different heart regions (Fig.1d-e). Atrial stimulation evoked supraventricular paced beats 
with normal QRS and wider P waves (P wave duration, basal: 14.28±0.26 vs left atrium 
photostimulation: 27.90±0.63, ms; n=15 mice). Ventricular stimulation from the heart base 
to the apex, in both the right and left sections, triggered beats with wider QRS complexes 
(QRS interval: basal 12.43±0.63 vs left ventricle photostimulation: 21.82±0.90, ms; n=10 
mice for each group) (Fig.1d). Repetitive stimulation of the same myocardial focus, 
produced paced heartbeats that, consistent with the fixed ventricular origin, had enlarged 
and identical QRS morphology (Fig.1e). Photo-pacing could be maintained for several 
minutes, and sinus rhythm started promptly when illumination was interrupted, suggesting 
that no functional or structural damage resulted from the activation protocol. In addition, 
disconnection of the fiber optics tip from the light source on the epicardial surface, as well 
as photostimulation of WT littermates did not cause any alteration in the sinus rhythm (data 
not shown).  
We thus demonstrated that experimentally induced ectopies can be evoked, using 
optogenetics, with high spatial and temporal resolution and implemented such methodology 
for the non-invasive investigation of cardiac electrophysiology. 
 
2. Voltage mapping of cardiac activation in optogenetically-paced ChR2 hearts. 
 
To address the effect of light pulses on ChR2 hearts directly at the local tissue level, 
cardiac optogenetics was combined with high speed optical mapping of membrane voltage, 
in Langendorff-perfused heart preparations. To achieve this, isolated hearts from α-MyHC-
ChR2-tg mice were loaded with a voltage-sensitive membrane dye (RH1691), and 
additionally monophasic action potentials were also recorded by a contact electrode from 
the heart surface (Fig.2a,b and Fig.S2). Light pulses achieved with the same optics used for 
in vivo experiments, caused reproducible local depolarizations that, strictly within the time 
window of the light pulse, were confined to a tissue area corresponding precisely to the 
optical fiber physical diameter. Moreover, the radial intensity distribution of 
photostimulation light applied was overall symmetric, and well-confined within the radius 
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of the optical fiber, with no appreciable fluorescence changes at the margins of the 
photostimulation area. Further considering the dynamic range of the voltage dye and the 
Signal/Noise ratio of the detection system, voltage changes at the edge of the region directly 
irradiated were below 1 mV. Above a light intensity threshold comparable to that observed 
in vivo, optical pacing resulted in an activation pattern that was initially radial symmetric, 
and subsequently spread by physiological, anisotropic propagation as shown in Fig.2c-f. 
Taken together, combined measurement of optogenetic tissue activation and epicardial 
voltage mapping demonstrates that local light delivery to ChR2 expressing hearts activates 
a relatively small tissue volume, that precisely correlated with the light source, and triggers 
focal ectopic beats or tertiary pacemakers. These results support as a proof of principle in ex 
vivo experiments the all-optical approach to simultaneously control and record cardiac 
electrophysiology.  
 
3. Direct optogenetic assessment of Purkinje fiber function in vivo using Cx40 driven 
expression of ChannelRhodopsin-2.  
 
The Purkinje fiber network constitutes the distal ventricular conduction system, 
branching throughout the subendocardial cell layers of both ventricles, with a high density 
in the right ventricular wall. In vitro studies and mathematical modelling indicate that 
Purkinje fiber cells have unique structural and electrophysiological properties, but the direct 
assessment of their function in vivo, with conventional approaches (i.e. electrical 
stimulation), is limited by their subendocardial location and proximity to surrounding 
working CMs. To interrogate the specific role of Purkinje fiber myocytes in heart physiology, 
we genetically targeted ChR2 expression to the ventricular conduction system cells. Double-
floxed ChR2-tdTomato mice were crossed with Cx40-Cre mice, previously shown to drive 
transgene expression throughout the conduction system cells, including Purkinje fibers, and 
atrial myocardium 185(Fig.3a). ChR2 expression was assessed by confocal imaging of the 
red fluorescence of td-Tomato, and its specific expression by Cx40 expressing cells was 
confirmed by immunofluorescence. ChR2 was thus detected in atrial CMs and Purkinje 
fibers, consistent with the expression of Cx40 (Fig.3b-d and Fig.S3). Hearts from Cx40-
ChR2 mice had normal morphology and function (Heart Rate, Cx40-ChR2: 351±20 vs 
control: 335±15, in bpm; n=10 mice for each group) (QRS interval, Cx40-ChR2: 12.82±0.25 
vs control: 12.35±0.47, in ms; n=10 mice for each group), indistinguishable from control 
littermates (Fig.S4a,b). We therefore used the photoactivation protocol described above 
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(Fig.1c) to selectively stimulate, by illuminating the epicardial surface, discrete foci of 
Purkinje fibers in the intact heart in vivo, and analyze the effects on cardiac electrical 
activation. Consistent with the ubiquitous expression of ChR2 in atrial cells, photoactivation 
of the right and left atria resulted in supraventricular pacing, with ECG morphology 
superimposable to that obtained in the α-MyHC-ChR2 transgenic hearts at corresponding 
pacing sites (Fig.3e and Fig.S4c). By scanning the heart surface with the fiber optic tip, the 
ventricular conduction system was activated at different sites, corresponding to proximal 
(septal) and distal regions of the Purkinje fiber network, both in the RV and LV. Consistent 
with the physiological characteristics of the different conduction system regions, ectopies 
triggered by photoactivation of the AV bundle had QRS duration identical to the 
spontaneous complex (Cx40-ChR2 basal QRS: 12.82±0.25 vs photostimulated QRS: 
13.04±0.33, in ms; n=10 mice for each group) (Fig.3f). While stimulation of the distal 
Purkinje fibers of the RV yielded ectopic beats with enlarged QRS duration (photostimulated 
QRS duration: 23.2±0.52, in ms; n=10 mice for each group), light pulses failed to activate 
ectopies when delivered to the much thicker LV wall (Fig.3e,f). 
In contrast to the uniform response to photoactivation of the α-MyHC-ChR2 
ventricles, Purkinje fibers stimulation yielded highly variable effects depending on the 
illumination site. Ectopies were in general evoked with the stimulation of all RV regions, 
however, successfully coupled light pulses were almost 100% in a small (about 2 mm2 wide) 
region of the lateral RV free wall (Fig.3e,f and Fig.4a), corresponding to the origin of the 
right ventricular outflow tract (RVOT). We thus used confocal immunofluorescence and 
Optical Projection Tomography in intact Cx40-GFP mouse hearts to investigate the 
relationship between the geometry of Purkinje fibers arborization and the response to 
photostimulation. The small RV hyperactivable region identified functionally with 
optogenetics (Fig.4a) was characterized by the presence of Purkinje fibers arranged in 
multiple cell layers (Fig.4b). Moreover the 3-D reconstruction of the ventricular conduction 
system network showed that in this region, Purkinje fibers of the RV free wall connect to 
the right septal branch (Fig.4c-f), suggesting that the increased responsiveness to local 
activation might be explained by the high degree of interconnection between sectors of the 
conduction system. Regardless of the photoactivation site or intensity, the response to RV 
photoactivation of Cx40-ChR2 hearts was abolished by intracavital injection of 
iodine/potassium iodide solution (Lugol's solution), a common strategy used to ablate 
Purkinje fibers 160,186-190, further proving the specificity of the Cx40-ChR2 mouse model 
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(Fig.4g). Intracavital injection of physiologic solution did not alter heart responsiveness to 
photostimulation (data not shown, n=5 mice for each group).  
Our results show that the Cx40-ChR2 model represents a unique tool to investigate 
the role of the cardiac conduction system in vivo, using a simple experimental setup that 
allows accuracy and flexibility without requiring invasive approaches, i.e. endocardiac 
electrophysiology.  
 
4. Selective electrophysiological study of Purkinje fibers in vivo. 
   
To assess the maximal ventricular pacing rate, we photostimulated hearts with trains 
of light pulses delivered at incrementally shorter cycle repetition rate, from 10 to 25 Hz, and 
determined the threshold for 1:1 capture by analyzing the ECG trace. The α-MyHC-ChR2 
hearts were responsive up to 18 Hz (1080 bpm) (n=5 mice), while the Cx40-ChR2 mice 
responded with 1:1 capture up to about 15 Hz (900 bpm) (n=5 mice), and above this 
threshold, stimulation was effective in a variable percentage of activation flashes (Fig.5a). 
These results are compatible with the increased refractoriness reported for conduction 
system cells with respect to working CMs. However, the Effective Refractory Period (ERP) 
of Purkinje fibers, has only been determined in ex vivo preparations 164,188,191-194, or inferred 
using intracavital microelectrodes to deliver electrical pulses to an area that includes, but is 
not limited to, the conduction system 172-174,195,196. We thus performed non-invasive 
epicardial optical programmed stimulation to determine selectively the ERP of Purkinje 
fibers and that of the working CMs in vivo. The standard electrophysiological protocol of 
'extrastimulus' (see methods and Fig.5b), was used for optical stimulation. In agreement 
with the data acquired using ex vivo preparations, the ERP of Purkinje fibers, measured 
directly in vivo, was significantly longer than that of the working myocardium (ERP, RV 
Cx40-ChR2: 59.7±1.2 vs α-MyHC-ChR2: 38.4±2.6, in ms; n=5 Cx40-ChR2 mice and n=10 
α-MyHC-ChR2 mice) (Fig.5c). This latter values was indistinguishable from those obtained 
with conventional electrical stimulation 197.  
 
5. Requirement for afterdepolarizations to trigger ectopies in the working vs 
conducting myocardium.   
 
Propagation of focal arrhythmic beats in the heart occurs when the current density 
generated by the abnormally depolarizing CMs (current source) is sufficient to overcome the 
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electrotonic sink of the surrounding polarized tissue. The critical cell number needed to bring 
the sink to its activation threshold has never been determined directly in the intact heart. 
Similarly, the individual contribution of the two distinct myocyte populations (i.e. working 
vs Purkinje myocytes) has not been elucidated. Here, we exploited the ability of optogenetics 
to specifically control a distinct myocardial cell population, in a well-defined volume, to 
determine the tissue requirements for the generation of a globally spreading wavefront 
causing arrhythmic beats in vivo.  
Calculation of blue light attenuation by the myocardium. The optogenetics experiments 
were based on the local photoactivation of ChR2 in confined myocardial volumes. Therefore, 
to calculate the tissue depth irradiated by light at sufficient intensity to activate ChR2, we 
first sought to determine the blue light attenuation coefficient of the myocardium. To this 
aim, the fiber optic illuminator was placed on one side of a myocardial slice and light 
intensity emerging across the slice was measured with a radiometer (Thorlabs GmbH, 
Germany). The fractional light absorption was estimated for slices of incrementally higher 
thickness, from 25 to 800 µm. This allowed determination of the light attenuation coefficient 
of the myocardium, by fitting the experimental data to the commonly used light-matter 
interaction model, Lambert law: I(h) = Ioe-h/δ 116,198,199, where I0 is the light intensity at the 
source, h the depth in the tissue and δ is the scattering length (Fig.6a). Data fitting gave us 
a scattering length δ of 240 µm with a good coefficient of determination (R2 > 0.9 ). The 
experimental data obtained for light attenuation were fitted to another light-matter 
interaction model, the Kubelka-Munk model 200,201 (data not shown), resulting in the estimate 
of the scattering parameter S = 14-20 mm-1 (S parameter previously calculated for the brain 
is 12 mm-1 200). Based on ChR2 activation threshold values, obtained by us and confirmed 
by others in isolated cells (1-0.5 mW/mm2) 107,116, we were thus able to determine the depth 
of photoactivated ChR2 into the myocardium in each experimental condition.  
The physical features of the optic fibers define an emerging light cone with an a very 
narrow opening angle, around 15°, which was calculated from the NA of the fiber (0.39 for 
all fibers with the exception of the 100 µm diameter fiber which was 0.22) and the refractive 
index of the myocardium (1.44, 202). Subsequently, to experimentally assess the degree of 
lateral delimitation of the incident light beam and the effect of tissue light scattering, we 
captured the image of the light, as emerging from the myocardial slices. The analysis of the 
beam intensity profile indicates that, although the beam shape has the tendency to diverge 
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with distance from the light source, over the 90% of total light intensity was confined in a 
volume that can be approximated to a cylinder (Fig.6b and Suppl. Fig.5).   
Optogenetic assay of the minimal myocardial volume to obtain PVCs. To quantify the 
relationship between the number of activated cells and the ability to generate ectopies, we 
then implemented an optogenetic assay based on gradually increasing the photoactivation 
light intensity (at the fiber tip) in differently-sized fiber optics (light intensity: 0.36 to 27 
mW/mm2; fiber tip diameter: 100 to 1500, µm). 
We were thus able to control the light penetration depth (h) and width (d), respectively, 
thus shaping the volume of illuminated myocardium as shown in Fig.6c. When all CMs were 
photoactivated (α-MyHC-ChR2, n=10 mice), ventricular beats were triggered upon 
illumination of a minimal tissue volume of 12.6-18 nL (d: 200; h: 400-570, in µm) in the 
LV, and 5.1-5.7 nL (d: 100; h: 650-720, in µm) in the RV, that would result, when 
considering the average cardiomyocyte volume (10 pL) and orientation in the different cell 
layers, to about 1300-1800 (LV) and 511-570 (RV) cells, respectively (Fig.6d,e). It is likely 
that the differences observed in the critical tissue mass in the two ventricles may reflect the 
contribution of Purkinje fibers, mainly found in the subendocardial layers, to the 
photoactivation of the thinner RV; although a role played by the different 
electrophysiological properties of RV and LV CMs cannot be excluded. To more specifically 
establish the critical tissue requirements to generate premature ventricular contractions 
(PVC) upon RV stimulation, we chemically ablated Purkinje fibers using intracardiac 
injection of Lugol's solution in α-MyHC-ChR2 mice. In these conditions, the minimal 
photoactivated cell number, in the RV, increased to values comparable to those measured in 
the LV (RV+Lugol’s solution: 1800-2300 working myocytes: d: 200, h: 570-740, in µm, 
n=5 mice) (Fig.6e). Due to the higher thickness of the LV wall, Purkinje fibers failed to be 
photoactivated with epicardial photostimulation. Consistently, LV intracavital Lugol's 
solution injection did not cause significant changes in susceptibility to photoactivation, and 
consequently in the minimal tissue volume required for generating an ectopic beat. 
It is well established that Purkinje fibers are prone to develop early or delayed 
afterdepolarizations that, in turn, represent common trigger mechanisms of ventricular 
arrhythmias. How many Purkinje fiber cells are needed to simultaneously fire, for successful 
propagation of their AP into the myocardium, has not been determined so far. Thus, we 
calculated the minimal volume to be irradiated to evoke Purkinje fiber driven PVCs in the 
most responsive regions of the RV, which resulted of about (d: 200; h: 570-740, µm), 
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corresponding, based on our immunohistochemical quantification to about 90-160 cells (n=8 
Cx40-ChR2 mice). 
Collectively, our results demonstrate that ectopies can be triggered in vivo by the 
afterdepolarization of either a substantial number of working CMs, or a much lower quantity 
of Purkinje fibers. Although with disparities in the cell number presumably due to species 
differences, our findings support the concept suggested by computational modelling of the 
rabbit heart, whereby afterdepolarizations arising in Purkinje fibers are more likely to 
overcome the source-sink mismatch and trigger ectopic beats 33.  
 
6. Optogenetic discrimination of arrhythmia trigger sites during myocardial ischemia. 
 
Sudden cardiac death (SCD) caused by ventricular arrhythmias in the early phase of 
acute myocardial ischemia accounts for a large number of fatalities 157. Ischemia induces 
heterogeneities in excitability, refractoriness and/or conduction that generate a permissive 
myocardial environment (substrate) upon which abnormal depolarizations, although 
uneventful in the healthy heart, may act as a trigger for self-sustained arrhythmias. What are 
the factors, i.e. location relative to the ischemic area, size and cell type (i.e. working vs 
Purkinje myocytes), that characterize an efficient focal trigger for sustained ventricular 
arrhythmias during ischemia has not been addressed directly. 
To explore this, optogenetics was used during the acute phase of experimental ischemia 
in  α-MyHC-ChR2 and Cx40-ChR2 mice. Myocardial ischemia was obtained by ligating the 
left anterior descending (LAD) coronary artery, during continuous ECG monitoring. The 
associated myocardium became immediately pale and within the first fifteen minutes, 
ischemia caused the expected alterations in the QRS complex (Fig.S6).  
The susceptibility to focal arrhythmia triggering was assessed using a 
phostostimulation protocol consisting of a burst of ten light pulses (5 ms), at repetition rates 
from 10 to 20 Hz (cycle length from 100 ms to 50 ms), that was applied to a series of 
reference epicardial sites of the left and right ventricles (1: LV anterior, 2: LV septal, 3: 
lateral; 4: RV free wall, 5: septal; at basal, mid and apical regions). In both the α-MyHC-
ChR2 (n=10 mice) and the Cx40-ChR2 (n=8 mice) hearts, responses to focal 
photostimulation were, in the initial phase (0-15 min.), similar to non-ischemic controls, 
with the exception of the anterior LV region, that became progressively unresponsive due to 
the direct effect of ischemia. Local burst activation at none of the cardiac foci resulted in 
sustained arrhythmias (Fig.7a-b) (0 out of 10 mice for α-MyHC-ChR2 and 0 out of 8 mice 
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for Cx40-ChR2). Fifteen-to-thirty minutes after ischemia, in α-MyHC-ChR2 mice, the 
identical photostimulation protocol, applied to a restricted area of the RV basal free wall, 
(corresponding to the junctional region between the septal and RV conduction system (see 
Fig.4)) evoked frequent episodes of non-sustained runs of polymorphic ventricular 
tachycardia (VT), lasting few beats after pacing in all animals analyzed (Fig.7c, top panel). 
Such behaviour was never evoked by applying the identical stimulation protocol in the 
Cx40-ChR2 mice (Fig.7c, bottom panel) (n=6 mice for each group). Interestingly, during 
the transitional phase to irreversible ischemic damage (45-60 min. after LAD ligation, 59-
61), photostimulation of the same region of the RV triggered sustained polymorphic VT and 
VT/VF, lasting up to 50 s, in 8 out of 10 of the α-MyHC-ChR2 mice analyzed (Fig.7d, top). 
On the contrary, the same protocol applied to all other myocardial areas explored, outside 
this region, failed to evoke sustained VT/VF. Moreover, the arrhythmia protocol applied to 
stimulate the Purkinje fibers of ischemic Cx40-ChR2 hearts never induced sustained 
arrhythmias, regardless of the stimulation frequency and location (Fig.7d, bottom). In sham-
operated mice (n=4), photostimulation, either in single pulses or in bursts, never triggered 
sustained arrhythmias (data not shown). 
These results indicate that, during LV myocardial ischemia, the propensity of focal 
ectopic beats to trigger arrhythmias varies with the anatomical sites, as identical ectopies 
had remarkably different effect, ranging from single stimulated beats to the triggering of 
sustained arrhythmias. The highest arrhythmogenic potential was found for ectopies 
occurring in the region corresponding to the root of the RVOT, and involving both Purkinje 
fibers and working CMs. The depolarization of the sole Purkinje fibers was, in fact, not able 
to trigger sustained arrhythmias.  
 
 
DISCUSSION 
 
Most ventricular arrhythmias are caused by the combined effect of factors creating a 
substrate in the heart tissue favouring electrical instability, with events of localized 
depolarization in the CMs serving as trigger 32,33. While great progress has been made in the 
identification of the mechanisms determining the pro-arrhythmogenic substrate (e.g. genetic 
mutations altering the single cell electrophysiology or cell-cell communication, myocardial 
fibrosis) 25,155,156, the fundamental requirements of arrhythmia triggers are as yet poorly 
understood. Cardiac optogenetics was used to define such requirements, by determining the 
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minimal cell number of working vs conducting CMs that characterize a trigger focus of 
ectopic heartbeats in the normal heart. The arrhythmogenic potential of such ectopies was 
explored during acute myocardial ischemia, a condition associated with increased 
arrhythmia susceptibility 158,161,162. In this study, the optogenetic approach discriminated 
with high precision the location of arrhythmia trigger sites in the heart and the different cell 
systems involved (working vs conducting CMs).  
 
Critical determinants of arrhythmogenic foci 
Ectopic heartbeats are common disturbances of the heart rhythm whereby the 
untimely depolarization of groups of CMs, mainly due to early- or delayed-
afterdepolarizations, disrupts the physiologic sequence of impulse formation resulting in 
premature contractions. The electrotonic coupling of the myocardium protects from the 
propagation of arrhythmogenic action potentials triggered by afterdepolarizations, only after 
a sufficient number of CMs are activated simultaneously to overcome the source-sink 
mismatch, an ectopic beat will occur 32,33. Here we quantitatively studied the critical 
determinants of arrhythmogenic focal sources, including the minimal cell number, their 
cardiac topology and the type of cells involved. These aspects have, thus far, only indirectly 
been estimated in ex vivo preparations or with simulation modeling based on cellular data 
32,33. We used optogenetics that allowed the direct activation of selective cardiac cell 
populations expressing the photoactivable channels (i.e. ChR2 in this study) in confined 
regions of the heart wall, thus mimicking focal spontaneous electrical activity. As a 
prerequisite to our experimentation, we determined the attenuation of the blue light across 
the myocardial wall, by combining light penetrance data in tissue, with mathematical 
modelling, and were thus able to accurately control the three dimensional size of the ectopic 
foci. Our data demonstrated that the minimal number of CMs required to form a focal ectopic 
site of ventricular activation is, in the mouse heart, in the order of few thousand (from 1300 
to 1800) cells. When premature depolarization was selectively induced in the Purkinje fiber 
cells, a much lower number of simultaneously depolarizing cells (about 100) was needed to 
trigger ventricular activation. This observation is in agreement with the prediction of 
simulation modelling 33 suggesting that, irrespective of their sensitivity to develop 
afterdepolarizations, a working CMs to overcome the protective effect of myocardial current 
sinks, solely due to their quasi mono-dimensional arrangement. Notably, when light pulses 
were delivered to this region at supra-threshold intensity, the success rate in the activation 
of ectopic heartbeats was close to 100%. Taken together, these results demonstrate that the 
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selective optogenetic interrogation of the Purkinje fibers, combined with the topological 
study of their distribution, informs on the structure/function relationship of this cardiac sub-
system with unprecedented detail.  
 
Triggered arrhythmias during myocardial ischemia. 
Acute myocardial ischemia is a major cause of sudden cardiac death (SCD) 158,159. 
The sudden cessation of myocardial blood flow causes heterogeneities in excitability, 
refractoriness and/or conduction. All of these factors contribute to creating the pro-
arrhythmogenic myocardial substrate that, in the presence of ectopic excitation from focal 
sources, may trigger the lethal ventricular arrhythmias 161,203,204. Having established the 
tissue determinants for the generation of focal ectopic beats, we ascertained the 
characteristics of focal ectopic triggers of ventricular arrhythmias potentially causing SCD, 
by coupling optogenetic investigation to the experimental model of acute myocardial 
ischemia. Central to such experimental design, the optogenetic investigation is non-invasive, 
and does not associate to heterogeneity in myocardial depolarization nor to tissue damage 
that might be caused by the production of damaging gases (Cl2, H2, O2) and pH alterations, 
during conventional electric stimulation 205,206, especially during prolonged experiments. 
Focal ventricular pacing at various regions in the healthy heart could be performed even at 
elevated rate and for a prolonged period of time (up to 30 min), and never triggered 
arrhythmic episodes. Local deep tissue pacing during myocardial ischemia triggered instead 
several arrhythmia types, progressing from short runs of extra beats to sustained ventricular 
tachycardia/fibrillation, along with ischemia time. Remarkably, the longer and more 
complex arrhythmias were triggered by local pacing in correspondence of the right 
ventricular portion showing a complex organization in the terminal Purkinje fibers. 
Interestingly, the same structure has been identified in the human heart 207,208, and it is 
tempting to speculate that such anatomical organization of the cardiac conduction system 
network might contribute to the generation of arrhythmias triggered by ectopies arising from 
the RVOT, as well reported in the literature 209. 
 
Limitations and perspectives of the study. 
The study applies cardiac optogenetics to a murine model of cardiovascular 
pathology (i.e. myocardial ischemia) and describes the focal arrhythmia trigger determinants. 
The main limitation of the study is that, although the genetic restriction of ChR2 expression 
to atrial and conduction system cells allowed to selectively interrogate the Purkinje fiber 
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function, in the alternative model used the α-MyHC promoter drives ChR2 expression to all 
cardiomyocyte types, and not solely to the working CMs. We aimed to overcome such 
disadvantage by combining optogenetics with the conventional pharmacologic strategy used 
to ablate Purkinje fibers, in a subset of experiments. Such approach, however, could not be 
applied to the in vivo assessments during ischemia, due to the complex adverse effects of the 
treatment. The study methodology and the accuracy of the estimates of the cell number 
needed to generate PVCs relies centrally on the measurements of tissue light absorption. 
One limitation of such measures is that they have been performed using cardiac slices that, 
although freshly cut, are not physiologically perfused by the blood, which may have a 
modest but noticeable effect on tissue light penetration. The protocols developed in the 
current investigation can potentially be combined to emerging methods of voltage imaging 
of the heart in vivo, to define in higher detail the electrophysiologic effect of local 
photoactivation and the mechanisms of arrhythmia dynamics. We have used here a rather 
simple hardware setup for the photoactivation experiments in the mouse, but our preliminary 
investigations indicate that technical strategies allowing complex light patterns, e.g. multiple 
photopacing foci or delivery of complex spatial illumination patterns, can be used to mimic 
relevant arrhythmogenic phenotypes, including bidirectional ventricular tachycardias or 
spiral depolarization wavefronts. In addition, stable implant of miniaturized LED in the 
mouse thorax can be pursued to achieve optical stimulation of PVCs in the freely moving 
animal, allowing the investigation of the effects of focal ectopies in chronic disease models 
and the longitudinal study of drug effects. 
 
Conclusions.  
In essence, our study extended the cardiac optogenetics toolkit with a novel murine model 
with ChR2 expression restricted to the conduction system, and developed experimental 
protocols to address physiological and pathological mechanisms relevant to the 
understanding of cardiac arrhythmias. In perspective development, optogenetics can be 
employed for the study of other arrhythmia-linked genetic (e.g. LQTS, CPVT) or acquired 
arrhythmogenic conditions and for pharmacological research aimed at the identification and 
testing of antiarrhythmic compounds.  
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Figure 1. Cardiac optogenetics allows non-invasive investigation of heart electrophysiology in vivo. 
(a) Bright field (left panel) and fluorescence (right panel) images of α-MyHC-tdTomato-ChR2 heart. The right 
image of tdTomato fluorescence shows expression of ChR2 in both atria and ventricles. RA, right atrium; LA, 
left atrium; RV, right ventricle; LV, left ventricle. (b) Confocal image of ventricular cryosections from α-
MyHC-tdTomato-ChR2 transgenic hearts showing ChR2 localization at the level of cardiomyocyte 
sarcolemma (white arrows) and t-tubuli.  (c) Set up used for epicardial photostimulation in open-chest 
anesthetized mice. LED stimulation occurred through fiber optics delivering time-controlled pulses of 470 nm 
blue light. (d-e) Representative ECG traces of ectopic beats originated by epicardial light-stimulation of 
different regions of the myocardium from α-MyHC-ChR2 mice (n=10 mice). Blue arrows in (d) and (e) 
indicate light pulses. LA, RV and LV photostimulation originates ectopic beats with different QRS shape.  
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Supplementary Figure 1. Tissue specific expression of ChR2 in the heart by using the cre-lox genetic 
system. 
(a) Transgenic mice expressing cre-recombinase under the control the cardiomyocyte specific promoter, α -
Myosin Heavy Chain (α-MyHC), were crossed with B6.Cg-Gt (ROSA) 26Sortm27.1 (CAG-COP4*H134R/tdTomato) 
Hze/J. The resulting offspring had the STOP cassette deleted in CMs, driving the expression of the hChR2 
(H134R)-tdTomato fusion protein. (b) Confocal image analysis of atrial cryosections from control (left panel) 
and α-MyHC-ChR2 transgenic mice (right panels). (c) Haematoxilin-eosin staining on ventricular cryosections 
from control (top panel) and α-MyHC-ChR2 transgenic mice (bottom panel), showing no significant alterations 
in myocardial histology in ChR2 expressing hearts. (d) Evaluation of heart rate (in beat per minute, bpm) (left 
panel) and QRS interval (in ms, right panel) in control (black bars) and α-MyHC-ChR2 transgenic mice (white 
bars).  Bars represent s.e.m. (NS, not significant; n=10 mice for each group). 
  
 
 
 89 
Figure 2. Optogenetics based investigation of heart electrophysiology ex vivo.  
(a) Activation map of one photostimulation pulse on the RV. The dashed line indicates the stimulation fiber 
position. Scale bar: 0.5 cm, colorbar in (ms).  (b) Example of monophasic potential (MAP) signal during 
photostimulation. (c) Optical mapping (Vm) of one light pulse. The fiber position is adumbrated in the first 
snapshot by the grey dashed line. All propagation showing snapshots are separated in time by 2 ms. Scale bar: 
0.5 cm. The asterisk shows the MAP electrode position. (d-f) Optical measurement of photostimulation and 
spread of activation in a Langendorff-perfused intact mouse heart. (d) Intensity distribution of photostimulation 
using an optical fiber (OF, diameter 0.4 mm). The position of the fiber tip is indicated by the gray-shaded 
rectangle. The isochrones indicate the relative intensity (colors of the isochrones correspond to colorbar). RV 
= right ventricle, LV = left ventricle. (e) Cross section of the intensity distribution. The intensity profile is 
given along the blue line shown in the inset. (f) Activation map showing the propagation of wave fronts 
following photostimulation. 
 
Supplementary Figure 2. Ex vivo photostimulation of α-MyHC-ChR2 hearts. 
(a) Percentage of successful coupling on the left (LV, left panel) and right (RV, right panel) ventricles at 
different stimulation frequencies and with different sized fibers (200 µm, green; 400 µm, black and 800µm, 
red). 
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Figure 3. Direct optogenetic assessment of Purkinje fiber function in vivo. 
(a) Scheme of the generation of the transgenic mouse expressing the fused protein, tdTomato-ChR2, under the 
control of Connexin-40 (Cx40) promoter, (Cx40-ChR2). (b) Bright field (left panel) and fluorescence (right 
panel) images of a longitudinally sectioned whole Cx40-ChR2 heart. The right image shows specific 
expression of ChR2 in the atria and the conduction system. RA, right atrium; LA, left atrium; RV, right 
ventricle; LV, left ventricle. (c-d) Confocal immunofluorescence analysis on ventricular (c) and atrial (d) 
cryosections from red fluorescent Cx40-ChR2 mice stained with an antibody specific for Cx40 (green signal). 
(e-f) Representative ECG traces of ectopic beats originated by epicardial photostimulation of different regions 
of the myocardium from Cx40-ChR2 mice (n=8 mice). Blue arrows indicate light pulses. RV and IVS 
photostimulation originates ectopic beats with different QRS shape in all mice, while LV epicardial stimulation 
always failed to induce ectopies. 
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Supplementary Figure 3. Selective expression of ChR2 in conducting cardiomyocytes.  
(a) Hearts from a Cx40-ChR2 transgenic mouse were cut longitudinally and slices were analyzed at the 
fluorescence stereomicroscope. The image evidences the presence of ChR2 expressing bundles in the 
interventricular septum (IVS), as well as in the right ventricle (RV) subendocardium. ChR2 positive fibers can 
be detected in the left ventricular (LV) wall. (b) Confocal image analysis of atrial cryosections from Cx40-
ChR2 transgenic mice. (c) Confocal immunofluorescence analysis on ventricular cryosections from a α-
MyHC-ChR2 transgenic mouse stained with an antibody to Cx40. The red signal is the fluorescence of td-
Tomato-ChR2 expressing cells. The green signal, indicating the expression of Cx40, is specifically restricted 
to the subendocardial layers of Purkinje Fibers. (d) Confocal immunofluorescence analysis on ventricular 
cryosections from a α-MyHC-ChR2 transgenic mouse stained with a 488-conjugated anti-rabbit secondary 
antibody. The red signal is the fluorescence of td-Tomato-ChR2 expressing cells. The absence of the green 
signal indicates no a-specific staining of the secondary antibody.  
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Supplementary Figure 4. ChR2 expression in the cardiac conduction system does not affect heart 
morphology and function. 
(a) Haematoxilin-eosin staining on ventricular cryosections from control (left panel) and Cx40-ChR2 
transgenic mice (right panel). (b) Evaluation of heart rate (in beat per minute, bpm) (left panel) and QRS 
interval (in ms, right panel) in control (white bars) and Cx40-ChR2 transgenic mice (black bars). Bars represent 
s.e.m. (NS, not significant; n=8 mice for each group). (c) Representative ECG trace of ectopic beats originated 
by epicardial light-stimulation (10 Hz) of the left atrium (LA) from Cx40-ChR2 mice (n=8 mice). Blue arrows 
indicate light pulses (5 ms).  
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Figure 4. Correlation between distribution and function of the Purkinje fiber network in the right 
ventricle. 
(a) RV epicardial surface of Cx40-ChR2 heart. The black box indicates the RV region with the highest 
responsiveness to photostimulation. (b) Bright field (left panel) and fluorescence (right panel) images of the 
RV section at the anatomical level enclosed in the black box in (a). (c-f) Three-dimensional reconstruction of 
the RV Purkinje fiber arborization obtained in Cx40-GFP transgenic mice by optical projection tomography. 
Images in (e,f) highlight the connecting bundle between septal and the right ventricular branches of PF. (g) 
Representative ECG traces of ectopic beats originated by epicardial light-stimulation of the RV from Cx40-
ChR2 mice before and after (15 min) RV intracavital Lugol’s solution injection (n=5 mice). Blue arrows 
indicate the light pulses. Lugol’s solution treatment caused enlargement of the QRS complex and abolished 
light induced ectopies in all mice analyzed. 
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Figure 5. Optogenetics allows selective interrogation of Purkinje fiber electrophysiology in vivo. 
(a) Stimulation rate/cardiac capture relationship obtained in α-MyHC-ChR2 and Cx40-ChR2 mice. Bars 
represent s.e.m. (*, p<0.05, **, p<0.01; n=5 mice for each group). (b) Optical programmed stimulation using 
the extrastimulus (S1-S2) protocol to measure the effective refractory period (ERP). Blue arrows indicate the 
light pulses. (c) Evaluation of the ERP in the RV of both α-MyHC-ChR2 (grey bar) and Cx40-ChR2 (black 
bar) mice. Bars represent s.e.m. (**, p<0.01; n=10 α-MyHC-ChR2 mice and n=5 Cx40-ChR2 mice). 
 
 
Supplementary Figure 5. Estimation of the shape of the light penetrating the myocardial tissue. 
Shape of the light emitted by a 200 µm optical fiber as it emerges from myocardial slices of different thickness.  
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Figure 6. Optogenetic assay of the minimal myocardial volume required to trigger focal ectopic beats in 
the normal myocardium. 
(a) Measure of 470nm light penetrance into the ventricular myocardium upon epicardial illumination. 
Experimental data were fitted to a monoexponential decay function (R2>0.9) 200, shown with solid line. Bars 
represent s.e.m. (n=10). (b) Images of the optical fiber's light beam, as emerging from myocardial slices of 
incremental thickness. For each image the beam intensity profile is shown; the red bar indicates the diameter 
of the optical fiber (c) Modulation of light intensity and fiber diameter shapes depth (h) and width (d), 
respectively, of the illuminated myocardial cylinder. (d-e) Optogenetic assay of minimal myocardial volume 
required for successful trigger of ectopies in the LV (d) and RV (e). The red circle in the columns in (e) 
indicates the percentage of successfully captured beats after Purkinje fiber ablation with Lugol's solution. Black 
arrows in (d) and (e) indicate the liminal tissue volume to be irradiated to evoke ectopic beats. Red arrow in 
(e) indicates the liminal tissue volume after Lugol's solution injection in the RV. Bars represent s.e.m. 
(measures repeated in triplicate, in n=10 mice).  
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Supplementary Figure 6. Left descending coronary artery ligation in α-MyHC-ChR2 mice. 
(a) Image of a whole heart from a α-MyHC-ChR2 undergone left anterior descending (LAD) coronary artery 
ligation and subsequent intravenous injection of Evans Blue, to identify the ischemic pale area. White arrow 
indicates the coronary ligation. LV: left ventricle; RV: right ventricle. Scale bar: 1 mm. (b) Representative 
ECG traces from α-MyHC-ChR2 transgenic mouse at baseline, 5 and 30 minutes after LAD ligation. ECG 
recording evidences alterations of the QRS complex upon ischemia, which are absent in sham operated mice 
at the same time point. 
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Figure 7. Induction of sustained ventricular arrhythmias by optical stimulation in the advanced post 
ischemic phase.  
(a) Photograph of the optogenetic experiment, picturing the heart of the anesthetized mouse, seen through the 
toracotomic window, during delivery of a light pulse to the RV epicardium via the optical fiber. The white 
arrowhead shows the region described in Fig.4c-f. (b) ECG traces of RV photostimulation during the first 15 
minutes after LAD ligation in α-MyHC-ChR2 (top panel) and Cx40-ChR2 (bottom panel) hearts (n=10 and 
n=8 mice, respectively). (c) ECG trace recorded between 15 and 30 minutes after LAD ligation in α-MyHC-
ChR2 (top panel). Photostimulation of the origin of the RVOT induced episodes of un-sustained polymorphic 
ventricular tachycardia. (bottom panel) ECG trace recorded 15 to 30 minutes after LAD ligation in Cx40-ChR2 
mouse. (d) (top panel) ECG trace of sustained arrhythmias originated by light-stimulation of the RV, at the site 
indicated above, in α-MyHC-ChR2 during post-ischemic phase 2. Sustained arrhythmias were induced in 8 
out of 10 mice. The same photostimulation protocol failed to trigger sustained arrhythmias in Cx40-ChR2 mice 
(n= 8 mice) (bottom panel). Blue arrows indicate the light pulses. 
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MATERIALS AND METHODS 
 
 
Mouse models. For ex vivo study, we used transgenic adult (3 mo.) male mice expressing the 
hChR2(H134R)-tdTomato fusion gene under the control of alpha-Myosin Heavy Chain α-
MyHC) promoter; mice were backcrossed into the C57B6J background. For in vivo study, 
transgenic adult  male mice, with a genetic background C57B6J, expressing cre-recombinase 
under the control of either α-MyHC or Connexin-40 (Cx40) promoter were bred with B6.Cg-
Gt(ROSA)26Sortm27.1(CAG-COP4*H134R/tdTomato)Hze/J expressing  mice (Jackson Lab. Bar Harbor, 
Maine, USA). The resulting offspring has the STOP cassette deleted in the heart, resulting in 
cardiomyocyte (α-MyHC-ChR2) or Purkinje fibers (Cx40-ChR2) expression of the 
hChR2(H134R)-tdTomato fusion protein. Both α-MyHC-cre+/- and Cx40-cre+/- lines were 
used to maintain the colonies. Hearts from cx40-GFP transgenic mice were also analyzed 210. 
All experimental procedures described in this manuscript have been approved by the local 
ethical committee (Authorization number C54) and communicated to the relevant Italian 
authority (Ministero della Salute, Ufficio VI), in compliance of Italian Animal Welfare Law 
(Laws n 116/1992, D.Lgs 26/2014 and subsequent modifications). 
 
Optical Mapping. The electrical activity of hearts of transgenic channelrhodopsin-2 (ChR2) 
mice was visualized in Langendorff isolated perfused hearts, via epicardial voltage mapping. 
To eliminate cross-talk between stimulating light and fluorescence emission the dye RH1691 
[40 µM] was used, which has a deep red emission spectrum. The recording system consisted 
of the commercially available microscope MVX10 (Olympus, Germany) and the MiCam 
camera system, which allows to record with a framerate of up to 1 kHz at a spatial resolution 
of 100 × 100 pixel. As light source for the photostimulation a High Power LED with an 
emitting peak wavelength of 470 nm was coupled to multimode optical fibers (Thorlabs 
GmbH, Germany) with decreasing diameters (∅ 1000 µm, 800 µm, 400 µm and 200 µm). 
The LED was triggered via a high power, 1-channel LED driver with pulse modulation 
(Thorlabs GmbH, Germany). 
 
In vivo epicardial photostimulation. Adult ChR2 expressing transgenic male mice and 
littermate controls were anesthetized by isoflurane administration (1,5%-3%), secured to the 
table in supine position and intubated with a 24G needle for ventilation (tidal volume 0.4 
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ml; 120 strokes/min) from an artificial ventilator (SAR-830). Body temperature was 
monitored constantly during the experiment. The skin was dissected by a lateral sub-
ascellary 1.5 cm cut, subcutaneous muscles were removed and a 0.5 cm incision was 
performed at the level of the 4th intercostal space. Self-retaining microretractors were then 
used to separate the 3rd and 4th ribs enough to get adequate exposure of the operating region. 
The heart was exposed and different epicardial regions from the atria and the left and right 
ventricles were stimulated by differently-sized (from 100 to 1500 diameter, in µm) fiber 
optics (Thorlabs, Germany), coupled to a 470 nm LED (Thorlabs, Germany), controlled by 
an ECG-coupled recording system (Powerlab 8/30, LabChart 7.1 software; AD Instruments). 
Trains of 5 ms light pulses were delivered with a cycle-length of 100 ms, with the exception 
of the burst stimulation used for the study of arrhythmia triggering.  
 
ECG recording and analysis. A standard lead I ECG was recorded (Powerlab 8/30, 
Bioamp; AD Instruments) during the experiment. ECG parameters (QRS, PR interval and 
heart rate) were calculated by using LabChart 7.1 software (AD Instruments).  
 
Measurement of The Ventricular Effective Refractory Period (VERP). The VERP of 
both the working CMs and Purkinje fibers was evaluated in α-MyHC-ChR2 and cx40-ChR2, 
respectively, by using the extrastimulus technique 211,212. The epicardial surface of the right 
ventricle was photostimulated by a train of 10 light pulses (5 ms), at a frequency of 10 Hz 
(cycle length = 100 ms) (S1), followed by a premature optical stimulus (S2) at progressively 
shorter coupling interval until the S2 failed to trigger an ectopy at the VERP (see Fig. 5b). 
 
Burst photoactivation protocol. Brief trains of 5 ms light pulses were delivered to a fixed 
epicardial region with repetition rates ranging from 10 Hz to 25 Hz (cycle length: 100 ms to 
40 ms). For each experiment, stimulation was delivered to five reference regions at the heart 
base and mid portion, that specifically were: 1: LV anterior, 2: LV septal, 3: lateral; 4: RV 
free wall, 5: septal. The apex was considered separately.  
 
Pharmacological Purkinje fibers ablation. Ten µl of Lugol’s solution (5% (wt/v) iodine 
and 10% (wt/v) potassium iodide, in distilled water) supplemented with an equal volume of 
Heparin (all from SIGMA), was carefully injected into either the RV or the LV cavity by 
using a Hamilton syringe supporting a 34G needle. To increase permanence of Lugol’s 
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solution in the ventricles, the pulmonary artery or the aorta were transiently clamped (about 
10 s).  
 
Optical Projection Tomography. Hearts from Cx40-GFP transgenic mice were analyzed 
as previously described in 28. 
 
Left anterior descending (LAD) coronary artery ligation. The main trunk of the LAD 
coronary artery was ligated under microscope guidance, by using a 7/0 polypropylene suture 
213. Epicardial photostimulation was performed at different time points (from 5 to 90 minutes) 
after coronary occlusion, during constant ECG recording.  
 
Measurement of blue light attenuation in the myocardium. Hearts from both control and 
ChR2 expressing mice were harvested and the left and right ventricular walls dissected. Intact 
ventricles, as well as longitudinally cut ventricular slices of different thickness were placed 
in contact with the light sensor of a power meter (Thorlabs, PM100D). The same fiber optics 
used in the in vivo experiments were used to determine tissue light attenuation, by 
illuminating the slices while measuring the emerging light intensity with the power meter. 
Emerging light intensity was measured for each fiber diameter (from 100 to 1500 µm), at 
varying light intensities (from 0.36 to 27 mW/mm2), and all these measures were performed 
in slices of different thickness (from 25 to 800 µm) . Myocardial light attenuation was 
modelled by adapting previous studies made in the brain 200. Briefly, values of light intensity 
experimentally determined using the tissue phantoms described above were fitted to a 
monoexponential decay curve to extrapolate light intensity as a function of the depth from 
the epicardial surface. Light intensity threshold for ChR2 activation were obtained from 
107,116. To determine the lateral discrimination of the illuminating beam in the myocardium, 
slices were imaged through a modified inverted microscope (Nikon eclipse 200) equipped 
with a 2048x1024 pixel CCD detector (Hamamatsu, Japan), to acquire the image of the fiber 
optic carried 470 nm light, as emerging through myocardial tissue samples of incremental 
thickness. In each image the shape, brightness, pixel intensity distribution, intensity linear 
profile were calculated using image analysis software (ImageJ, Wayne Rasband, NIH, 
Bethesda, USA). 
 
Tissue samples and immunofluorescence analysis. The hearts were harvested from 
transgenic, as well as control mice, fixed in 2% paraformaldehyde (PFA) (Sigma) for 1 hour 
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at room temperature, equilibrated in sucrose gradient at 4°C, embedded in OCT and frozen 
in liquid nitrogen. Ten-micron myocardial sections were obtained with a cryostat (Leica 
CM1860) and processed for histological and immunofluorescence analyses. 
Immunofluorescence analysis was performed as described in 1 . Rabbit anti-cx40 (1:200, 
Invitrogen) and AlexaFluo antirabbit-488 (Jackson) was used. Sections were analyzed with a 
Leica TCS SP5 confocal microscope. 
 
Tamoxifen treatment. Adult (3 month) Cx40-ChR2 transgenic mice were injected with 
Tamoxifen (Sigma) (100 mg/kg, ip.) for 5 consecutive days. Mice underwent in vivo ChR2 
photostimulation two weeks after the conclusion of the pharmacological treatment. 
Tamoxifen delivery was also performed in a subset of α-MyHC-ChR2 mice leading to 
exclude that such treatment causes per se alterations in cardiac activity or affects arrhythmias 
susceptibility. 
 
Evans blue staining. A subset of control and ChR2 transgenic mice were injected, upon LAD 
coronary ligation, with 1% Evans Blue (Sigma) (w/v) in phosphate-buffered saline (PBS, pH 
7.5) sterilised by passage through a 0.22 µm filter (Millipore). Intravenous injections were 
made to either of the dorsal veins of the tail. Thirty minutes upon injection, mice were 
sacrificed, the hearts were harvested and fixed in 4% paraformaldehyde (PFA) o.n. at 4°C.  
 
Statistical analysis. All data are expressed as the mean±s.e.m. Comparison between the 
experimental groups was made by using the non-paired Student’s t and Anova tests followed 
by Bonferroni correction, with P<0.05 being considered statistically significant. 
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Optogenetic interrogation of cardiac sympathetic neurons shed 
light on the “neuro-cardiac junction”. 
(manuscript in preparation) 
 
Collaborators: Tania Zaglia, Francesca Da Broi, Anna Pia Plazzo, Valentina Prando 
Mauro Franzoso and Marco Mongillo 
 
ABSTRACT 
 
Rationale: The heart is innervated by sympathetic neurons that regulate cardiac function 
during exercise or stress through the release of norepinephrine (NE) activating β-adrenergic 
receptors. Abnormal sympathetic activity is involved in the development and progress of 
cardiovascular disease. In this context, it is important to understand whether and how 
sympathetic neurons (SNs) communicate with cardiomyocytes (CMs). 
Objective: To investigate the characteristics of the interaction between SNs and CMs and 
its functional outcome in the context of the physiological role of SNs in the modulation of 
heart rate in the intact heart. 
Methods and Results: Co-cultures between rat neonatal sympathetic neurons and 
ventricular CMs were set up as an in vitro model of neuro-cardiac interaction. Neurons 
develop adrenergic phenotype, in the presence of NGF, and extend processes forming 
synapsin1-enriched varicosities contacting different CMs. By means of a live imaging 
FRET-based approach we observed that neuronal depolarization lead to intracellular cAMP 
and PKA activity increase specifically in innervated CMs. A single neuron action potential 
released an amount of NE sufficient to initiate cAMP signaling, that remained confined in 
the coupled cardiomyocyte. Optogenetic stimulation of SN innervating sinoatrial node in 
vivo resulted in an increase in heart rate with fast and repeatable kinetics, supporting the 
hypothesis of a specialized interaction SN-CM. 
Conclusions: SNs develop ‘cardiac synapses’ with target CMs to provide fast, economic 
and repeatable modulation of cardiac function. 
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INTRODUCTION 
 
Sympathetic neurons modulate cardiac function to match the perfusional demand of 
the organism through the release of NE that, by activating CM β-ARs, triggers the cAMP-
dependent increase in heart rate and contraction force, a phenomenon called “fight-or-flight” 
response. NE activates adenylyl cyclase producing the second messenger cyclic AMP 
(cAMP) and leading to activation of PKA in the cAMP/PKA pathway. PKA mediates its 
functional effect by phosphorylating several cytoplasmic and nuclear targets involved in the 
increase in force and frequency of heart contraction. Thanks to many FRET-based 
biosensors developed in the recent years, it has been possible to monitor cAMP variations 
in real time in living cells, highly improving the knowledge of intracellular cAMP dynamics 
in CMs. This response is characterized by a fast and repeatable outcome and this contrasts 
with the traditional model of SN modulation of cardiac activity, which relies on the paracrine 
effect of NE released by SN into the myocardial interstitium. However, whether sympathetic 
control of heart function occurs through the activation of a fraction of the receptors localized 
at the neuro-cardiac interaction site or through the activation of all the receptors localized in 
the cardiomyocyte membrane is still debating. In literature there are growing amount of 
evidence in favor of a different model, in which a direct contact between SNs and CMs is 
described, resembling a sort of “neuro-cardiac junction”. Electron microscopy analysis 
demonstrated that in SN-CM co-cultures, neurons form varicosities containing synaptic 
vesicles along their axons 20-30 nm from the cardiomyocyte surface127,214, and that SNs 
activation modulates neighboring CM beating rate129. More recently, it has been shown that 
there is an accumulation of anchoring and signaling proteins at the portion of CM membrane 
adjacent to sympathetic terminals, supporting a model in which the neuro-cardiac interaction 
occurs through a well-organized structure similar to the neuromuscular junction131. Although 
these structural evidence point in the direction of a neuro-cardiac junction, the functional 
implication of this interaction, so far, have been poorly characterized in vitro and has never 
been directly proved in vivo.  
In this study, we sought to use an in vitro model of SN-CM co-cultures, coupled to 
state-of-the-art live cell imaging to monitor in real time the adrenergic signaling occurring 
in a single neuron-cardiomyocyte couple. Moreover, we developed a novel optogenetic 
approach to test the functional implications of this interaction in vivo. This tool is based on 
the expression of the photo-activated cation channel ChannelRhodpsin-2 (ChR2) in the 
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adrenergic neurons of the heart, under the control of the promoter of tyrosine hydroxylase 
(TOH) gene. 
The understanding of the mechanism of SN-CM interaction is of great clinical 
relevance since local cardiac innervation impairment has been associated to a growing 
amount of pathological situations, such as myocardial infarction, diabetes and different types 
of cardiomyopathies. 
 
 
RESULTS  
 
1. Intercellular signalling between sympathetic neurons and cardiomyocytes 
 
SNs innervate abundantly the ventricular myocardium of mammals, in particular 
what we observed from IF analysis on ventricular cryosections of mouse heart is that SN 
terminals, stained with synapsin-I, are closely juxtaposed to CM membrane, suggesting that 
a direct contact between SN terminals and CMs occurs (Figure 1a-c). Moreover. EM 
analysis highlighted the presence of some features that suggest the existence of a specialized 
interaction between SN varicosities and CMs, such as polarization of the neurotransmitter 
vesicles, thickening of the membrane and reduced intermembrane space (Fig. 1d-e). To 
analyze at single-cell level the dynamics of the intercellular coupling between SNs and CMs, 
we used co-culture of primary neonatal rat superior cervical ganglia neurons and primary 
neonatal rat ventricular CMs. SNs in culture extended processes and interacted with 
surrounding CMs forming discrete contact sites corresponding to synapsin I-enriched neuron 
varicosities (Fig. 1g). Consistent with previous reports, the majority of neurons in the culture 
were adrenergic, as shown by immunoreactivity for anti-dopamine-β-hydroxylase 
antibodies, a specific marker of adrenergic neurons, being the last enzyme involved in the 
biosynthesis of NE (Fig.1f). Moreover, EM analysis of SN-CM co-cultures showed the same 
characteristic features observed in the myocardial sections at the intersection between SN 
varicosities and CMs (Fig.1h). We thus exploited real-time fluorescence imaging of 
intracellular cAMP in CMs to analyze the dynamics of the response to the activation of the 
coupled neuron, with the attempt to mimic in vitro the interaction occurring in vivo. To this 
aim, CMs in co-culture with SNs were transfected with the FRET-based cAMP sensor 
Epac1-camps215 (Fig.2). In Epac1-camps expressing CMs, an increase in intracellular 
[cAMP] is expected to decrease FRET efficiency between the CFP and YFP moieties 
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flanking the cAMP-binding site in the Epac1-camps protein. Therefore, by monitoring the 
variation of CFP/YFP emission upon CFP illumination, changes in [cAMP] (i.e. upon NE 
administration, Fig.2b) can be estimated in real time, with high spatial and temporal 
resolution. Epac1-camps expressing CMs had normal cell morphology and spontaneous 
contraction rate. In the co-culture a number of CMs interacted with neurons that developed 
axonal varicosities at the contact site (Fig. 2a.1, arrowheads), while others were passed 
over by neuronal processes that did not show apparent changes in morphology (Fig. 2a.2). 
To activate the neurons and elicit NE secretion from sympathetic terminals, the cells were 
briefly depolarized with a solution containing 50 mmol/L KCl perfused in the bathing 
solution. Depolarization of SNs in co-culture induced an increase in intracellular [cAMP] in 
coupled CMs with a ΔR/R0 = 5.10 % ± 0.42 (n=16) (Fig. 2c, i.e. a cell as depicted in Fig. 
2a.1, and Fig. 2e) and a t1/2 of 20.42 s ± 1.88 (n=16). The same treatment did not activate 
cAMP signaling in the CMs not interacting directly with neuronal terminals in the co-culture 
(i.e. a cell as depicted in Fig. 2A.2, ΔR/R0 = 1.62 % ± 0.35, n=7, Figure 2d and 2e) as well 
as in CMs cultured without neurons (ΔR/R0 = 0.61 % ± 0.17, n=15, not shown). All groups 
showed comparable cAMP responses to direct application of NE (NE 10 nM, ΔR/R0: 14.98 
% ± 1.54, n=16, coupled to sympathetic neurons; 16.45 % ± 2.59, n=6, uncoupled to 
sympathetic neurons; 15.59 % ± 1.79, n=12, CMs alone). Addition of the cell bathing 
solution, collected after neuronal depolarization, to Epac1-cAMPs expressing CMs was not 
able to induce any cAMP response, indicating that the [NE] in the bulk medium was too low 
to activate β-ARs (not shown). To investigate whether the cAMP cascade is confined only 
in the innervated CMs, we focused on small clusters of isolated CMs in the co-culture, that 
showed a SN process innervating only one CMs of the cluster. Then we stimulated the 
neuron with KCl and monitored cAMP variation both in the innervated CM and in the 
adjacent non-innervated ones (Fig.2f). Interestingly, only the innervated cell showed 
intracellular cAMP increase that did not propagate to a coupled CM (Fig. 2g). 
To probe the efficiency of the cellular neuro-cardiac system, we used shorter neuron 
stimulation protocols to gradually decrease neuronal activation. To achieve this, a 
micropipette containing a 50mM KCl solution was placed in proximity to the soma of the 
SN. By modulating the injection time and pressure, the system was calibrated to obtain a 
controlled number of action potentials in the neuron (Fig.3a-b). Stimulation of a single AP 
evoked a reproducible cAMP increase in the target cardiomyocyte, with a ΔR/R0 of 1.56 % 
± 0.20 (mean ± SEM, n=6), a rapid onset (2.08 s ± 0.74) (Fig.3c-d), and fast kinetics (time 
to half maximal amplitude: 3.43 s ± 0.59 (n=6)).  
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Collectively, these results indicate that SNs establish functional contacts with CMs 
and suggest that communication between the two cell types is exerted at the contact site. 
 
2. Generation of the transgenic mouse expressing ChannelRhodopsin-2 in sympathetic 
neurons: in vivo and in vitro characterization  
 
To investigate the functional implications of the direct contact between SNs and CMs 
in vivo we exploited the specificity and selectivity of cardiac optogenetics, through the 
generation of a transgenic mice expressing ChR2 in SNs. To achieve the expression of ChR2 
selectively in adrenergic neurons of the heart we crossed transgenic mice expressing Cre 
recombinase under the control of the promoter of TOH (B6.129X1-Thtm1(cre)Te/Kieg) with 
transgenic mice harboring in their genome the ChR2 variant H134R flanked by LoxP sites 
(B6.Cg-Gt(ROSA)26Sortm27.1(CAG-COP4*H134R/tdTomato)Hze/J). The resulting 
offspring expressed ChR2 only in SN expressing TOH. We characterized the animals for 
basal heart activity parameters (ECG) and histology and they showed a phenotype 
undistinguishable from control littermates (TOH-Cre+/-). Moreover, also the morphology 
and pattern of SN expressing ChR2 is undistinguishable from control littermates (Fig. 4)  
Before moving to in vivo photostimulation experiment, we characterized SNs from 
transgenic mice by culturing them in vitro. SNs were isolated from the superior cervical 
ganglia of TOH-ChR2 mice, and maintained in culture for several days, their morphology 
was undistinguishable from that of cultured SNs, isolated from WT mice. SNs isolated from 
transgenic mice expressed ChR2 at a high level and with a correct membrane localization, 
as shown by of tdTomato fluorescence (Fig.5a-b). Whole cell voltage clamp demonstrated 
activation of the typical ChR2 photocurrent upon illumination of the cells with 470nm light 
focused on the cells through the microscope objective (Fig.5c). The effect of optical 
stimulation on the neuronal membrane potential was assessed using the current clamp 
configuration. The activation of ChR2 inward current by a brief (10 ms) light flash, caused 
SN membrane depolarization, sufficient to trigger a neuronal action potential, with identical 
kinetics of a spontaneous occurring one (Fig.5d). These results indicate that ChR2 is 
successfully expressed in peripheral sympathetic neurons in the TOH-ChR2 mouse, enabling 
the control of neruonal activation using non-invasive optical stimulation with 470nm light. 
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2. Photostimulation of sympathetic neurons innervating sinoatrial node in vivo 
 
The experimental setup used for optogenetic stimulation of SN innervating the heart, 
is similar to the one described in our previous study120 (see Results), where we used 
optogenetics to interrogate working and conducting CMs. Briefly, we anesthetized the 
mouse, attached it to an artificial ventilator and opened a surgical window between the 1st 
and 2nd ribs with thoracotomy, through which the optical fiber was inserted into the thorax. 
The illumination site was identified with the help of the surgical stereo-microscope. 
Continuous ECG recording was maintained during the stimulation, for real time 
measurement of HR. The optical fiber was coupled to an LED emitting 470 nm light. Brief 
flashes of light (10 ms) were used to photostimulate the neurons, in the forms of a single 
pulse, multiple pulses or trains of pulses characterized by a different inter-pulse distance, 
that we defined as frequency of stimulation.  
We decided to stimulate SN processes directly at the level of sinoatrial node (SAN), 
not at their cell bodies in the ganglia, in order to dissect only the effect of SN activation on 
heart rate, among the various effects of SNs on heart activity. SAN is the pacemaker of the 
heart and it is highly innervated by SNs (Fig.6a), whose activation determines an increase 
in SAN automaticity, which outcome is an increase in HR. To test the feasibility of our 
approach, we performed a first proof-of-principle photostimulation of SNs using a train of 
light pulses with 20 Hz frequency, based on our previous in vitro data.   This attempt resulted 
in an increase in HR, which lasted the duration of the stimulation and then rapidly went back 
to the HR showed before stimulation (fig.6b top panel). To asses if this response was due 
to the induction of an aspecific arrhythmic event, we analyzed the ECG parameters during 
photostimulation (QRS duration, p wave-QRS correlation) and we demonstrated that these 
are compatible with a standard increase in the frequency of sinus rhythm (chronotropy). 
Having demonstrated the feasibility of our approach, we decided to screen different types of 
photostimulations to characterize SN modulation of HR. First we used trains of light pulses 
with fixed-number of pulses and gradually decreased the frequency of stimulation, from 20 
Hz to 5 Hz. What we observed is that we were always able to elicit an increase in HR with 
all the different stimulation, and that the kinetics was only slightly different (Fig.6b). Then 
we wanted to find out which was the minimal number of stimulations needed to elicit a 
change in the HR, and to do that we fixed the frequency of stimulation and we gradually 
reduced the number of pulses. The result obtained was that just 2 light pulses are sufficient 
to generate a single shorter sinus beat (Fig.7a). This result showed that only 2 depolarizing 
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stimuli in the SNs are sufficient to trigger an increase in the automaticity of target SAN cells, 
consistently with our findings in the in vitro model. This result demonstrates the high 
efficiency and precision of SN modulation of heart frequency, having the possibility to 
interfere with HR at the level of the single beat. 
Based on these evidence, and on IF analysis on SAN innervation, that showed how 
SNs are closely associated to pacemaker cells (Fig.6a), what we would expect from in vivo 
photostimulation experiments, is that the delay between the light pulse and the onset of the 
first shorter sinus beat (measured at the start of the p wave) was short (Fig.7a). Indeed, we 
measure a mean value of 44±3 ms, which is fully compatible with the hypothesis that the 
sympathetic-releasing terminals are in direct contact with the ‘postsynaptic’ cardiomyocyte 
membrane, much faster than the activation time that would require the simple release and 
diffusion of the neurotransmitter, that would be almost an order of magnitude higher214. 
Moreover, we found that trains of photostimulations made of 20-40 pulses, can be repeated 
up to 10 times during a time window of 2 minutes, without apparent changes in the kinetics 
of the hear rate increase (Fig.7b). This result is a clear sign of the highly repeatable nature 
of this mechanism, which could be possible only if the release of the NE is limited to a 
restricted space between SN releasing site and CM membrane and the mechanisms for 
avoiding its spillover into the myocardial interstitium are tightly regulated, as in the case of 
a specialized junctional site.  
 
 
DISCUSSION 
 
The adrenergic neurons innervating the heart are responsible for the continuous 
adjustment of cardiac performance, through activation of β-ARs, occurring in both the daily 
activities and in acute stress as part of the fight-or-flight response. Whether the neuronal 
control of heart activity occurs through a direct coupling between the NE-releasing 
varicosities along the neuronal axon and the target CMs remains a debated topic in the 
literature (REF). Indeed, although it has been shown in SNs-CMs co-cultures that the 
distance between synaptic terminal and CM membrane is in the order of 80 nm127 and that 
the junctional site between the two cells is characterized by specialization of both the pre- 
and post-synaptic membranes131, the functional role of the apposition of the two membranes 
in the signal transmission from the SN to the CM remains largely unexplored. 
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In this study we examined SN-CM interaction signaling, performing real-time live 
imaging with FRET-based biosensors, to explore the effects of this interaction at the 
subcellular level. We demonstrated that minimal activation of sympathetic neurons (i.e. one 
action potential) triggers cAMP pathway exclusively in the target CMs, leading to cAMP 
elevation and PKA phosphorylation. We did not observe significant increase of cAMP in 
non-innervated CMs, suggesting that β-ARs activation in coupled cardiac cells is due to NE 
released by the innervating neuron and not to NE released in the bathing solution by all 
depolarized-neurons in culture. This hypothesis was confirmed by stimulating CMs with 
neuronal-conditioned medium, where any intracellular cAMP increase was detected (data 
not shown), suggesting that the concentration of NE released by stimulated neuron in the 
culture medium is too low to lead an β-AR activation sufficient to elicit a cAMP rise, 
essential in the modulation of cardiac contraction. Our model shows that the neuro-cardiac 
interaction forms a structure that allow to control cardiomyocyte intracellular signaling with 
high efficiency, where only one releasing event (i.e. one action potential, Fig.3c) is sufficient 
to evoke a repeatable cAMP increase in the coupled cardiomyocyte (Fig.3d). Such event 
remained confined only in the innervated cell (Fig.2g), supporting the hypothesis that 
neuron/cardiomyocyte interaction is specialized contact, and the regulation of heart activity 
by sympathetic nervous system occurs through a specific cell-to-cell signalling.  
Then to test the functional outcome of a direct interaction between SNs and CMs in 
vivo, we exploited a novel optogenetic approach. The results of the optogenetic stimulation 
of SNs innervating SAN showed a rapid increase in HR upon stimulation and a rapid 
decrease after the end of stimulation, a short delay between the stimulation and the response 
and that multiple subsequenet stimulation are possible resulting always in HR increase with 
the same kinetics. These results are consistently with our in vitro data and demonstrate, in 
the intact heart, the existence of a quasi-synaptic interaction between SNs and CMs, that 
allows a fast, repeatable and efficient control of heart rate at the level of SAN. 
In this study, we provided the first example, to the best of our knowledge, of in vivo 
optogenetic stimulation of SN processes innervating the heart. The only other example of 
optogenetic stimulation of cardiac SNs present in literature, is a work recently published by 
the group of Kay216 in which they used the ex vivo model of Langendorff isolated and 
perfused heart. They observed that isolated heart responded to optogenetic stimulation of 
SN processes with an increase in HR and contraction force, however this system is highly 
questionable since in isolated hearts, the SN processes are deprived from their cell bodies 
that are located in sympathetic ganglia. 
 
 
 111 
 
Figure 1. Sympathetic neurons establish close interactions with target cardiomyocytes both in vivo and 
in vitro.  
(a)  Confocal immunofluorescence analysis on ventricular cryosections from adult mouse heart stained with 
an antibody to tyrosine hydroxylase (TOH, green signal). The image shows a detail from the left ventricular 
wall. (b-c) Confocal immunofluorescence analysis on ventricular cryosections from adult mouse heart co-
stained with an antibody to dystrophin (red signal) and either TOH (b) or synapsin1a (c, SYN1a) (all green 
signals). Arrows evidence the close contact between cardiac SN varicosities and CM membrane. (d-e) Electron 
microscopy analysis on semi-thin ventricular sections from adult normal mouse heart. The images highlight 
the strict interaction between SN varicosities (green line) and target CMs. The red line indentifies the CM 
membrane. (f-g) Confocal immunofluorescence analysis on seven-day SN-CM co-cultures. CMs were stained 
with an antibody to cardiac troponin-I (cTnI, red signal), while SNs were identified by antibodies specific for: 
dopamine-β-hydroxylase (f, DβOH) and SYN1a (g) (all green signals). Nuclei in (f) were counterstained with 
DAPI (blue signal). The high magnification in (f) shows the SN-CM strict contact. White arrows in (g) evidence 
SN varicosities interacting with a target CM. (h) Electron microscopy analysis on semi-thin sections from SN-
CM co-cultures, showing that SNs establish a close contact with CMs, similar to that observed in heart sections. 
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Figure 2. Norepinephrine released upon sympathetic neuron depolarization initiates cAMP signaling 
selectively in target cardiomyocytes. 
(a) Bright field and fluorescence image analysis of a SN-CM co-culture in which CMs were transfected with 
the FRET-based cAMP sensor Epac1-camps (light blue signal). The higher magnifications show, respectively, 
a CM contacted by SN process varicosities (1, arrows), and a non-innervated CM (2). The white lines in (1 and 
2) show the SN processes. Note in (2) that the CM is passed by a SN which does not establish a structural 
contact with the CM. (b) EPAC1-camps expressed in neonatal CMs allowed to monitor intracellular cAMP 
variation. Upon NE administration, binding of intracellular cAMP induces a decrease in FRET efficiency 
expressed as ratio between the 480 nm/535 nm emission signals (R) over the value at t =0 s (R0). (c-d) 
Evaluation of cAMP increase in the Epac1-camps expressing CMs, upon SN depolarization induced by 50 
mmol/L KCl. The trace in (c) refers to the CM contacted by a SN shown in panel A1, while the trace in (d) 
shows the response of the not-contacted cell in A2. SN depolarization induced an increase in cAMP 
concentration only in the innervated CM (c). NE (10 nM) addition to the cell bath was performed at the end of 
the experiment, as positive control, and evoked the same response in both the CMs analyzed. (e) Quantification 
of cAMP increase observed in coupled and non-innervated CMs in co-culture with SNs upon neuronal 
depolarization. (f) Bright-field (left) and fluorescence (right) images of two adjacent EPAC1-camps expressing 
CMs. The green line indicates a SN contacting only one of these two cells. The innervated CM is surrounded 
by a red line, while the not innervated one is identified by a black line. (g) Selective stimulation of the SN 
innervating the CM in (f, red line) was obtained by a puff of KCl (black arrows). Variations in cAMP 
concentration were evaluated in both coupled and uncoupled cells. Interestingly, increase in cAMP 
concentration occurred only in the innervated CM. NE was administered at the end of the experiment as 
positive control. Bars indicate s.e.m. (***p<0.001; n=20 CMs for each group). 
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Figure 3. A single action potential in sympathetic neurons is sufficient to trigger cAMP signaling in 
coupled cardiomyocytes.  
(a-b) Depolarization of SNs, innervating CMs, were induced by 50 mmol/L KCl for 30s and changes in 
membrane potential were evaluated by patch clamp (a). The corresponding effects in coupled CMs were 
estimated as cAMP increase (b). The traces in (a) and (b) are representative of the responses obtained. (c-d) A 
single action potential was generated in SNs by brief pulses of KCl applied to the SN soma via the tip of a 
picospritzer pipette (5-10 psi for up to 10 s) (c). cAMP variations, upon the brief SN activation, were evaluated 
in the innervated CMs. Arrows in (d) indicate the time in which a single action potential was induced in a SN. 
The representative trace in (d) demonstrates that a single action potential is sufficient to trigger a cAMP 
response in the innervated CM.  
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Figure 4. TOH-ChR2 hearts have a normal morphology and function as well as a normal innervation 
pattern. 
(a) ECG traces from controls and TOH-ChR2 mouse heart, showing no alterations in the transgenic model. (b) 
QRS values of controls and TOH-ChR2 hearts are undistinguishable, demonostrating no defects in the 
ventricular conduction in the transgenic model. (c) Haematoxylin and Eosin staining shows no difference in 
the histology between controls and TOH-ChR2 hearts. (d) IF staining with an antibody to TOH showing that 
TOH-ChR2 hearts present a normal innervation pattern of sympathetic neurons, whose morphology is identical 
to the one of the controls. 
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Figure 5. Channelrhodopsin-2 allows modulation of sympathetic neuron activity in vitro.  
 (a) Confocal immunofluorescence analysis on cultured SNs, isolated from the superior cervical ganglia of 
TOH/ChR2 neonatal mice, showing ChR2 localization at the level of the SN membrane and neuritic processes. 
(b) Confocal immunofluorescence analysis on cultured SNs stained with an antibody to TOH (left panel, green 
signal). The middle panel shows ChR2 expression (red signal) while the right panel is the merge of the two 
signals. ChR2 expressing ganglionic cells differentiate into SNs in culture. (c) Patch clamp was performed in 
cultured TOH/ChR2 SNs to measure changes in the membrane potential upon 470nm blue light 
photostimulation. The light pulse (blue bar) causes an inward current which started with the cell illumination 
and stopped immediately after cell photostimulation cessation. (d) Comparison of spontaneous (left panel) and 
light-induced (10ms, 470nm light pulse) (right panel) action potentials (AP) in cultured SNs isolated from 
TOH/ChR2 mice. The images show no differences in the kinetics of both APs.  
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Figure 6. SNs are tightly coupled to SAN cells and respond to photostimulation with an increase in HR. 
(a) Confocal immunofluorescence analysis on a cryosection of the sino-atrial node (SAN), from an adult 
control mouse, stained with antibodies to HCN4 (green signal), to identify the SAN cells, and TOH (red signal). 
The high magnification (right panel) evidences the strict contact between SN and the targeted HCN4 positive 
cells. (b) Representative ECG traces of TOH-ChR2 heart photostimulation with trains of different frequency. 
The black trace represents the ECG, the blue trace the heart rate and the green dashes the light pulses.  
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Figure 7. SN mediated increase in heart rate is highly efficient and repeatable.  
(a) Representative ECG traces of TOH-ChR2 heart photostimulation showing the minimum number of light 
pulses needed to evoke a shorter sinus beat. (b) Representative ECG traces of TOH-ChR2 heart 
photostimulation showing multiple photostimulation of SNs in a short time window. The black trace represents 
the ECG, the blue trace the heart rate and the green dashes the light pulses.   
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MATERIALS AND METHODS 
 
Mouse models. Transgenic mice expressing cre-recombinase under the control of tyrosine 
hydroxylase (TOH) promoter B6.129X1-Thtm1(cre)Te/Kieg (Hemma Laboratories, 
KCTT/EMMA/Johannes Wilbertz Stockholm SWEDEN) were bred with B6.Cg-
Gt(ROSA)26Sortm27.1(CAG-COP4*H134R/tdTomato)Hze/J expressing  mice (Jackson 
Lab. Bar Harbor, Maine, USA). The resulting offspring has the STOP cassette deleted in 
dopaminergic and adrenergic neurons, thus expressing the hChR2(H134R)-tdTomato fusion 
protein. TOH-CRE+/- lines were used to maintain the colonies. All experimental procedures 
described in this manuscript have been approved by the local ethical committee 
(Authorization number C54) and communicated to the relevant Italian authority (Ministero 
della Salute, Ufficio VI), in compliance of Italian Animal Welfare Law (Law n 116/1992 
and subsequent modifications).  
 
Neonatal cardiomyocyte isolation and culture. Primary cultures of cardiac myocytes 
(NRVMs) were prepared from P1-P3 Sprague Dawley rats, as previously described217. 
Briefly, hearts were removed, minced in ADS (5 mM glucose, 106 mM NaCl, 5.3 mM KCl, 
20 mM Hepes, 0.8 mM Na2HPO4, and 0.4 mM MgSO4, pH7.4) and enzimatically 
dissociated with collagenase A (0.4 mg/ml, Roche) and pancreatine (1.2 mg/ml, Sigma). 
Cells were plated onto laminin-coated (10 µg/cm2, BD Biosciences) round glass coverslips, 
at a density of 60000 cells/cm2, in culture medium containing: 75% D-MEM-Hepes, 17% 
M199, 5% horse serum, 0.5% newborn calf serum, 200 mM glutamine, 50 µg/ml penicillin-
streptomycin, (all from Invitrogen) and maintained in a humidified atmosphere (5% CO2) at 
37°C. Twenty-four hours after seeding, VRVMs were transfected with the appropriate FRET 
based sensor, GcAMPs (for cAMP accumulation measurements, courtesy of Dr. Martin 
Lohse) or the fluorescent PKA activity reporter AKAR3 (for PKA activity, kind gift of Dr. 
Jin Zhang) using transfectin (Bio Rad) as recommended by the manufacturer. 
 
Sympathetic neuron isolation and co-culture with CMs. Sympathetic neurons (SNs) were 
isolated from either P1-P3 Sprague Dawley rats or P1-P3 TOH/ChR2 mice, by adapting the 
procedure of Zareen and Greene218. Superior cervical ganglia were minced in complete 
medium (RPMI supplemented with 10% horse serum, both from Invitrogen) and then 
enzimatically dissociated in 0.25% Trypsin with no EDTA (Invitrogen) for 30 min at 37°C. 
Cells were plated onto laminin-coated round glass coverslips. ChR2 expressing SNs were 
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cultured alone, while rat SNs were seeded at a density of 1500 cells/cm2 with NRVMs. Cells 
were maintained in cardiomyocyte medium supplemented with 100 ng/ml NGF (Sigma). 
Half of the medium was replaced every two days. 
 
Stimulation of sympathetic neurons and FRET imaging of co-cultured CMs. FRET 
imaging experiments were performed 7-10 days after the establishment of the co-culture. 
Cells were maintained in Hepes-buffered Ringer-modified saline (in mmol/L, 125 NaCl, 5 
KCl, 1 Na3PO4, 1 MgSO4, 5.5 glucose, 1.8 CaCl2, 20 Hepes, pH 7.4) at room temperature 
and imaged on an inverted Olympus IX50 microscope coupled to a CCD camera (Sensicam 
QE, PCO) and a beam-splitter optical device (Microimager). Images were acquired using 
custom-made software and processed using ImageJ (National Institutes of Health). 
Variations in FRET efficiencies were measured by drawing a region of interest (ROI) in the 
cell cytosol and by monitoring changes in the 480 nm/545 nm fluorescence emission signals 
(R) on excitation at 430 nm after background subtraction. FRET values were expressed as 
ΔR/R0, where R0 is the ratio at t = 0 s and ΔR = R - R0. The beginning of FRET variations, 
indicative of intracellular cAMP concentration, was defined as the time of the first frame 
after which two consecutive values fell outside the standard deviation of values in basal 
condition. Membrane depolarization of sympathetic neurons was obtained by applying high 
potassium solution (in mmol/L, 80 NaCl, 50 KCl, 1 Na3PO4, 1 MgSO4, 5.5 glucose, 1.8 
CaCl2, 20 Hepes, pH 7.4) either via a perfusion system or via pulses delivered by means of 
a software-controlled pressurized micropipette in proximity of the analyzed cell. 
 
Electrophysiology Whole cell current-clamp experiments were performed at room 
temperature (~23°C) on single cells visualized with an inverted microscope (Olympus IX50, 
Tokyo, Japan). Data were recorded using a EPC-7 amplifier (HEKA electronic, Lambrecht, 
Germany) and Axon Instruments pClamp10 software. Data were sampled at 10 kHz. Patch 
pipettes were prepared by pulling borosilicate glass capillaries (1.5 mm outer diameter and 
1.16 mm inner diameter, Harvard Apparatus LTD, Massachusetts, United States) using a 
micropipette puller (Narishige, Japan). Pipette resistance was 2-4 MΩ when filled with 
intracellular solution. Extracellular solutions contained (in mmol/L): 125 NaCl, 5 KCl, 1 
Na3PO4, 1 MgSO4, 20 Hepes, 5.5 Glucose, 1.8 CaCl2, pH 7.4 with NaOH. Intracellular 
solution was (in mmol/L): 100 K-gluconate, 20 KCl, 10 Hepes, 10 phosphocreatine, 4 Mg-
ATP, 0.3 GTP, pH 7.3 with KOH. All membrane potential values were corrected for liquid 
junction potential, calculated as -14.5 mV. 
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In vivo SN photostimulation in TOH/ChR2 mice. Adult wild-type and TOH/ChR2 male 
mice were anesthetized by avertin administration (Tribromoethanol 2,5%, Sigma), secured 
to the table in supine position and intubated with a 24G needle for ventilation (tidal volume 
0.4ml; 120 strokes/min) from an artificial ventilator (SAR-830). Body temperature was 
monitored constantly during the experiment. The skin was dissected by a lateral sub-
ascellary 1.5 cm cut, subcutaneous muscles were removed and a 0.5 cm incision was 
performed at the level of the 1th to 2nd intercostal space. Self-retaining microretractors were 
then used to separate the 1rd and 2th ribs enough to get adequate exposure of the operating 
region. The sinoatrial node have been exposed, and stimulated by differently-sized (from 
800 to 1500 diameter, in µm) fiber optics (Thorlabs, Germany), coupled to a 470 nm LED 
(Thorlabs, Germany), controlled by an ECG-coupled recording system (Powerlab 8/30, 
Bioamp and LabChart 7.1 software; AD Instruments).  
 
ECG recording and analysis. A standard lead I ECG recording was performed (Powerlab 
8/30, Bioamp; AD Instruments) during the experiment. ECG parameters (QRS, PR interval 
and heart rate) were calculated using LabChart 7.1 software (AD Instruments).  
 
Statistics. Data are shown as mean ± s.e.m., unless differently indicated. For the analysis of 
significance, unpaired Student’s t-test was used, with p-values < 0.05 (*), < 0.005 (**) and 
< 0.001 (***) considered statistically significant. 
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Cardiac optogenetics as an alternative to electrical pacemaking 
and cardioversion: insights from an in vivo animal model  
(manuscript in preparation) 
 
Collaborators: Giulia Borile, Tania Zaglia and Marco Mongillo. 
 
 
INTRODUCTION 
 
The use of electronic devices for the treatment of heart rhythm disturbances is a well 
established therapeutic intervention, in heart diseases with either dysfunctional cardiac 
activation (bradyarrhythmia), or increased risk of sudden cardiac death due to arrhythmias 
(ventricular tachyarrhythmia)219-221. 
In particular, in the former case, the most popular device is the electronic pacemaker, 
which is constituted by a generator of the electrical impulse with a battery and usually two 
electric lead that are inserted into the atrial and ventricular cavity. Low energy electrical 
currents are delivered to the heart to substitute the physiologic nodal pacemaker and achieve 
continuous and sequential depolarization and regulate the timing of cardiac activation222. For 
the treatment of ventricular tachyarrhythmias, including fibrillation, the device used is the 
implantable cardioverter defibrillator (ICD), which has a similar structure, but a more 
complex functioning, that is based on: i) monitoring and real-time of analysis of ECG to 
detect abnormal heart rhythms and ii) delivery of electrical stimulation, using either a single 
high-energy impulse to terminate a ventricular fibrillation (VF), or a train of low energy 
stimuli synchronized to the QRS, called overdrive pacing or anti-tachycardia pacing, to 
terminate ventricular tachycardia221. 
Although these approaches are the only therapeutic option in a subset of drug 
resistant arrhythmias, in severe conditions of heart rhythm impairment or in cardiac 
pathologies where no other approaches are available, they present some disadvantages: I) 
invasive procedure of intra-cavity catheter implantation, II) interference of the catheter leads 
with cardiac valve leaflets, thus leading to increased risk of endocarditis223, III) interference 
with other electronic devices and IV) possible tissue damage due to frequent electrical 
currents imposed to the same site and due to the constant physical contacts with the lead224. 
Evidence of a detrimental effect of ICD implantation in the follow-up of patients that 
received multiple electrical shocks have been clearly showed in two important clinical trial: 
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Multicenter Automatic Defibrillator Implantation Trial (MADIT II)225 and Sudden Cardiac 
Death in Heart Failure (SCD-HeFT)226, in which it was reported that patients who undergone 
ICD implantion and received electrical shocks had a greater mortality index in the long term 
follow up period225-230. 
For these reasons, the use of cardiac optogenetic was suggested in many studies as 
an attractive alternative to standard electrical techniques231.  
The distinctive features of the optogenetic approach, which are instrumental for the use in 
cardiac therapies are certainly cell type selectivity and the ability to precisely control the 
activated tissue volume. These properties derive from the biophysics at the basis of 
optogenetic control of membrane potential in cells. Indeed, optogenetic tissue depolarization 
does not depend on the presence of factors causing discontinuities in tissue conductivity, 
such as blood vessels, changes in fiber orientation, fatty tissue and intercellular clefts, all of 
which can influence the propagation of electric fields in the tissue.  As a result of such factors, 
in conventional electrical stimulation, the site of direct contact of the electrode with the tissue 
is the point source of depolarization that may cause irregular conductance and heterogeneous 
dispersion of the cardiac activation wave current. Optogenetics, by contrast, has the potential 
to overcome the drawbacks of conventional electrical stimulation, given its capacity to 
obtain the depolarization of myocardial tissue without physical contact, with cell-type 
specificity and a high spatial-temporal resolution. 
Moreover, with the development of miniaturized devices for light stimulation232 and 
detection233 and the development of cardiomyocyte (CMs)-specific genetic targeting of 
voltage-sensitive dyes234, the perspective of an all-optical (sensor and actuator) optogenetic 
system for the treatment of heart rate disturbances seems plausible235.  
Although these characteristics seem promising, only few studies investigate the translational 
potential of cardiac optogenetics and are based on in vitro or computational models111. In a 
previous study, we demonstrated the potential of cardiac optogenetics as a tool to investigate 
the electrophysiological properties of different cell-type of the heart, and their involvement 
in arrhythmogenesis, in the intact heart120 (see Results).  
In this study, we used mouse models to provide a proof-of-principle of the clinical 
applicability of cardiac optogenetics. 
 
 
 
 
 
 
 123 
PRELIMINARY RESULTS 
 
 
1. Cardioversion with light: optogenetic termination of ventricular tachycardia  
 
To assess the feasibility of cardiac optogenetics in obtaining the termination of VT, 
we set up an anesthetized open-chest mouse model, expressing light-gated cation channel 
ChannelRhodospin-2 (ChR2) specifically in CMs, under the control of α-MyHC promoter. 
We delivered light stimulation pulses using an optical fiber coupled to an LED emitting 470 
nm light (the model is characterized in detail in Zaglia and Pianca et al120, see Results). To 
deliver the light pulses at precise moments in the cardiac cycle, we used a digitizer device 
that allowed us to record ECG and to automatically control the delivery of light pulses based 
on the ECG trace. In order to obtain a clinically relevant condition associated to the 
development of ventricular arrhythmias, we induced left ventricle (LV) myocardial ischemia 
through ligation of left anterior descending coronary artery (LAD), a well defined condition 
creating a tissue substrate prone to the development of arrhythmic events158. Ventricular 
arrhythmias were triggered by photostimulation of a specific heart region in correspondence 
of the origin of right ventricular outflow tract, that we previously demonstrated to be highly 
arrhythmogenic120 (see Results). VT was reproducibly induced by bursts of light flashes at 
high frequency.  
In the attempt to terminate the VT, we mimicked the overdrive pacing approach used 
by conventional ICD. To this aim, we synchronized light pulses with the QRS of VT, to 
achieve a paced heart rate faster than the one imposed by VT (overdrive pacing). When 
optical stimulation was 'captured', i.e. when optical pacing was successful, we were able to 
stop the VT, that occurred (Fig. 1) in 4 out of 6 mice. 
 
2. Optogenetic pacing 
 
With the same set up described above, we tested the possibility of using the 
optogenetic approach to perform prolonged cardiac pacing, from atria and ventricles. As 
stated above, the main disadvantages of electrically-stimulated pacing, caused by the 
physical contact of cathethers with the tissue and the damage produced by electrical currents, 
are intrinsically avoided using contactless photostimulation. We demonstrated that 
epicardial photostimulation is able to produce a stable ventricular paced rhythm, carried on 
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for up to 30 minutes, without any structural or functional alteration (Fig.2a). 
Atrioventricular (AV) block is a condition in which the depolarization wave is not 
correctly spread from the atria to the ventricles, because of an impairment in the AV node. 
Transient AV block is a commonly observed consequence of myocardial ischemia, and 
consistently, we recorded the ECG characteristics of AV block in experiementally induced 
ischemia following LAD ligation. We thus used light assisted stimulation to assess whether 
optical pacing was able to restore sinusal rhythm during complete AV block. Short term 
ventricular pacing was successful in overcoming the electrophysiologic abnormalities as 
shown in Fig.2b.  
 
3. Simulation of reversible bundle branch block 
 
In addition to provide a proof of principle of optogenetic-based cardioversion and 
pacing, we here wanted to assess whether the flexibility and ease of optical stimulation could 
be used to experimentally mimic, in the animal model, clinically relevant situations like the 
bundle branch block (BBB), a clinical condition caused by abnormal function of a part of 
the cardiac conduction system (i.e. the bundle branch). Given the cell-type specific nature 
of this pathologic condition, such investigation would not be feasible with conventional 
electrophysiologic techniques. For this experiments, we used a mouse model in which ChR2 
is expressed specifically in the ventricular conduction system, under the control of 
Connexin-40 promoter. With the same experimental set up described above, we illuminated 
the epicardial surface of the anterior region of interventricular septum at the intersection with 
LV wall, in anesthetized mouse, with an optical fiber of 1500 µm diameter, by delivering a 
continuous light stimulation of 2 s duration. Such stimulation protocol resulted in the 
refractoriness to depolarization of the cells in the illuminated area, corresponding to the left 
bundle branch (LBB) and caused their reversible inability to conduct the endogenous 
depolarization wave coming from SA node/AV bundle, thus mimicking in mice the effects 
of left bundle branch block (LBBB) (Fig.3). This condition is reversible, in fact, if light 
stimulus is turned off BB recover its function.  In human pathology, BBB occurs as a result 
of structural or functional damage to the conduction system cells236. The possibility to mimic 
BBB in an animal model is fundamental to understand its effects on cardiac dynamics, and 
it is achievable only thank to the specificity of the optogenetic approach. 
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DISCUSSION 
 
 
Optogenetics offers the possibility of non invasive, cell type specific and contactless 
stimulation of heart depolarization. These features make this technique a promising 
alternative to conventional electrical depolarization methods, used to control heart rate. Our 
recent work120 (see Results) showed the feasibility of the simultaneous optical detection, 
using Ca2+ sensitive dye, and stimulation using optogenetics in ex vivo preparations, and this 
approach was also tried by the group of Nussinovitch at the same time237. Moreover, in recent 
reports described the development of genetically-encoded voltage sensitive sensors234, that 
offer the possibility, combined with gene or cell therapy, to perform the study of single cell 
electrophysiology in the intact heart, in vivo. In addition, recent advances in LED 
miniaturization, led to the development of flexible meshes of micron-scale LED, that could 
be used to achieve complex geometrical stimulations on the heart surface232. These 
methodologies could be exploited to directly investigate common arrhythmia mechanisms, 
including, e.g. cardiac 'rotors', atrial and ventricular flutter, or polymorphic ventricular 
arrhythmias, all of which are characterized by complex spatial and temporal depolarization 
pattern. The combination of the aforementioned tools with miniaturized sensing optical 
elements238, would predictably pave the way to the all-optical sensor-stimulator control of 
heart rate, with important implications in the study of arrhythmogenic mechanisms. 
Moreover, thank to the cell-type selectivity of optogenetics, stimulation of selected parts of 
the central conduction system can be achieved, prospecting the possibility of even more 
precise and specific ways to control heart electrical activity. 
To achieve the goal of optogenetic control of heart rate in vivo, however, some problems 
need to be solved: like methods for a stable implantation of illumination and sensing 
elements, that were solved in the neuroscience field using stable implantation of optrodes on 
the skull bone, but for the use in cardiology will require to deal with the continuous 
movement during the heart cycle.  
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Figure 1. Representative ECG trace showing the photostimulation of a sustained VT and the subsequent light-
induced overdrive cardioversion. Green lines show the light flashes, each one 5 ms long.  
                                                                                                                   
 
 
Figure 2. (a) ECG representative trace showing that optogenetic pacing for up to 30 minutes causes no damage. 
(b) ECG trace showing the recovery from AV block with photostimulation. 
 
 
 
Figure 3. ECG representative trace of the continuous photostimulation of LBB of a Connexin-40-ChR2 heart, 
showing that this led to the inability of LBB to conduce electrical stimuli and thus resulting in LBBB. 
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MATERIALS AND METHODS 
 
 
Mouse models. Transgenic adult  male mice, with a genetic background C57B6J, expressing 
cre-recombinase under the control of either α-MyHC or Connexin-40 (Cx40) promoter were 
bred with B6.Cg-Gt(ROSA)26Sortm27.1(CAG-COP4*H134R/tdTomato)Hze/J expressing  mice (Jackson 
Lab. Bar Harbor, Maine, USA). The resulting offspring has the STOP cassette deleted in the 
heart, resulting in cardiomyocyte (α-MyHC-ChR2) or Purkinje fibers (Cx40-ChR2) 
expression of the hChR2(H134R)-tdTomato fusion protein. Both α-MyHC-cre+/- and Cx40-
cre+/- lines were used to maintain the colonies. All experimental procedures described in this 
manuscript have been approved by the local ethical committee (Authorization number C54) 
and communicated to the relevant Italian authority (Ministero della Salute, Ufficio VI), in 
compliance of Italian Animal Welfare Law (Laws n 116/1992, D.Lgs 26/2014 and subsequent 
modifications). 
 
In vivo epicardial photostimulation. Adult ChR2 expressing transgenic male mice and 
littermate controls were anesthetized by isoflurane administration (1,5%-3%), secured to the 
table in supine position and intubated with a 24G needle for ventilation (tidal volume 0.4 
ml; 120 strokes/min) from an artificial ventilator (SAR-830). Body temperature was 
monitored constantly during the experiment. The skin was dissected by a lateral sub-
ascellary 1.5 cm cut, subcutaneous muscles were removed and a 0.5 cm incision was 
performed at the level of the 4th intercostal space. Self-retaining microretractors were then 
used to separate the 3rd and 4th ribs enough to get adequate exposure of the operating region. 
The heart was exposed and different epicardial regions from the atria and the left and right 
ventricles were stimulated with 1500 µm diameter fiber optic (Thorlabs, Germany), coupled 
to a 470 nm LED or directly with the bare LED (Thorlabs, Germany), controlled by an ECG-
coupled recording system (Powerlab 8/30, Bioamp and LabChart 7.1 software; AD 
Instruments).  
 
ECG recording and analysis. A standard lead I ECG was recorded (Powerlab 8/30, 
Bioamp; AD Instruments) during the experiment. ECG parameters (QRS, PR interval and 
heart rate) were calculated by using LabChart 7.1 software (AD Instruments).  
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Burst photoactivation protocol. Brief trains of 5 ms light pulses were delivered to a fixed 
epicardial region with repetition rates ranging from 10 Hz to 25 Hz (cycle length: 100 ms to 
40 ms).  
 
Left anterior descending (LAD) coronary artery ligation. The main trunk of the LAD 
coronary artery was ligated under microscope guidance, by using a 7/0 polypropylene 
suture120 .Epicardial photostimulation was performed in the time window of 30-90 minutes 
after coronary occlusion, during constant ECG recording.  
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Conclusions  
 
During my PhD training I had the opportunity to learn important techniques at the 
cutting edge in molecular biology, cell biology and also to participate in the development of 
new a scientific tool: cardiac optogenetics.  
With the use of the techniques learned and the interaction with other collaborators 
and my supervisors, I had the possibility to carry on my scientific research project which 
brought to the discovery of a novel role for sympathetic innervation of the heart in the locally 
modulation of the proteostasis of CMs; to the aforementioned implementation of cardiac 
optogenetics on CMs and Purkinje fibers, that allowed to propose the first in vivo 
determination of the critical mass of working and conducting CMs needed to obtain an 
extrasystole and the characterizion of Purkinje fibers physiology in vivo with unprecedented 
detail and specificity. Moreover, the achievement of the first example of in vivo optogenetic 
stimulation of sympathetic efferents to the heart, allowed to add a further prove of that 
control of heart rate by sympathetic neurons is achieved through a quasi-synaptic interaction 
between sympathetic neurons and CMs. Finally, I provided a proof-of-principle study for 
the application of cardiac optogenetics in clinical relevant conditions, as an alternative to 
current therapies based on electrical stimulation of the heart. 
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Future perspectives 
 
 
This thesis opens the way to various future perspectives, in particular regarding the 
physiologic relevance of the SN-CM interaction. We are following this path by investigating 
the possible implications of SN modulation of CM size, through the combination of cardiac 
optogenetics and molecular biology. Indeed, we have collected preliminary data, obtained 
through the denervation of α-MyHC-ChR2 hearts, that showed how denervated hearts are 
prone to develop sustained arrhythmia after optogenetic focal stimulation (Fig.P1), 
moreover we observed that after denervation there is a change in the expression level of the 
voltage gated potassium channel Kv4.2 (Fig.P1). These findings suggest that SNs could be 
determinant in modulating the electrophysiological properties of CMs, through the 
regulation of the expression level of proteins involved in the AP, for this reason in the next 
future we will explore the putative molecular players involved in the SN-mediated control 
of CM electrophysiology.  
We will implement cardiac optogenetics in the conscious freely moving mice through 
the permanent implantation of a LED in the thorax of mice. This will allow to perform a 
chronic stimulation of SNs, offering the possibility to analyze, with unprecedented detail, 
the effects of chronic SN activation in the heart of living animal. This is of great relevance 
since many pathological situations are associated to a continuous iperactivation of SNS 
during time, such as heart failure, moreover this approach also will allow to study SN 
activation during functional studies (i.e. exercise).  Moreover, this approach will allow to 
investigate the genesis of arrhythmias in the conscious mice and the involvement of the SN 
in the triggering of arrhythmia. 
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Figure P1. (a) ECG representative trace showing an example of sustained ventricular tachycardia, induced 
with photostimulation in α-MyHC-ChR2 denervated heart. (b) mRNA levels of Kv4.2 in the heart of control 
and denervated mice. ***: p<0.001 
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